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-ABSTRACT- 
Cardiovascular disease is the leading cause of mortality in The United States and 
Europe, accounting for approximately half of all deaths.  The most common form of 
cardiovascular disease is atherosclerosis, which is characterized by the formation of fatty 
atheromatous plaques that can grow to occlude the vessel lumen, thus causing ischemia 
distal to the occlusion. This is commonly treated using balloon angioplasty, which is 
usually done in conjunction with the deployment of a stent.  Stent deployment helps hold 
the vessel open following the local injury caused by balloon inflation and prevents elastic 
recoil and subsequent negative remodeling.  Stenting has been shown to significantly 
reduce restenosis rates from approximately 20-50% without a stent to about 10-30% with 
stent deployment.   
However, restenosis still remains the main cause of long-term stent failure.  In 
basic terms, a balloon angioplasty procedure is a forceful displacement of an 
atherosclerotic lesion serving to widen the vessel lumen to increase blood flow.  This 
procedure causes stretching of the vessel wall, tears in the atherosclerotic plaques, and 
general damage to the vessel in turn signaling a complex cascade of thrombosis, 
inflammation, intimal thickening, and vascular remodeling.  Stent deployment also 
further complicates the immunological response by triggering a foreign body response 
from the implantation of a biomaterial into the body.  When performing an angioplasty 
procedure, particularly in conjunction with stent deployment, a certain degree of vascular 
injury is inevitable.  However, the initial injury can be further complicated by the body’s 
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local reaction to the implanted biomaterial, the severity of which can ultimately dictate 
the degree of restenosis and subsequently affect procedural success. 
The proliferative response of VSMCs to the various afore mentioned stimuli 
results in the formation of often copious amounts of neointimal tissue, generally known 
as intimal hyperplasia.  The formation of this new tissue, primarily consisting of VSMCs 
of the synthetic phenotype and their subsequent extracellular matrix, is the sole causation 
of in-stent restenosis since the stent serves to prevent elastic recoil and negative 
remodeling.  
This doctoral research program is focused on endovascular stent biomaterials 
science and engineering.  Overall, this doctoral project is founded on the hypothesis that 
smooth muscle cell hyperplasia, as an important causative factor for vascular restenosis 
following endovascular stent deployment, is triggered by the various effects of stent strut 
contact on the vessel wall including contact forces and material biocompatibility.  In this 
program, a dynamic in vitro model of a stented blood vessel aimed at evaluating the 
effect of stent strut material selection, and surface coating on smooth muscle cell 
response was developed. 
The in vitro stented artery model was validated through the proliferation of 
VSMC in contact with stent struts.  Additionally, it was demonstrated that, with respect 
to known biocompatible materials such as Nitinol and 316L stainless steel, DNA 
synthesis and α-actin expression, as indicators of VSMC phenotype, are independent of 
stent material composition.  Furthermore, hydroxyapatite was shown to be a 
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biocompatible stent surface coating with acceptable post-strain integrity.  This coating 
was shown in a feasibility study to be capable of serving as a favorable drug delivery 
platform able to reliably deliver locally therapeutic doses of bisphosphonates, such as 
alendronate, to control VSMC proliferation in an in vitro model of a stented blood vessel.  
This stent coating/drug combination may be effective for reducing restenosis as a result 
of VSMC hyperplasia in vivo. 
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-CHAPTER 1- 
Introduction and Background 
 
1.1 Introduction 
Cardiovascular disease is the leading cause of mortality in The United States and 
Europe, accounting for approximately half of all deaths.[1, 2]  The most common form of 
cardiovascular disease is atherosclerosis.  Atherosclerosis is an inflammatory disease 
affecting the large and medium sized arteries and can occur in any part of the body.  It is 
characterized by the formation of fatty atheromatous plaques that can grow to occlude the 
vessel lumen, thus causing ischemia distal to the occlusion. Appendix A gives a more in 
depth background of blood vessel biology as well as the progression and diagnosis of 
atherosclerosis.  Atherosclerosis is commonly treated using balloon angioplasty, which is 
usually done in conjunction with the deployment of a vascular stent.  Stent deployment 
provides structural rigidity to the vessel wall, thereby helping to hold the vessel open 
following the local injury caused by balloon inflation and prevent elastic recoil and 
negative remodeling.  In fact, stenting has been shown to significantly reduce restenosis 
rates from approximately 20-50% without a stent to about 10-30% with stent 
deployment.[3]  However, this still leaves significant room for improvement.  As of 
2001, it was estimated that approximately 80% or more of all angioplasty procedures 
were done in conjunction with the deployment of a stent.[4]  As a result, the stent market 
has undergone tremendous growth in recent years and was estimated to be a 5.6 billion 
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dollar world market in 2006.[5] This makes research involving the optimization of 
treatments for occlusive vascular disease using vascular stents a very important and 
potentially profitable endeavor. 
Charles Dotter is widely credited with the invention of the intraluminal metallic 
stent similar to the form that is known today.[4, 6, 7]  He was also recognized as the first 
to successfully perform the technique of percutaneous transluminal stent deployment by 
implanting a “coilspring graft” stent in the femoral artery of a canine model in 1969.[8-
10]  Later, Andreas Grüntzig, building on the work of Dotter, developed a balloon 
catheter in 1977 that allowed the use of the percutaneous transluminal angioplasty 
(PCTA) procedure for the dilation of peripheral arteries.[4, 7, 8, 11]  Contrary to Dotter, 
Grüntzig had a more conservative personality and presented his findings in a more 
cautious approach that kept with the norms of the time.  This allowed Grüntzig to bring a 
greater acceptance of angioplasty as a viable alternative to the more invasive vascular 
surgeries of the period.[8] 
As mentioned previously, the deployment of an intravascular stent in conjunction 
with the angioplasty procedure reduces the risk of restenosis within the range of 10-30% 
versus the 20-50% restenosis risk of angioplasty alone.[3]  However, restenosis still 
remains the main cause of long-term stent failure.  In the most basic terms, a balloon 
angioplasty procedure is a forceful displacement of an atherosclerotic lesion serving to 
widen the vessel lumen area to increase blood flow.  In so doing, this procedure causes 
stretching of the vessel wall, tearing in the atherosclerotic plaques, and general damage to 
the vessel.[4]  This injury in turn signals a complex cascade of elastic recoil, thrombosis, 
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inflammation, intimal thickening, and vascular remodeling.[4]  Elastic recoil and 
negative remodeling are the primary causative factors of restenosis when vessel 
expansion is done by balloon only because of the lack of structural strength provided by 
the stent, which maintains the expanded luminal diameter.  Indeed, the post-procedural 
lumen diameter is the most telling predictor of the expected long term lumen diameter.[4]  
As mentioned previously, the deployment of a vascular stent greatly reduces the 
incidence of elastic recoil by serving to mechanically hold the vessel open.  However, in 
the treatment of calcified and highly fibrous lesions, acute stent recoil of up to 15-30% is 
commonly observed.[4]  Stent deployment also further complicates the immunological 
response by triggering a foreign body response from the implantation of a biomaterial 
into the body.  When performing an angioplasty procedure, particularly in conjunction 
with stent deployment, a certain degree of vascular injury is inevitable.  However, the 
initial injury can be further complicated by the previously mentioned inflammatory 
response, the severity of which can ultimately dictate the degree of restenosis and 
subsequently affect procedural success.  
Following balloon angioplasty, it is common to experience significant local 
damage to the endothelium or often a near complete denudation of the endothelial 
layer.[4, 12]  The acute reaction is an increased thrombogenic response because of the 
loss of inhibitory effects of the endothelium on thrombus formation and exposure of the 
thrombogenic underlying collagen and sub-endothelial matrix.[4, 13]  It also triggers an 
inflammatory response and the extrinsic coagulation pathway due to injury to the vessel 
wall.  To further amplify this thrombogenic response, the implanted biomaterial itself 
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also triggers the intrinsic coagulation pathway and amplifies the inflammatory response.  
With the use of current anticoagulant and anti-platelet therapy, thrombus formation to 
such an extent as to occlude the vessel lumen is relatively rare, and is not the primary 
determinant of long term procedural success.[4]  Alternately, it is the thrombus formation 
and recruitment of inflammatory cells leading to high local concentration of growth 
factors such as cytokines and PDGF, as well as fibrin that triggers a mitogenic and 
chemotactic response from smooth muscle cells.[4, 14]    The proliferative response of 
VSMCs to the various afore mentioned stimuli results in the formation of often copious 
amounts of neointimal tissue, generally known as intimal hyperplasia.  The formation of 
this new tissue, primarily consisting of VSMCs of the synthetic phenotype and their 
subsequent extracellular matrix, is the sole causation of in-stent restenosis since the stent 
serves to prevent elastic recoil and negative remodeling.[4] 
As stated previously, injury to the vessel wall triggers thrombosis and 
inflammation as the first stages of wound healing.[13]  Following this, the next step 
observed is often intimal thickening.  Intimal thickening is caused by the recruitment of 
VSMCs into the intima by chemotactic and mitogenic substances from thrombosis and 
inflammation.[12, 13]   These substances cause a local influx of migrating VSMCs to the 
area followed by cellular proliferation.  Additionally, the growth factor rich thrombus 
present at the stenting site can also form a favorable scaffold, which protrudes into the 
lumen, for the colonization and growth of VSMCs.[15, 16]  Additionally, these 
proliferative VSMCs are of a synthetic phenotype that also exhibit increased extracellular 
matrix production.  These factors lead to thickening of the vessel wall and in some cases 
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the lumen diameter is reduced to the extent that a follow up interventional therapy is 
needed to restore vessel patency.  The thickening of the intima to restrict blood flow 
following angioplasty is given the general term restenosis or, when experienced in a 
stented vessel, in-stent restenosis.  The degree of restenosis varies from case to case 
under similar circumstances due to mechanisms that are not yet fully understood.  
However, some factors such as host response to the implanted biomaterial and 
biomaterial thrombogenicity as well as degree of vascular injury upon stent deployment 
have been shown to have a significant influence.[17-19]  In addition to these factors, 
there are others that are thought to influence restenosis, such as contact stresses and 
rheological factors.  Low wall shear stress and wall shear stress gradients, which are 
discussed in more detail in Appendix B, are thought to be directly linked to VSMC 
hyperplasia and subsequent restenosis.  However, these factors can be modified by 
variations in stent design.  Therefore, careful consideration in stent design, paying special 
attention to reduction of vessel injury, biocompatibility of materials, and hemodynamics 
of blood flow, could lead to reduced restenosis and better long-term patency. 
Immediately following stent implantation, various blood proteins bind to the 
surface of the stent.[20]  Blood cells then accumulate at the site of stent deployment 
within minutes and thrombus formation occurs shortly thereafter.  VSMCs then respond 
to chemotactic factors from injury and clot formation, migrate into the area, and soon 
begin to proliferate.[4, 20, 21]  These synthetic VSMCs proliferate over a period of a few 
months when the majority of the restenosis takes place.[4, 21, 22]  It is generally 
accepted that restenosis will present itself within the first six to nine months if it is going 
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to occur, with restenosis initiated after twelve months being rare.[4, 22]  This is followed 
by a somewhat quiescent period several years after placement in which the neo-intimal 
material is composed primarily of extracellular matrix with a few scattered VSMCs.  
However, the degree of restenosis varies from case to case even under similar 
circumstances due to mechanisms that are not yet fully understood.[4, 23] 
The use of in vitro modeling can be very useful to gain an understanding of the 
mechanisms by which smooth muscle cells undergo the observed phenotypic shift 
following stent implantation.  For this reason, many researchers are developing complex 
dynamic testing systems in order to closely model how SMCs of various lineages are 
stimulated by their native environment and what effects can be observed by changing 
variables in this dynamic system.  These systems commonly employ the use of flow-
induced shear stress, mechanical stretching of cells, and/or compressive loading.  This 
may be done as a one-time stimulus to the cells, such as stretch induced injury for an 
angioplasty model, or may be applied cyclically to mimic the cyclic flow and/or 
mechanical stretch experienced in vivo.  A review of the effects stemming from the 
application of these various mechanical stimuli either singularly or in combination is 
given in Appendix B.  The in vitro system developed in our research group, which is able 
to subject cells to compressive loading using a model stent strut of varying material 
composition while mimicking the in vivo environment of concurrent cyclic strain and 
flow, is the subject of the current project and will be evaluated further in the coming 
chapters. 
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1.2 Research Hypothesis 
This doctoral research project is focused on endovascular stent biomaterials science 
and engineering.  Overall, it is founded on the hypothesis that smooth muscle cell 
hyperplasia, as an important causative factor for vascular restenosis following 
endovascular stent deployment, is triggered by the various effects of stent strut contact on 
the vessel wall including contact forces and material biocompatibility. A dynamic in vitro 
model of a stented blood vessel aimed at evaluating the effect of stent material selection, 
and surface treatment on smooth muscle cell response has been developed.  This research 
hypothesis is verified using the aims detailed below. 
 
• Aim 1: Computational Characterization of Simulator Contact Forces and 
Evaluation of Synthetic Phenotypic Behavior of Vascular Smooth Muscle Cells in 
Response to a Model Nitinol Stent Strut under Static Conditions In Vitro. 
• Aim 2: Investigation into the Effect of Nitinol Wire Corrosion on In Vitro VSMC 
Response. 
• Aim 3: Evaluation of Phenotypic Behavior of Vascular Smooth Muscle Cells 
Exposed to Concurrent Cyclic Strain and Flow Shear in Response to Model 316L 
Stainless Steel and Nitinol Stent Struts. 
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• Aim 4: Analysis of HA Coated Nitinol Stent Struts and Their Subsequent Effect 
on the In Vitro Phenotypic Behavior of Vascular Smooth Muscle Cells Exposed to 
Cyclic Strain. 
1.3 Summarized Project Aims 
Aim 1: Computational Characterization of Simulator Contact Forces and Evaluation of 
Synthetic Phenotypic Behavior of Vascular Smooth Muscle Cells in Response to a Model 
Nitinol Stent Strut under Static Conditions In Vitro. 
The present vascular simulator was designed to mimic the mechanical 
environment of a stented artery after deployment of an intravascular stent.  This is 
accomplished by providing clinically significant levels of cyclical strain and flow shear, 
as well as contact forces from the model stent strut on the adherent cultured cells.  In this 
initial study, characterization of this contact force is modeled to describe the mechanical 
environment of the simulator in order to further our understanding of VSMC response to 
mechanical stimulation.  These forces are computationally simulated using ABAQUS 
finite element analysis software.  This data can be used to better understand observations 
made as a result of strut contact on VSMCs. 
This study proved to be useful as an initial proof of concept for the development 
of our stented blood vessel model.  In this study, it was shown that stimulating vascular 
smooth muscle cells with a model stent strut composed of a round Nitinol wire under 
static conditions stimulates a phenotypic shift towards a more synthetic phenotype.  This 
was shown through characterization of cell morphology and proliferation.  The sample 
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strut stimulus caused a morphological change in the VSMCs indicated by a decreased cell 
aspect ratio.  Additionally, analysis of cell enumeration showed a slight decrease in 
VSMC enumeration at 24 hrs as compared to the control, which was presumably due to 
destruction of the underlying cells by the wire. However, the analysis of DNA synthesis, 
normalized to total protein content, demonstrated a significant increase in DNA synthesis 
for the remaining cells in response to the model stent strut.  This response was 
investigated further by subjecting cells to preconditioned media, which was reserved 
from the experimental groups and used to supplement cells not stimulated with a Nitinol 
wire. This was done in order to determine if the cell response was due to exogenous 
growth factors released by synthetic VSMCs; however, this was shown to have no 
significant effect on VSMC proliferation.  The cell response to the Nitinol wire was 
evaluated further by repeating the experiments using a 48 hr time point, which yielded 
similar results.   
 
Aim 2: Investigation into the Effect of Nitinol Wire Corrosion on In Vitro VSMC 
Response 
The nickel-titanium alloy Nitinol has become an increasingly popular biomaterial 
for use in vascular stenting due to its shape memory properties.  However, its high nickel 
content has been the cause for concern due to possible cell toxicity and alterations in 
cellular activity.  In the body, nickel ions can cause a number of different problems 
including cancer, allergic reaction, and inflammatory response. [24-26]  Additionally, 
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recent studies have linked nickel allergies to increased restenosis in patients that received 
nickel containing intravascular stents.[27, 28]   
Traditionally, in vitro material biocompatibility studies involved evaluating cell 
response where cells are cultured in the presence of a small sample of the material.  In 
this study, we present a slightly different approach to evaluate the biocompatibility of a 
metallic biomaterial.  Our study is based on estimating what local concentrations of 
metallic ions are present at the site of implantation of a stent based on other studies in the 
literature in order to establish a clinically significant concentration range for our cell 
studies.  We then quantified the concentrations of metallic ions present in conditioned 
media in which Nitinol wires were allowed to corrode, and compared cell response to 
actual ion concentration to provide better experimental reproducibility.  This was 
important to eliminate the variability of corrosion rates from metals (even from the same 
lot) under similar conditions. 
Cell culture experiments using vascular smooth muscle cells exposed to relevant 
concentrations of nickel ions released from Nitinol showed two important responses.  
First, a decrease in aspect ratio showing a morphological change possibly indicating a 
shift towards a more synthetic phenotype has been observed.  Secondly, a significant 
decrease in α-actin expression was identified by immunostaining with a fluorescent tag.  
At the highest concentration tested, average fluorescence decreased by approximately 
26%, indicating a loss of the cellular contractile mechanism further supporting a change 
in phenotype in response to the metallic ions.  It is reasonable to suspect that this loss of 
contractile marker smooth muscle α-actin combined with the decrease in aspect ratio 
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indicates a synthetic phenotypic shift, which may contribute to the development of in-
stent restenosis. 
 
Aim 3: Evaluation of Phenotypic Behavior of Vascular Smooth Muscle Cells Exposed to 
Concurrent Cyclic Strain and Flow Shear in Response to Model 316L Stainless Steel and 
Nitinol Stent Struts. 
Many studies have been published in the literature attempting to elucidate the role 
of the stent’s material properties on restenosis.  A major contribution to the minimization 
of the risk of restenosis is attributed to the optimization of various stent design attributes.  
One of the most important of these design criteria being evaluated is proper material 
selection.  The stent materials predominantly used clinically are 316L stainless steel and 
Nitinol.  Both of these materials are relatively biocompatible, and are generally selected 
for the individual application whether it is more desirable to have a self-expanding or 
balloon expanded stent.  However, to date there are no studies readily available in the 
literature comparing the effects of various metallic stent materials on smooth muscle cells 
under dynamic culture conditions of concurrent cyclic strain and flow. 
In the present study, we aimed at evaluating smooth muscle cell response to a 
model stent strut while subjected to concurrent cyclic strain and fluid shear stimulation.  
Results showed that under a dynamic culture environment, model stent implantation 
resulted in a phenotypic shift toward a more synthetic phenotype marked by increased 
DNA synthesis and decreased α-actin expression compared to the control.  This is similar 
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to the response expected in vivo.  Additionally, the study shows that with regard to DNA 
synthesis and expression of α-actin, Nitinol performs equally well to the traditionally 
accepted gold-standard 316L stainless steel with no significant difference between the 
two in any of the experiments carried out in this study. 
 
Aim 4: Analysis of HA Coated Nitinol Stent Struts and Their Subsequent Effect on the In 
Vitro Phenotypic Behavior of Vascular Smooth Muscle Cells Exposed to Cyclic Strain. 
Hydroxyapatite (HA) has recently been proposed as a possible coating for 
intravascular stents.  It is beneficial because, in addition to promoting favorable cell 
attachment, it may be used as a drug delivery platform.  However, there is some concern 
over the possible osteogenic potential of the material when implanted into an artery.  
Additionally, little is known about the in vitro response of VSMCs to hydroxyapatite-
coated biomaterials especially under dynamic culture conditions. This study utilized the 
dynamic capability of our experimental setup by incorporating stimulation of VSMCs 
using cyclic strain as well as the deployment of a model stent specimen.  In this study, 
stent strut geometry and material are held constant while surface coating is varied 
between bare Nitinol and hydroxyapatite-coated Nitinol.  This was done in order to 
highlight the effect the material coating alone has on VSMCs while cultured under 
clinically significant dynamic in vitro culture conditions.  Cell phenotypic response was 
evaluated by looking at DNA synthesis and α-actin expression.  Additionally, in order to 
evaluate the osteogenic potential of the HA coating, expression of alkaline phosphatase 
(ALP), expression of osteopontin, and cellular calcification were analyzed.  ALP and 
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osteopontin expression experiments were carried out under dynamic strain conditions in 
the vascular simulator.  However, in order to evaluate calcification of VSMCs over a 
longer time period, a static study was conducted using HA coated 316L stainless steel 
disks with calcium deposition evaluated at the end of the 10-day study. 
The integrity of the HA coating itself was also evaluated in the present study.  
This was done in two ways.  First, the coating was analyzed using an electron dispersive 
x-ray (EDS) method to insure that the surface was in fact coated with a thin layer of 
hydroxyapatite.   Secondly, the post strain integrity of the coating was evaluated by 
straining the stent at levels representative of those expected upon deployment followed 
by observation using scanning electron microscopy (SEM). 
Results showed that VSMC DNA synthesis and α-actin expression was not 
significantly different for the HA-coated Nitinol compared to the non-coated specimens.  
The results indicated that HA-coated stents will likely be equally well accepted when 
implanted in vivo compared to a bare Nitinol stent.  Additionally, it was shown that while 
alkaline phosphatase (ALP) expression was slightly elevated, cells showed no significant 
calcification response to the HA coating and did not stain positive for osteopontin.  This 
indicated that any possible osteogenic response to the HA coating was quite minimal. 
Additionally, EDS surface analysis studies demonstrated that the stent surface 
was in fact coated with a thin layer of hydroxyapatite with a calcium/phosphorus ratio on 
par with those observed by others in the literature for HA implants.  Furthermore, SEM 
analysis showed excellent post-strain integrity of the HA coating with minimal cracking 
and/or flaking observed. 
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-CHAPTER 2- 
Aim 1: Computational Characterization of Simulator Contact Forces and Evaluation of 
Synthetic Phenotypic Behavior of Vascular Smooth Muscle Cells in Response to a Model 
Nitinol Stent Strut under Static Conditions In Vitro. 
 
2.1 Introduction 
The vascular simulator presently described was designed to mimic the mechanical 
environment of a stented artery after deployment of an intravascular stent.[29]  This was 
accomplished by providing clinically significant levels of cyclical strain and flow shear 
as well as contact forces from the model stent strut on the adherent cultured cells.  In this 
study, we aimed at quantifying this contact force to fully characterize the mechanical 
environment of the simulator in order to further our understanding of VSMC response to 
mechanical stimulation.  In order to gain an accurate representation of the contact stress 
profile, a computational model of the contact geometry was developed. In the stented 
artery, cells are subjected to dynamic stimuli, such as concurrent cyclic strain and flow 
shear.  Additionally, the cells are also subjected to mechanical forces, such as the 
outward radial force that is imparted upon the vessel wall by the implanted stent. 
In the stented artery, the outward radial force of the stent upon the vessel wall is 
vitally important.  While it is important for the stent to provide mechanical forces to the 
vessel wall to prevent elastic recoil and negative remodeling, outward stresses can be 
high enough to cause significant trauma to the vessel wall leading to increased incidence 
15 
	  
of restenosis.[30-32]  To date, there is a lack of in vitro data examining the effect of a 
metallic indenter contacting the surface of a vessel wall.  There is however, available data 
evaluating similar conditions on articular cartilage and cartilage constructs.   
Bae et al. evaluated the effect on chondrocyte viability following the stimulation 
of human cartilage explants with bot spherical and flat-tipped indenters.[33]  The 
researchers showed that cell death was dependent on both indentation depth and number 
of cycles.  However, they also showed patterns of cell death dependent on areas of stress 
concentrations caused by the indenter geometry.  Spherical-tipped indenters caused 
higher cell death at the center of the indenter where stress should have been the highest, 
whereas flat-tipped indenters caused increased cell death at the edges of the indenter 
indicative of the expected stress concentrations in this area.[33]  Bae further confirmed 
that these areas of increased cell death did experience elevated peak levels of strain of up 
to approximately 5-30% which increased with increasing indentation displacement.[34] 
Other research groups have investigated the response of chondrocytes to 
compressive loading using a slightly different approach.  Many groups have used 
confined loading of cartilage constructs or explants in their models.[35-39]  De Croos et 
al. seeded porous calcium polyphosphate constructs with chondrocytes, which were then 
over-laid with a layer of alginate, and subjected to cyclic compressive loading of an 
estimated 1 kPa (1.4% strain) over 24 hours.[35]  It was observed that after cyclic 
compressive stimulation, the total collagen and proteoglycan production of the cells was 
significantly increased when compared to static controls.  These results are reinforced by 
a similar experiment by Ragan et al. where chondrocytes cast in alginate disks were 
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cyclically compressed resulting in similarly increased synthetic activity.[38]  Davisson et 
al. seeded chondrocytes onto porous poly-glycolic acid scaffolds and observed a similar 
synthetic response to cyclic compressive loading.[39]  Although the researchers did not 
make an effort to judge cell proliferation of the samples, the increased synthetic activity 
of the cells could potentially indicate and mitogenic response as well. 
In this study, we hypothesized that the in vitro loading of vascular smooth muscle 
cells with a model Nitinol stent strut would result in a synthetic response similar to that 
observed in the literature for chondrocytes.  This synthetic response was identified 
through the evaluation of proliferation and DNA synthesis as well as changes in cell 
morphology. 
 
2.2 Materials and Methods 
Contact Forces 
Meshed Models  
 A geometric model was generated using the Catia v5 CAD program.  This 
geometric model was then imported into Hypermesh (Altair Inc.) for mesh generation.  
The resulting mesh, as shown in Figure 2-1, was then imported into ABAQUS for 
analysis.  In our present model, continuum eight-node first-order reduced integration 
hexahedron elements were used to mesh the silicone membrane sub-domain.  The cell 
layer and wire were meshed with tetrahedral elements. In order to ensure that the results 
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obtained in the present study will not be changed significantly by further mesh 
refinement, a mesh sensitivity analysis was carried out. 
 
Figure 2-1: Hypermesh-Generated Mesh for FEM Analysis Using Both Hexahedral and 
Tetrahedral Elements for the Silicone Membrane and Cell Layer/Wire Respectively 
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Figure 2-2: Exploded Simplified Two-Dimensional Representation of Geometric Model 
Computational Algorithm 
 It was not necessary to account for problems caused by excessive mesh distortions 
due to the lack of very large strains and rotations in the model; therefore, the Lagrangian 
formulation was used in order to solve the governing equations.  Within the mesh, this is 
tied to the material allowing the two to move and deform together.   
In all cases, the transient non-linear dynamics calculations performed in the 
present work were accomplished via general purpose FEA software ABAQUS/Explicit 
[40].   Important relevant features of ABAQUS/Explicit were explained in further detail 
in a recent work available in the literature [41].  Therefore, the remainder of this section 
will provide only of brief general overview of this topic.  
Initial Conditions  
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 All nodal velocities and element stresses and strains were set to zero at the 
beginning of the simulation.  In other words, at time t=0, the model was considered 
quiescent and stress/strain free. 
Boundary Conditions and Material Properties 
 In order to solve the model, a number of boundary conditions and assumptions 
were made.  First, the ends of the wire that are mounted with the wax were considered 
fixed in space so that no displacement could occur.  Additionally, the Lexan post 
underneath the center of the silicone membrane was considered to be an infinite rigid 
solid.  Also, it was assumed that there was a “no slip” condition between the wire and the 
cell layer or silicone membrane.  The cell layer was also attached to the silicone 
membrane such that no sliding could occur between the two layers.  In order to reduce 
the computational power required for the model, we took advantage of its two planes of 
symmetry and only solved one quarter of the total model (Figure 2-6). 
 The wire, cells, and silicone were all assumed to be elastic.  Material properties 
for each part of the model are given in Table 2.1. 
Table 2.1: Material Properties of FEA Model 
Material	   Young’s	  Modulus	  (kPa)	   Poisson's	  Ratio	   Thickness	  (mm)	  
Density	  
(kg/mm3)	  
Nitinol	  Wire	   7.50E+07	   0.33	   0.1016	  (diam)	   6.45E-­‐06	  
Cell	  Layer	   13.5	   0.46	   0.0025	   1E-­‐06	  
Silicone	  Layer	   2.068E+04	   0.45	   0.381	   1.3E-­‐06	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Contact Interactions 
 Contact surfaces between the wire and cell surface shared elemental nodes, which 
thereby tied the two. The wire/contact surface normal interactions were analyzed in 
ABAQUS/Explicit using a penalty- contact algorithm. Within this algorithm, (normal) a 
set of linear springs served to resist contacting surface penetration, which thereby 
produced proportionality between contact pressure and penetration depth. In general, 
maximum default values were assigned to the (penalty) spring constants in order to 
ensure computational stability during the simulation. Equilibrium of force collinear to a 
direction normal to the contact-interface then caused the penetration to reach an 
equilibrium value, which was contact-pressure dependent. It is important to note that 
unless/until the “slave surface” nodes contacted/penetrated the “master surface” in the 
model no contact pressures were developed.   Additionally, there was no limit on the 
magnitude of the contact pressure that could be developed. 
Cell Culture 
In this Institutional Animal Care and Use Committee (IACUC) approved study, 
rat vascular smooth muscle cells (VSMC) were isolated from the aortas of Sprague-
Dawley female rats between 6-10 weeks of age (Appendix C) and maintained with 
Dulbecco’s Modification of Eagle Medium (DMEM) (Mediatech, Inc., 10-013-CV, 
Herndon, VA) supplemented with 10% heat inactivated Fetal Bovine Serum (FBS) 
(Sigma-Aldrich, F-4135, St. Louis, MO) and 1% Antibiotic-Antimycotic (Sigma-Aldrich, 
A5955, St. Louis, MO).  Experiments were carried out between passages 4-8.  For 
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experimental testing, cells were trypsinized using 0.25% Trypsin containing 0.2 mg/mL 
EDTA (Sigma Chemical Company, E6511, St. Louis, MO). 
 Cell Seeding for Mechanical Testing 
Silicone membranes were cut into circles 5.25 cm in diameter for each culture 
plate out of biomedical grade silicone sheets (Lot SM04106803, Specialty 
Manufacturing, Inc. Saginaw, MI, USA)  0.015" in thickness and 40 durometer Shore A.  
The cut silicone sheets were then cleaned using sonication in deionized water and press 
fit into the culture plates using an inner Lexan ring.  The culture plates were then 
autoclaved (Tuttnauer Brinkmann, 3870M, Jerusalem, Israel) at 121 degrees Celsius for 
30 minutes and put into their appropriate place in the main body of the simulator.  The 
assembled system was then UV sterilized for 3 hours.  To ensure the cells experience a 
uniform stimulus, they were confined to the central post using a Teflon retainer ring 2.75 
cm2 inner diameter and 1.75 cm in height.  This ring was then removed prior to 
mechanical testing.  The Teflon rings were sonicated (Aquasonic Model P250T) in a 1% 
detergent solution (Liquinox Critical Cleaning Detergent, Alconox, Jersey City, NJ, 
USA) for 15 minutes followed by three rinses DI water.  They were then autoclaved and 
centered on the Lexan post on top of the silicone membrane.  The area inside of the 
Teflon rings was then coated with Type I Collagen (Purecol 3mg/ml, Advanced 
Biomatrix, lot# 1356) diluted with sterile DI.  The coated membranes were rinsed with 
1.0 ml of Dulbecco’s Phosphate Buffered Saline (DPBS) (Media Tech, Inc., 21-031 CM, 
Herndon, VA) before cell seeding.  Cell counting was done using a hemocytometer 
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(Hausser Scientific), and cells were seeded at a density of 5 x 104 cells, suspended in 1.5 
ml culture media and incubated for 48 hours to allow the cells to attach.   
Experimental Setup for Mechanical Testing 
Immediately prior to mechanical testing, the DMEM containing FBS was 
removed and the cells were rinsed briefly with phosphate-buffered saline (PBS).  The 
media was then replaced with a serum free media containing 1% antibiotic/antimycotic 
for the duration of testing.  Nitinol wires (ASTM F2063, Small Parts, part # NW-005-36-
05) 4.4 cm long and 0.127 mm in diameter were ultrasonically cleaned similarly to the 
Teflon rings followed by EtO gas sterilization (AN 74i Anproline Gas Sterilizer, 
Andersen Products Inc.) for 12 hours.  The sterile wires were then carefully placed atop 
the cultured cells and secured at the ends using molten Surgipath EM-400 paraffin wax 
embedding medium (Surgipath Medical Industries Inc., Richmond, Illinois, USA) (Figure 
2-3).  The control groups also received the wax, but were not loaded with the wire.  The 
cells were then subjected to the wire loading stimulus for either 24 or 48 hours.  Each 
group contained three samples repeated in duplicate for a total of six samples.  The 
groups were a 24 hr control group (C24) (n=6), a 24 hr Nitinol wire loading group 
(NW24) (n=6), a 48 hr control group (C48) (n=6), and a 48 hr Nitinol wire loading group 
(NW48) (n=6).  
Mechanical stimulation of cells was done using a vascular simulator previously 
developed in our laboratory.[29]  Briefly, the simulator is comprised of two simulator 
bodies each having three independent channels such that six independent samples may be 
cultured simultaneously.  This dynamic simulator is capable of applying concurrent 
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cyclic strain and flow stimulation to cells through the use a computer controlled vacuum 
pump as well as peristaltic pumps to provide a flow induced shear stimulus.  However, in 
the present study, cells were cultured inside the simulator under static conditions.  The 
apparatus previously described by Acampora et al. was slightly modified in order to 
accept in order to accept a model vascular stent strut across the cell culture area, which is 
secured in place using paraffin wax. [29] 
 
 
 
 
 
 
 
 
 
 
Figure 2-3: Experimental Setup for Mechanical Testing Showing the Placement of the 
Model Stent Strut 
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Cell Morphological Analysis 
Rhodamine-Phalloidin/DAPI 
At the appropriate time point, the cells were removed from the incubator, fixed in 
a 2% paraformaldehyde solution, and the cytoskeletal F-actin and cell nuclei were stained 
using Rhodamine-Phalloidin (Invitrogen, R415) and by 4',6-diamidino-2-phenylindole 
(DAPI) (Molecular Probes, D-1306, Eugene, OR) respectively.  The cells were then 
imaged using fluorescent microscopy (Nikon Inc., Diaphot 300, Melville, NY).  
ImagePro Plus image analysis software (Media Cybernetics, Inc., Version 5.1, Silver 
Spring, MD) was then used to take cell measurements including cell area, minor axis, 
major axis, and aspect ratio. 
Cell Proliferation 
AQueous One Assay 
At the appropriate time point (24 or 48 hrs), Cell Titer 96 AQueous ONE Solution 
Cell Proliferation Assay (MTS) (Promega Corporation, G-3580, Madison, WI) was used 
to evaluate cell proliferation.  This was done by adding 1.25 ml of the AQueous One 
assay solution to each plate and incubating for 3 hrs.  After which, supernatant was 
collected and 125 µl was dispensed into three wells of a 96 well plate for each of the 
experimental plates such that each sample was repeated in triplicate.  The absorbance was 
then measured at 490 nm (Beckman Instruments, Inc., Model# DU® 640B, Fullerton, 
CA).  Three wells containing DMEM with the assay solution added and not incubated 
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with cells were used as controls to remove the background and obtain an adjusted 
absorbance. 
Evaluation of DNA synthesis 
After mechanical stimulation, DNA synthesis was evaluated via an enzyme-linked 
immunosorbent assay (ELISA) based bromodeoxyuridine (BrdU) incorporation assay 
(Roche).  Briefly, cells were BrdU labeled for a duration of 2 hours, after which they 
were fixed in the provided fixation/DNA denaturation solution for 30 minutes.  
Following this, the cells were incubated with an enzyme linked anti-BrdU antibody 
solution for 90 minutes.  After several rinses, the cells were then incubated with a 
substrate solution for 30 minutes and absorbance was read in triplicate at 370 nm with a 
reference wavelength of 492 nm.  The remaining cells were then lysed using a 1% Triton 
X-100 solution and the total protein content quantified via BCA assay in order to 
normalize the absorbance values. 
Conditioned Media 
Conditioned media was reserved from one replication of both the 24hr and 48hr 
studies.  This media was then used supplement cells grown in 12-well plates with fresh 
serum free DMEM serving as a control.  Cells were seeded at a density of 6x104 cells per 
well in DMEM containing 10% FBS and allowed 48 hrs to attach prior to the addition of 
the conditioned media or control.  Media from each sample was tested in duplicate such 
that for the 24 hr NW experiments, the three samples gave rise to six conditioned media 
samples.  Cell proliferation was observed using AQueous One.   
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Statistical Analysis 
All data was evaluated using an ANOVA statistical analysis paired with Tukey 
analysis.  This was done using SigmaStat statistical analysis software (Systat Software, 
Inc., San Jose, CA) with p<0.05 indicating a significant difference.     
 
2.3 Results 
Computational analysis 
 The FEA software was used to gain an accurate representation of the contact 
forces present in our vascular simulator.  Figure 2-4 shows an isometric view of the 
model taking advantage of two lines of symmetry for model simplification. In this figure, 
the contacting wire is shown in green, the cell layer in red, and the silicone membrane in 
yellow.  Analysis of the model showed wire greatest displacement of the wire at the 
edges as well as the center of the culture area in the negative z-direction.  Because the 
wire was fixed in space at both ends where no displacement could occur, this resulted in 
greatest displacement of the wire into the cell and silicone layers at the edge of the 
culture area.  The resulting wire displacement profile is shown in Figure 2-5.  Wire 
displacement resulted in a S-like shape for the wire.  Figure 2-6 shows the displacement 
profile of the wire scaled 30,000x in order to further illustrate the s-shaped profile of wire 
displacement.  Furthermore, the strain displacement of the cell and underlying silicone 
layer as a result of wire contact is shown in Figure 2-7.  Maximum strain levels for the 
cell and silicone layer in the model were estimated at approximately 1.065x10-5. 
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 The resulting von Mises and Principal stress profiles, shown in Figures 2-8 and 2-
9 respectively, illustrate that stress followed the displacement profile with areas of 
highest stress being at the edge of the culture area and the second highest being towards 
the center of the culture area.  Average principal stress at the center of the indenter 
neglecting the edge effect was approximately 3.75x10-3 kPa across the culture area.  
Additionally, the x-y plane stress profile demonstrated a stress profile that was dependent 
on indenter geometry.  Using the cylindrical indenter employed in the present study, this 
resulted in maximum stress at the center of the indenter where displacement was the 
greatest and decreasing at the indenter edges. 
 
Figure 2-4: FEA Model Taking Advantage of Two Planes of Symmetry 
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Figure 2-5: Displacement Profile of Nitinol Wire in FEA Model 
 
Figure 2-6: Displacement Profile of Nitinol Wire Scaled 30,000x 
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Figure 2-7: Strain Profile of Cell and Silicone Layer as a Result of Wire Displacement 
 
Figure 2-8: Von Mises Stress Profile as a Result of Wire Contact 
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Figure 2-9: Max Principal Stress Profile as a Result of Wire Contact 
 
Static In Vitro Studies 
Cell Morphological Analysis 
The Rhodamine-Phalloidin stain was imaged and analyzed using ImagePro Plus 
software.  A statistical analysis showed a nearly identical aspect ratio (AR) for both the 
24 and 48 hr control groups (C24 and C48).  However, the experimental groups (NW24 
and NW 48) demonstrated significantly decreased aspect ratios (P=<0.001 in both cases), 
representing a reduction of approximately 29% and 19% respectively compared to the 
controls shown in Figure 2-10.  The aspect ratio was also shown to be significantly 
different between NW24 and NW48 (P=<0.001).   
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Figure 2-10: Comparison of Aspect Ratios Following the Application of a Model Nitinol 
Stent Strut Vitro (* indicates a significant difference as compared to the control with P< 
0.05) 
 
Cell Proliferation 
AQueous One Assay 
Data analyzed from the 24 hr static study showed a significant decrease in cell 
number compared to the control (P=0.012) (Figure 2-11).  The 24 hr static group 
demonstrated a cell number approximately 13% lower than that of the control.   
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Figure 2-11: AQueous One Comparison of VSMC Enumeration Following the 
Application of a Model Nitinol Stent Strut In Vitro (* indicates a significant difference as 
compared to the control with P< 0.05) 
 
BrdU assay 
Data analyzed from the 24 hr BrdU assay, illustrated in Figure 2-12, showed a 
significant increase in overall DNA synthesis for the NW group as compared to the 
control group (P=0.045).  The NW group showed an increase of approximately 76%.   
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Figure 2-12: DNA Synthesis of VSMCs Following the Application of a Model Nitinol 
Stent Strut In Vitro (* indicates a significant difference as compared to the control with 
P< 0.05) 
 
Conditioned Media 
Cell Proliferation 
There was no significant difference in VSMC proliferation in response to the 24 
or 48 hr conditioned media as observed by AQueous One cell proliferation assay.  This 
suggested the difference in proliferation observed in the static study was likely due the 
contact of the wire on the cell rather than exogenous growth factor production.  
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2.4 Discussion 
The FEA software was used to gain an accurate representation of the contact 
forces present in our vascular simulator.  This may be useful for possible future studies 
utilizing different strut sizes in order to determine how VSMCs respond to varying 
contact forces.  Additionally, this data allows us to predict the fate of the VSMCs 
immediately under the model stent strut that cannot be imaged.  The maximum strain 
values for the cell and silicone layers in the FEA model were calculated at approximately 
1.065x10-5 as a result of the weight of the stent strut on the surface.  This is far below the 
value of approximately 0.54 shown in the literature to cause cell membrane rupture in 
mouse myoblasts subjected to compressive loading in vitro.[42] These results suggest 
that the strains encountered as a result of compressive loading from the weight of the 
stent strut would not be high enough to rupture the underlying cells when implanted into 
the in vitro model.  
The present model was used to represent the contact condition of the model stent 
strut across the culture area under fully static conditions.  However, many dynamic 
studies were conducted in aims 3 and 4, which utilized cyclic straining of the silicone 
membrane by applying vacuum suction to stretch the membrane across the central Lexan 
post.  It is important to note that this linear stretching of the membrane across the post 
would result in effectively “thinning” the membrane due to Poisson’s effect.  This 
thinning effect on the membrane would cause more of the weight of the wire to be born at 
the ends fixed in space within the model.  This would likely cause a slightly higher 
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deformation of the wire combined with a slightly decreased strain on the cell and silicone 
layers. 
It is important to note that silicone membrane was coated with type I collagen 
prior to cell seeding for in vitro studies; however, the collagen coating was not included 
as a layer in the computational model.  This may be one possible limitation of the current 
model as the interlocking collagen fibers interwoven with the cultured cells would likely 
lend structural rigidity to the layer giving it material properties closer to those of whole 
tissue.  However, the bulk properties of this extremely thin heterogeneous composite 
layer would not be easily measured experimentally.  For this reason, we utilized 
previously published values for material properties of cultured cells for the FEA 
model.[43] 
Cell morphological analysis showed a significant decrease in cell AR for both the 
24 and 48 hr wire contact groups as compared to their control.  Additionally, results 
showed a significant difference between the NW24 and NW48 groups.  This data 
suggested that the VSMC response with respect to aspect ratio was rapid within the first 
24 hrs after which it began to return to a more normal state. 
AQueous One analysis showed a decrease in overall cell number for the Nitinol 
group compared to the control group.  This decrease in cell number is likely due to a 
mechanical destruction of the underlying cells as a direct result of scraping during the 
placement of the wire across the culture surface. For this reason, the BrdU assay was 
conducted in order to separate the rate of cellular proliferation from overall cell number. 
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In contrast to results from the AQueous One assay which showed that overall cell 
number decreases, the BrdU assay showed DNA synthesis of the remaining cells is 
increased.  This demonstrated that, while overall cell number was decreased due to 
damaged caused by the placement of the wire, it lead to a very significant increase in 
DNA synthesis of the remaining cells in response to the injury.  This was somewhat 
similar to the response observed in using in vivo models, which have routinely shown 
increased neointimal thickness due to VSMC proliferation.[44-47] 
Results from the present study indicate an increase in VSMC proliferation paired 
with a simultaneous change in cell differentiation state.  Traditionally, many studies 
indicated a coupling of control mechanisms between regulation of cell proliferation and 
differentiation making a cell incapable of doing both simultaneously.[48-51]  It was 
generally accepted that a cell must exit the mitogenic cycle to G1/G0 phase before a 
change in differentiation state could occur.  However, current research has demonstrated 
that while these two events are at least somewhat independent allowing them to occur 
simultaneously.[48]  Studies which utilized myeloid cells have shown expression of 
differentiation markers such as IL-8 and ICAM-1 coupled with simultaneous BrdU 
incorporation.[52, 53]  Furthermore, HL60 leukemia cells have been shown capable of 
differentiation after being halted in various phases of the cell cycle.[48]  These studies 
demonstrate that DNA synthesis, as an indicator of proliferation, can occur in parallel 
with differentiation.  Additionally, cellular differentiation is independent of the phase of a 
cell’s mitogenic cycle. 
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2.5 Conclusion 
 Results from the present study demonstrated a slightly more complex than 
expected contact condition between the cellular layer and the Nitinol wire indenter.  The 
displacement profile resulted in highest principal stresses at the edge and at the center of 
the contact area in the y-z plane.  Additionally, the cylindrical geometry resulted in 
principal stresses highest in the center of the cylindrical indenter, where displacement is 
greatest in the x-z place with stress magnitudes decreasing towards the indenter edge. 
 In vitro results from this proof-of-concept study showed an increase in DNA 
synthesis as a result of Nitinol wire implantation compared to the control.  This response 
was paired with significant decrease in aspect ratio.  Together, these results point toward 
a phenotypic shift toward a more synthetic phenotype in response to implantation of a 
model Nitinol stent strut, thus validating our present model.  Furthermore, model strut 
implantation resulted in a decrease in overall cell number as shown in results from the 
AQueous One indicating that contact forces encountered upon wire implantation are 
likely high enough to destroy underlying cells, however; this destruction of cells is likely 
a result of elevated forces encountered at the moment of wire placement as forces 
modeled from the weight of the wire itself were not shown to cause strains high enough 
to cause rupture of cellular membranes.  Additionally, results from conditioned media 
studies showed conditioned media reserved from the static studies to have no effect when 
subsequently added to VSMC static cultures.  As such, the phenotypic shift was likely a 
direct result of wire contact conditions rather than the release of exogenous growth 
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factors.  Overall, this study was successful at validating our model of a stented blood 
vessel, making it a useful tool for further experimentation. 
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-CHAPTER 3- 
Aim 2: Investigation into the Effect of Nitinol Wire Corrosion on In Vitro VSMC 
Response 
 
3.1 Introduction 
The nickel-titanium alloy Nitinol has become an increasingly popular biomaterial 
for use in vascular stenting due to its shape memory properties.  However, its high nickel 
content has been the cause for concern due to possible cell toxicity and alterations in 
cellular activity. 
In the body, nickel ions can cause a number of different problems including 
cancer, allergic reaction, and inflammatory response. [24-26]  Additionally, recent studies 
have linked nickel allergies to increased restenosis in patients that received nickel 
containing intravascular stents.[27, 28]  In an effort to understand these interactions 
between the body and nickel-rich alloys, there have been many in vitro studies evaluating 
the biocompatibility of Nitinol.  Most of these studies evaluated biocompatibility of 
Nitinol based upon observations such as cellular proliferation, apoptosis, and DNA 
synthesis.  However, more subtle changes such as altered protein expression are often 
ignored.  In many in vitro studies, cells are simply cultured in the presence of a small 
sample of Ni/Ti alloy followed by the evaluation of cellular response. These studies pay 
no attention to the inconsistency of corrosion rates and ion concentrations caused by 
variations in surface area and material treatment.[54-57]  Additionally, the majority of 
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studies present in the literature do not utilize vascular smooth muscle cells (VSMCs). The 
understanding of VSMC response following stent implantation is vitally important as it is 
the synthetic response of VSMCs and subsequent proliferation and extracellular matrix 
production that leads to the development of in-stent restenosis.[4] 
VSMC response to Nitinol wire has been studied by Shih et al.[58]  This group 
utilized the accelerated electrochemical corrosion of Nitinol wire in growth media in 
order to obtain test samples.  This conditioned growth media was added to static cultures 
of rat aortic VSMCs in order to demonstrate the toxicity of the corrosion byproducts on 
cells, which was thought to be directly related to the nickel content.  These experiments 
showed a cytotoxic effect caused by the corrosion media that resulted in altered cell 
morphology, [3H]-thymidine uptake ratio, and decreased cell number compared to the 
control.  These experiments employed relatively high nickel ion concentrations (up to 
267 ppm).  Growth inhibition was shown to be significant at a still relatively high nickel 
concentration of 9 ppm and above. 
Experiments that utilized corrosion of Nitinol wires in culture media without 
applied voltage demonstrated much lower nickel concentrations. Rose et al. corroded 
Nitinol in RPMI media with a ratio of 180 mm2 metallic surface per ml culture media for 
72 hrs and measured a final nickel concentration of 0.02 ppm, which showed no 
significant effect on L-929 mouse fibroblast proliferation.[59] Ryhanen et al. also showed 
no decrease in cell proliferation caused by culturing human fibroblasts and osteoblasts in 
the presence of Nitinol disks that led to nickel concentrations in the media of 8 and 5 ppb 
respectively at 8 days as determined by flameless atomic absorption 
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spectrophotometry.[60]  Additionally, other studies have shown the addition of nickel 
ions in concentrations of approximately 29 ppm induce an apoptotic response in human 
bronchial epithelial cells in vitro. [61, 62]  However, none of these studies involved 
VSMCs in an attempt to look at the expression of contractile markers, such as smooth 
muscle α-actin in response to varying concentrations of metallic ions present in the 
culture media.  This is of great importance as the proteome expressed by a cell is the most 
telling indicator of cellular differentiation state.  In the case of VSMCs, a decrease in 
expression of contractile proteins is a primary concern in order to maintain normal 
contractility. 
Limited information is available in the literature about the nickel concentration 
accumulated in vascular tissues immediately adjacent to an implanted Nitinol stent;  
therefore, the clinical significance of the various ion concentrations used in the previous 
studies is somewhat uncertain.  However, the normal human serum concentration of Ni 
can vary somewhat based on diet and other environmental factors but is approximately in 
the range of 0.095-0.13 ppb  [63-65].  The normal tissue concentrations of Ni are also 
very low.  In a recent study, Rahil-Khazen et al. analyzed human tissue samples from the 
brain (front lobe and cerebellum), heart, kidney (cortex and medulla), liver, pancreas, 
spleen, and ovary.[66]  For all of the tissue samples analyzed, the Ni levels were found to 
be below the instrument limit of detection of approximately 2.9 ppb.[66, 67]  There has 
been some research into ion concentrations resulting from various metallic implants other 
than vascular stents.  Two studies evaluating serum concentrations of various metallic 
ions following the implantation of Co-Cr-Mo orthopedic implants found mean Ni serum 
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concentrations of 0.7 ppb [68] and 0.4 ppb [69] respectively.[63]  Another study by 
Wataha et al. utilized a laser ablation technique combined with inductively coupled mass 
spectroscopy (LA-ICPMS) to characterize tissue concentration of Ni ions at increasing 
distances from subcutaneously implanted wire.[70]  Pure nickel wire elicited an intense 
inflammatory response compared to a polyethylene control implant and local tissue 
necrosis up to 1mm from the wire with Ni concentrations as high as 48 ppm immediately 
adjacent to the implant.[70]  However, the Ni concentrations in the tissue fell off 
exponentially 3-4 mm from the implants to below the 0.5 ppm limit of detection of the 
method.  This observation regarding high dependency of Ni concentration in tissue on 
distance from the implant site is important because it could mean that SMCs immediately 
adjacent to an implanted stent are experiencing levels of Ni ions much higher than 
measured in serum or average tissue concentrations. 
In the present study, we aimed at developing a clinically relevant in vitro model 
useful to evaluate the response of VSMCs to varying low levels of Ni ions that should be 
more representative of tissue concentrations found following the implantation of a 
vascular stent.  While we tested for more dramatic cell responses, such as altered 
morphology and proliferation rate, we also evaluated the equally important expression of 
the contractile marker smooth muscle cell α-actin.  Additionally, the inconsistency of 
metallic corrosion rates was eliminated by quantifying Ni concentrations prior to cell 
culture experiments.  This allowed cell response to be scaled with respect to the actual 
concentration of Ni ions present rather than corrosion time.   
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3.2 Materials and Methods 
Nitinol wire specimens 
Nitinol wires (ASTM F2063, Small Parts, part # NW-005-36-05) 4.4 cm long and 
0.127 mm in diameter were ultrasonically cleaned and ethylene oxide sterilized (AN 74i, 
Anprolene gas sterilizer, Andersen Products inc., Haw River, NC, USA) for 12 hours.  
Two wires were then placed in 15 ml conical tubes with 10 ml serum-free Dulbecco’s 
Modification of Eagle Medium (DMEM) (Mediatech, Inc., 10-013-CV, Herndon, VA, 
USA) and allowed to corrode for varying time points.  At the predetermined time point, 
the media was removed from contact with the wire, and transferred to another sterile 
15ml tube. 
Quantification of Metallic Ions 
Metallic ions present in the conditioned media were quantified using inductively 
coupled plasma optical emission spectrometry (ICP-OES) (Ultima 2, Horiba JY, 
Longjimeau, France). This is an analytical technique that is commonly employed to 
detect trace metal concentrations.  The instrument is equipped with a Meinhard 
concentric glass nebulizer, a radial-view plasma, and a cyclonic spray chamber.  The 
Ultima 2 spectrometer consists of a 1.0 m Czerny-Turner monochromator equipped with 
2400 grooves mm_1 holographic grating, controlled by JY Analyst v5.2 data acquisition 
software.[71]  Measurements were taken using a slight adaptation of a protocol 
developed previously.[71] Briefly, nickel and titanium standards (High Purity Standards 
100036-2 and 100062-2, Charleston, SC, USA) were used to construct a standard 
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calibration curve in DI water at two different wavelengths for each ion (Figure 3-1).  This 
was then used to construct a correlation plot of known vs. measured concentrations of 
metallic ions in DMEM to validate the method, and in conjunction with the limit of 
detection, determine the optimal wavelength to use for experimental measurements.  The 
correlation plots for the two optimal wavelengths are shown in Figure 3-2.  Additionally, 
the limits of detection for each metal over a concentration range of 0-0.3 ppm was 
determined (LOD= 3σblank/ m where (σblank) represents the standard deviation of the blank 
sample containing no metallic ion and (m) represents the slope of the calibration curve) 
as shown in Tables 3.1 and 3.2. 
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Figure 3-1: Standard Curves for Nickel and Titanium 
 
 
 Figure 3-2: Correlation Plots for Nickel and Titanium to Validate Method for Potential 
Interference of Cell Media with Metal Signal 
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Table 3.1: LOD for Nickel Ions 
Nickel  221.647 nm 341.467 nm 
Concentration 
(ppm) intensity 
SD 
blank intensity 
SD 
blank 
0 3652.12 104.99 12684.17 235.32 
0.025 6594.76 206.22 16105.72 191.09 
0.05 9846.93 166.3 18915.32 333.61 
0.1 16599.51 973.19 25944.59 470.92 
0.3 43937.16 883.32 52186.5 1891.2 
          
LOD (ppm) 0.00233061   0.00535634   
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Table 3.2: LOD for Titanium Ions 
Titanium 323.452 nm 334.941 nm 
Concentration 
(ppm) intensity 
SD 
blank intensity 
SD 
blank 
0 1397.65 24.96 713.49 16.33 
0.025 4582.61 95.46 1943.19 24.82 
0.05 7815.27 9.88 3128.58 27.65 
0.1 14262.21 111.18 5706.84 18.2 
0.3 40941.32 417.49 16296.4 378.02 
          
LOD (ppm) 0.000567   0.00093941   
 
Smooth Muscle Cell Culture 
In this IACUC approved study, rat aortic smooth muscle cells were isolated from 
Sprague-Dawley female rats between 6-10 weeks of age and maintained with Dulbecco’s 
Modification of Eagle Medium (DMEM) (Mediatech, Inc., 10-013-CV, Herndon, VA) 
supplemented with 10% heat inactivated Fetal Bovine Serum (FBS) (Sigma-Aldrich, F-
4135, St. Louis, MO) and 1% Antibiotic-Antimycotic (Sigma-Aldrich, A5955, St. Louis, 
MO).  Experiments were carried out using VSMCs between passages 4-8.  For 
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experimental testing, cells were trypsinized using 0.25% Trypsin containing 0.2 mg/mL 
EDTA (Sigma Chemical Company, E6511, St. Louis, MO).  Cell counting was done 
using a hemocytometer (Hausser Scientific), and cells were seeded at a density of 2 x 104 
cells into each well of a 24-well plate suspended in 1 ml culture media and incubated for 
48 hours to allow the cells to attach.  
Experimental Groups 
This experiment was divided into 4 experimental groups of cells subjected to 
various increasing concentrations of Ni ions.  A group maintained in normal serum free 
DMEM served as the control.  The experimental groups corresponded to corrosion times 
of 2, 10, 18, and 31 days.  Each group including the control was repeated in triplicate.  
Following the 48 hr attachment period, the culture media was removed from each well 
and replaced with 1ml of either control serum free media or various corrosion 
conditioned media samples.  The cells were subjected to the test media solutions for a 
duration of 48 hrs.  Following the exposure time, the media was removed and the cells 
evaluated using the test methods described in the following sections.   
Cell Morphology 
After the duration of conditioned media exposure, media was removed, and cells 
were fixed in a 2% paraformaldehyde solution.  The cytoskeletal F-actin and cell nuclei 
were stained using Rhodamine-Phalloidin (Invitrogen, R415) and by 4',6-diamidino-2-
phenylindole (DAPI) (Molecular Probes, D-1306, Eugene, OR) respectively.  The cells 
were then imaged using fluorescent microscopy (Nikon Inc., Diaphot 300, Melville, NY).  
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ImagePro Plus image analysis software (Media Cybernetics, Inc., Version 5.1, Silver 
Spring, MD) was then used to measure the major and minor axes of the cells.  The aspect 
ratio was then calculated as the ratio of the major to minor axis lengths. 
Cell Proliferation 
At the appropriate time point, the conditioned media was removed and replaced 
with fresh serum free DMEM containing Cell Titer 96 AQueous ONE Solution Cell 
Proliferation Assay (MTS) (Promega Corporation, G-3580, Madison, WI) at a ratio of 5:1 
and incubated for 3 hrs.  After which, the solution was collected and 125 µl was 
dispensed into three wells of a 96-well plate for triple replications of each experimental 
group.  The absorbance was then measured at 490 nm (Beckman Instruments, Inc., 
Model# DU® 640B, Fullerton, CA) in order to evaluate the cell proliferative response. 
Three wells containing DMEM with the assay solution added and not incubated with 
cells were used as controls to remove the background and obtain an adjusted absorbance. 
Expression of α-actin 
Following the 48 hr duration of the corrosion media experiment, the media was 
removed, and the cells were fixed in a 2% paraformaldehyde solution.  The cells were 
then covered with 1ml blocking solution (47ml PBS, 2g bovine serum albumin, 3ml 
donkey serum, and 25µl Triton X) for 30 minutes at room temperature.  They were then 
treated with the primary mouse anti-α-actin antibody for 12 hrs at 4 °C followed by a 2hr 
treatment with donkey anti-mouse secondary antibody.  The cells were then stained using 
4',6-diamidino-2-phenylindole (DAPI) to assist in distinguishing individual cells after 
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imaging.  Imaging was done using fluorescent microscopy (Nikon Inc., Diaphot 300, 
Melville, NY).  ImagePro Plus image analysis software (Media Cybernetics, Inc., Version 
5.1, Silver Spring, MD) was used to measure the green densitometry of the stained cells. 
Statistical Analysis 
Data was evaluated using an ANOVA statistical analysis paired with Tukey 
analysis.  This was done using SigmaStat statistical analysis software (Systat Software, 
Inc., San Jose, CA) with p<0.05 indicating a significant difference.    
 
3.3 Results 
Quantification of metal ions released 
For the determination of metallic ion released from Nitinol into DMEM, 11 
different samples ranging in corrosion time from 24 hrs to 31 days were utilized.  The 
instrument was calibrated such that the control media where no additional nickel was 
added was set as the standard zero point.  In actuality, the blank media contained Ni 
concentrations of approximately 1.1 ppb.  The standardized measured ion concentrations 
are given shown in Figure 3-3.   
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Figure 3-3: Nickel Concentrations Released from Nitinol Wire with Respect to Time 
 
Cell morphology 
Cell morphology was evaluated by the measurement of cell aspect ratio (major 
axis/minor axis).  Higher aspect ratios are known to be one indication of a more 
contractile phenotype in smooth muscle cells.[72]  There was a significant difference in 
aspect ratio in all of the groups as compared to the control, which can be seen in Figure 
3-4 (P=<0.001).  However, a significant difference was not observed amongst the 
different experimental groups in response to increasing ionic concentrations. At the 
highest Ni concentration tested, the mean aspect ratio was decreased by approximately 
25% compared to the control.   
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Figure 3-4: Cell Aspect Ratio vs. Nickel Concentration 
 
Cell proliferation 
There was no significant difference in cellular proliferation in response to any of 
the nickel ion concentrations employed in the present study as evaluated using the 
Aqueous One cell proliferation assay.  This can be clearly observed in Figure 3-5 
(P=0.228).   
Expression of α-actin 
Interestingly, the most significant difference observed in cell response was with 
respect to the expression of α-actin (P=<0.001).  This is clearly illustrated in Figure 3-6.  
A significant difference in fluorescence compared to the control was observed at all but 
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the lowest concentration of Ni ions tested in this study.  At the highest concentration 
tested, a 26% decrease in fluorescence intensity was observed as compared to the control.   
 
 
Figure 3-5: Results of AQueous One Cell Proliferation Assay 
 
 
Figure 3-6: Fluorescence Intensity of Immunostained α-Actin vs. Nickel Concentration 
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3.4 Discussion 
Metal Ion Quantification 
Results from the metal ion quantification demonstrated a high variability of Ni 
release over time from the various wire samples.  This differential Ni ion release points to 
the aforementioned lack of predictability and exact reproducibility of experimental 
conditions from simply culturing cells in the presence of a sample of a metallic 
biomaterial. Furthermore, no measurable concentrations of Ti ions were observed in any 
of the samples.  This is presumably due to the high reactivity of Ti ions.  Any Ti ions 
released from the Nitinol wire would have immediately reacted with oxygen forming 
titanium oxide or dioxide and precipitated out of solution and thus not been measured by 
the ICP-OES analysis. 
Cell Morphological Analysis 
Cell morphological analysis demonstrated a significant decrease in cell aspect 
ratio in response to nickel ions present in conditioned media samples.  However, there 
was no significant difference observed amongst the different experimental groups in 
response to increasing nickel ion concentrations.  This was presumably due to the 
relatively low ion concentrations employed in this experiment.  At higher Ni 
concentrations, greater morphological changes would likely be observed due to ion 
toxicity. 
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Cellular Proliferation 
No significant difference in cell proliferation was observed for any of the nickel 
ion concentrations employed in the present study.  Similar to the results from the 
evaluation of cell morphology, the lack of observed differences in cellular proliferation 
was likely the result of the low ion concentrations employed in these experiments.  It is 
common knowledge that very high nickel concentrations are toxic.  The toxicity 
threshold for VSMCs at which proliferation starts to become significantly inhibited was 
demonstrated by Shih and collaborates to be approximately 9ppm in vitro.[58]  It was not 
our intention in these experiments to observe cellular changes under extreme conditions 
that would likely never be encountered in vivo.  Implanted Nitinol stents are not known to 
cause excessive levels of local tissue necrosis indicating that they likely do not cause high 
levels of cellular death as a direct result of metallic ion release. 
α-Actin Expression 
The most prominent response observed in this study was a steady decrease in α-
actin expression in response to increasing nickel ion concentration.  The decrease in α-
actin expression indicates a progressive loss of the contractile mechanism present in the 
cell resulting in a decrease in the contractile ability of the cell and subsequently result in a 
lack of muscular tone in the vessel wall.  The lack of muscular tone in the vessel wall 
would lead to an increase in vessel wall strains.  This is of a great importance because 
increasing mechanical strain has been linked to increased proliferation of VSMCs in vitro 
[73-77].  Furthermore, high blood pressure, and thus increased force on the vessel wall, 
and increased strain by as much as 15%, causes thickening of the blood vessel wall due in 
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part to VSMC proliferation in vivo.[76, 78-80]  It is reasonable to expect that increased 
strains as a result of loss of VSMC contractility would cause a similar adaptive 
thickening in a stented artery thereby contributing to the development of restenosis.  It is 
also plausible to assume that the trend of decreasing α-actin expression, as indicated by 
fluorescence intensity, would continue with increasing ionic concentrations below those 
concentrations shown to affect cell proliferation in vitro previously mentioned in the 
introduction by Shih and others further reducing VSMC contractility. 
Possible mechanisms of action Nickel Ions on Eukaryotic cells 
In this study, we have shown increasing concentrations of nickel ions in culture 
media to affect VSMC morphology and expression of α-actin.  While our study showed 
no effect on cell proliferation, other studies available in the literature demonstrated that 
nickel concentrations higher than those we employed do significantly affect cell 
proliferation.  The questions that immediately arise from these observations are how and 
why do nickel ions have this effect on eukaryotic cells?  While the exact mechanism by 
which nickel ions affect various aspect of cell metabolism remains somewhat unclear, 
several studies available in the literature may help to shed some light on the matter.  One 
early study by Webb et al. looked at the in vitro distribution of nickel ions in the various 
subcellular fractions of mouse dermal fibroblasts following the addition of nickel 
chloride.[81]  It was shown that highest nickel concentrations in the cell in decreasing 
order were in the cell nuclei, cell sap, mitochondria, and microsomes.[81]  Within the cell 
nuclei, the majority of the nickel was recovered in the nucleoli.  This result agrees with 
previous data gathered from a study by Heath et al. in which tumors were induced in rats 
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by injection of metallic nickel powder in suspension.[82]  Analysis of tissue samples 
from these tumors demonstrated nickel content to be highest in the nuclear fraction 
followed by the mitochondrial and microsomal fractions in decreasing order.[82]   
From these studies, it is reasonable to speculate that increasing concentrations of 
nickel ions would first affect ribosomal RNA transcription by accumulating in the 
nucleolus.  As nickel concentrations increased, it would likely then lead to an increased 
inhibition of RNA transcription as well as inhibitory concentrations in the mitochondria 
affecting ATP synthesis.  This assumption would follow with the observations of nickel 
ions first affecting protein expression, which increases with increasing nickel 
concentration followed by inhibition of cellular proliferation as the concentration 
increases further eventually causing cell death. 
Additionally, the observed decrease in aspect ratio could be explained by several 
studies available in the literature that evaluated the effect of nickel ions on the F-actin 
and microtubules.  A study by DalleDonne et al. demonstrated that the addition of nickel 
to the polymerization of actin and tubulin monomers in solution results in the formation 
of shorter polymers compared to the control.[83]  Additionally, the Ni induced actin 
filaments were prone to aggregating in groups of twos and threes.  Li et al. demonstrated 
significant change in cytoskeletal morphology marked by the aggregation of microtubules 
in 3T3 cells in response in 2mM concentrations of NiCl2 for 20 hrs in vitro compared to a 
control.[84]  Furthermore, Gunaratnam et al. observed decreased F-actin expression in 
combination with what was thought to be condensation of the F-actin filaments in 
response to exposure of rat hepatocytes to 500µM concentrations of Ni ions compared to 
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a control.[85]  The disruption to the normal cytoskeleton cited in the aforementioned 
studies is a possible cause of the decrease in aspect ratio observed in the present 
experiment. 
The exact mechanism by which Ni ions elicit various observed cellular responses 
has not been completely elucidated.  However, it is thought to be linked to an ability of 
Ni ions to compete with Mg ions at various binding sites as well as affect various calcium 
ion channels.[86, 87]  Several studies have shown that increasing the extracellular Mg 
concentration blocks the various effects of Ni ions on cells in vitro including damage to 
and polymerization inhibition of DNA as well as inhibition of cell proliferation.[88-90]  
Furthermore, Mlinar et al. demonstrated the ability of Ni ions to block T-type voltage 
gated calcium channels in rat and human C cell lines in a concentration dependent 
manner.[91]  This effect was not inhibited by increasing the extracellular calcium 
concentration.  The channel block was hypothesized to be due to occlusion of the channel 
pore by the metal ion by binding to a calcium binding site outside of the membrane 
electric field.[91]   
 
3.5 Conclusion 
In this study, a lack of predictability of corrosion rates and subsequent ion release 
even amongst metallic samples from the same lot held under the same conditions was 
demonstrated.  This variability of experimental conditions was eliminated by using ICP-
OES to quantify the concentrations of Ni present in our experimental media.  This allows 
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the experimental conditions to be predictably reproduced in future studies in order to 
evaluate other aspects of cellular response. 
As shown by others [59, 60], no change in cellular proliferation was observed at 
the low nickel ion concentrations employed in this study.  However, the studies present in 
the literature that did show a significant difference in various indicators of cellular 
proliferation [58, 61, 62] employed relatively high Ni concentrations that would be 
unlikely to occur in vivo as a direct result of an implanted medical device.  This is 
especially true for an intravascular stent where such a small amount of biomaterial is 
present in the tissue.  The present study utilized much lower ionic concentrations in an 
effort to evaluate the more subtle effects that such low concentrations have on cell 
response that would be more likely to carry over into clinical observations.  Our results 
have shown altered cell morphology as well as a decreased smooth muscle cell α-actin 
expression in response to low nickel concentrations in vitro.  These observations shed 
some light on one possible contributing factor to the development of in-stent restenosis. 
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-CHAPTER 4- 
Aim 3: Evaluation of Phenotypic Behavior of Vascular Smooth Muscle Cells Exposed to 
Concurrent Cyclic Strain and Flow Shear in Response to Model 316L Stainless Steel and 
Nitinol Stent Struts. 
 
4.1 Introduction 
Many studies have been published in the literature attempting to elucidate the role 
of the stent, as well as its properties, on restenosis.  A major contribution to the 
minimization of the risk of restenosis lies in the optimization of various stent design 
attributes.  One of these design criteria that will be evaluated in this study is material 
selection.  Table 4.1 lists the most important properties of a biomaterial surface that affect 
its interactions with proteins and subsequent thrombogenicity (Dee et al) emphasizing 
material composition as a major determining factor. The predominant stent materials used 
today are 316L SS and Nitinol.  Both of these materials are relatively biocompatible, and 
they are generally selected for the individual application whether it is more desirable to 
have a self-expanding or balloon expanded stent.  However, there are few studies 
available in the literature comparing the effects of various metallic stent materials on 
smooth muscle cells under dynamic culture conditions. 
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Table 4.1: Properties of Surfaces that Affect Their Interaction With Proteins [13] 
Feature Effect 
Topography Greater texture exposes more surface 
area for interaction with proteins 
Composition Chemical makeup of a surface will 
determine the types of intermolecular 
forces governing interaction with 
proteins 
Hydrophobicity/ Free Surface Energy Hydrophobic surfaces tend to bind more 
protein 
Heterogeneity Non-uniformity of surface characteristics 
results in domains that can interact 
differently with proteins 
Electrical Potential  Surface potential will influence the 
distribution of ions in solution and 
interaction with proteins 
 
As a metallic surface is exposed to air, a certain degree of oxidation takes place.  
For example, stainless steel and chromium based alloys form a surface layer composed 
primarily of hydroxide or chromium oxide, whereas titanium readily oxidizes on its 
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surface to form the quite stable titanium dioxide.[92]  The stability of these ceramic 
oxidized layers is taken advantage of by using a process called passivation as a surface 
treatment method for metallic implants.[93]  Passivation is performed to further enhance 
the surface stability following electropolishing in order to form a thicker stable oxide 
layer on the surface.  In this process, stainless steel stents are rinsed with deionized water 
following electropolishing and then soaked in a nitric acid and sodium dichromate 
solution to form a stable chromium dioxide layer on the stent surface.[94]  This 
passivation step is generally not needed for titanium alloy stents, as they readily oxidize 
to form a titanium oxide rich layer under atmospheric conditions.[94]   In addition to 
enhancing the surface characteristics of an implant, the formation of an oxide layer on the 
material surface has also been shown to help “seal” the implant and reduce the release of 
metal ions in the body.[93, 95, 96]  This may be of particular interest in dealing with the 
high levels of nickel contained in the alloy Nitinol.   
The corrosion byproducts of both stainless steel and Nitinol have been shown by 
Shih et al. to inhibit VSMC growth at high concentrations in static culture.[58, 97]  
However, the afore mentioned studies utilized electrochemical corrosion of sample wires 
to obtain concentrations of corrosion products that are much higher than those that would 
be expected in vivo.  Additionally, experimentation was done under static conditions, 
which may not be representative of the cellular response in a dynamic culture 
environment.  Other experiments have compared the static corrosion byproducts of 
Nitinol and stainless steel.  Ryhanan et al. immersed samples of Nitinol and stainless steel 
in DMEM and observed an initially higher release of Ni ions from the Nitinol sample, as 
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determined by flameless atomic adsorption spectrophotometry, compared to the stainless 
steel sample.[60]  However, the concentrations leveled out after approximately two days 
and remained so until the 10 day final time point.  Furthermore, stainless steel contains 
small amounts of chromium that could be released into the culture media. Chromium has 
been shown to lead to DNA damage, cellular apoptosis, and carcinogenesis.[98-100] 
The purpose of this study is to evaluate smooth muscle cell response to a model 
stent strut while subjected to concurrent cyclic strain and flow shear mechanical 
stimulation.  This model is used to elucidate any variable response of the cells due to 
variations in strut material while holding all other variables constant. 
 
4.2 Materials and Methods 
Cell Culture 
In this IACUC approved study, rat vascular smooth muscle cells (VSMC) were 
isolated from the aortas of Sprague-Dawley female rats between 6-10 weeks of age 
(Appendix C) and maintained with Dulbecco’s Modification of Eagle Medium (DMEM) 
(Mediatech, Inc., 10-013-CV, Herndon, VA) supplemented with 10% heat inactivated 
Fetal Bovine Serum (FBS) (Sigma-Aldrich, F-4135, St. Louis, MO) and 1% Antibiotic-
Antimycotic (Sigma-Aldrich, A5955, St. Louis, MO).  Experiments were carried out 
between passages 5 to 8.  For experimental testing, cells were trypsinized using 0.25% 
Trypsin containing 0.2 mg/mL EDTA (Sigma Chemical Company, E6511, St. Louis, 
MO). 
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 Cell Seeding for Mechanical Testing 
Silicone membranes were cut into circles 5.25 cm in diameter for each culture 
plate out of biomedical grade silicone sheets (Lot SM04106803, Specialty 
Manufacturing, Inc. Saginaw, MI)  0.015" in thickness and 40 durometer Shore A.  The 
cut silicone sheets were then cleaned using sonication in deionized water and press fit 
into the culture plates using an inner Lexan ring.  The culture plates were then autoclaved 
(Tuttnauer Brinkmann, 3870M, Jerusalem, Israel) at 121 °C for 30 minutes and put into 
their appropriate place in the main body of the simulator.  The assembled system was 
then UV sterilized for 3 hours.  The Teflon rings were sonicated in a 1% detergent 
solution (Liquinox Critical Cleaning Detergent, Alconox, Jersey City, NJ) for 15 minutes 
followed by three rinses DI water.  They were then autoclaved and centered on the Lexan 
post on top of the silicone membrane.  The area inside of the Teflon rings was then 
coated with Type I Collagen (Purecol 3mg/ml, Advanced Biomatrix, lot# 1356) diluted 
with sterile DI.  This resulted in a collagen coated culture area contained to the top of the 
simulator post such that the cultured cells experienced equibiaxial strain stimulation.  The 
coated membranes were rinsed with 1.0 ml of Dulbecco’s Phosphate Buffered Saline 
(DPBS) (Media Tech, Inc., 21-031 CM, Herndon, VA) before cell seeding.  Cell counting 
was done using a hemocytometer (Hausser Scientific), and cells were seeded at a density 
of 6 x 104 cells per plate, suspended in 1.5 ml culture media, and incubated for 48 hours 
to allow the cells to attach.   
65 
	  
 
 
Experimental Setup for Mechanical Testing 
Nitinol wires (ASTM F2063, Small Parts, part # NW-005-36-05) and 316L 
stainless steel wires (ASTM F138, Small Parts, part # GWXX-0050-60-05) 4.4 cm long 
and 0.203 mm (0.008 inches) in diameter were ultrasonically cleaned similarly to the 
Teflon rings followed by EtO gas sterilization (AN 74i Anproline Gas Sterilizer, 
Andersen Products Inc.) for 12 hours.  The sterile wires were then carefully placed atop 
the cultured cells and secured at the ends using molten Surgipath EM-400 paraffin wax 
embedding medium (Surgipath Medical Industries Inc., Richmond, Illinois, USA).  The 
control groups also received the wax, but were not loaded with the wire.  The cells were 
then subjected to the wire loading combined with concurrent cyclic strain and flow shear 
stimulation for 24 hours.  The study consists of four groups each containing three 
samples.  The groups were a Nitinol wire group (NiTi), a stainless steel wire group (SS), 
a sham injury group (Sham), and a control group (Ctrl) containing no wire.  For the sham 
injury group, a Nitinol wire was placed for approximately 5 seconds and removed in an 
attempt to separate the effect of strut contact from that of cell injury or death as a result of 
wire placement. 
The vascular simulator described presently is comprised of two simulator bodies 
each having three independent channels (Figure 4-1).[29]  This thereby allows for six 
different samples, each independent from one another.  Equibiaxial strain was applied to 
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cells cultured on the silicone membrane by applying vacuum suction in order to stretch 
the membrane over the central post at a rate of 1 Hz.  To ensure the cells experienced a 
uniform strain stimulus, they were confined to the central post region using a Teflon 
retainer ring of 2.75 cm2 inner diameter and 1.75 cm in height.  This ring was then 
removed prior to mechanical testing.  Additionally, silicone lubricant was applied atop 
the Lexan post in order to reduce friction between the membrane and post.  The strain 
was controlled at 5% by regulating cyclic vacuum pressure using Flexcell 3000 system.  
A peristaltic pump was employed in order to provide a flow rate of 400 ml/min across the 
culture area.  This was previously calculated to result in a low level of wall shear stress of 
approximately 0.3 dynes/cm2 in order to promote cell proliferation.[29, 101]  The 
experimental setup is shown in Figure 4-1. A variety of design parameters such as 
entrance length, channel depth, and channel width were carefully selected in order to 
mimic various physiological flow conditions including laminar flow, fully developed 
flow at the cells, and desired levels of shear stresses.  These parameters were confirmed 
by calculating the Reynold’s number for the channel flow.[102] 
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Figure 4-1: Dynamic Vascular Simulator Setup 
 
Evaluation of DNA Synthesis 
After mechanical stimulation, DNA synthesis was evaluated via an ELISA based 
bromodeoxyuridine (BrdU) incorporation assay (Roche).  Briefly, cells were BrdU 
labeled for a duration of 2 hours after which they were fixed in the provided 
fixation/DNA denaturation solution for 30 minutes.  Following this step, the cells were 
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incubated with an enzyme linked anti-BrdU antibody solution for 90 minutes.  After 
several rinses, the cells were then incubated with a substrate solution for 30 minutes and 
absorbance was read at 370 nm with a reference wavelength of 492 nm.  The remaining 
cells on the culture plate were then lysed using a 1% Triton X-100 solution and the total 
protein content quantified via BCA assay in order to normalize the absorbance values. 
Expression of α-Actin 
The expression of α-actin was measured using a slight modification of an 
established ELISA assay (Appendix D).[103]  Briefly, the cells were PBS rinsed and 
fixed in a 2% paraformaldehyde solution.  The cells were then covered with 1ml blocking 
solution (47ml PBS, 2g bovine serum albumin, 3ml FBS, and 25µl Triton X-100) for 45 
minutes at room temperature.  They were then treated with the primary mouse anti-α-
actin antibody diluted 1:200 for 2 hrs at RT, followed by a 2 hr treatment with a 
biotinylated mouse IgG secondary antibody diluted 1:200.  The cells were then incubated 
for 45 minutes at 37 °C with a streptavidin conjugated alkaline phosphatase diluted 1:500 
in TBST buffer (pH 8).  Finally, the cells were incubated with the subtrate solution (3mM 
pNpp, 0.05 M Na2CO3, 0.05 mM MgCl2) for 45 minutes at 37 °C, and the absorbance 
read at 405 nm.  The cells were then lysed using a 1% Triton X-100 solution and total 
protein measured using BCA in order to normalize the absorbance values to total protein 
content. 
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Statistical Analysis 
All data was evaluated using an ANOVA statistical analysis paired with Tukey 
analysis.  This was done using SigmaStat statistical analysis software (Systat Software, 
Inc., San Jose, CA) with p<0.05 indicating a significant difference.     
4.3 Results 
DNA Synthesis 
DNA synthesis was used as a tool to evaluate cell proliferation.  Data showed 
both SS (P=0.026) and Nitinol (P=0.002) stent struts demonstrated a significant increase 
in DNA synthesis as compared to the control. However, there was not a significant 
difference between the SS and Nitinol groups (P=0.274).  Additionally, there was no 
significant difference between the control and sham groups (P=0.585).  Both 316L 
stainless steel and Nitinol yielded significantly increased absorbance of approximately 
81% and 125% respectively over the control group.  However, the sham group was not 
significantly different to the control with absorbance values returning to within 
approximately 29% of the control group in the 24hr time point tested.   
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Figure 4-2: BrdU Assay of VSMCs Subjected to Concurrent Cyclic Strain and Fluid 
Shear (* indicates a significant difference as compared to the control with P< 0.05) 
 
Expression of α-Actin 
There was a significant decrease in α-actin expression in the SS (P=0.012), NiTi 
(P=0.002), and Sham (P=0.042) groups as compared to the control; however, no 
significant difference was observed with Nitinol compared to 316L stainless steel or 
either group compared to the sham group.  This resulted in an approximately 42%, 55%, 
and 32% decrease in absorbance for the SS, NiTi, and Sham groups respectively as 
compared to the control.  
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Figure 4-3: α-Actin ELISA Assay of VSMCs Exposed to Concurrent Cyclic Strain and 
Flow Shear (* indicates a significant difference as compared to the control with P< 0.05) 
 
4.4 Discussion 
DNA synthesis 
BrdU analysis showed a decrease in DNA synthesis for both the SS and NiTi 
groups as compared to the control; however, no significant difference was observed 
between the two. This indicated that with respect to cell proliferation, as illustrated 
through the evaluation of DNA synthesis, there was not significant difference regarding 
the effect of stent strut composition between 316L stainless steel and Nitinol.  
Additionally, it appeared that the observed response of increased DNA synthesis caused 
by stent strut contact with the smooth muscle cells was a rapidly reversible one further 
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indicated by the lack of difference between the control and sham groups after a time 
period of 24 hours. 
Expression of α-Actin 
Results demonstrated a significant decrease in α-actin expression in all of the 
experimental groups as compared to the control; however, no significant difference was 
observed between the SS and NiTi groups.  This response indicated that the loss of α-
actin expression was a rapid event that likely occurs in response to injury incurred upon 
placement of the model stent strut.  Similar to results observed from DNA synthesis, the 
decreased α-actin expression appeared to be independent of stent material composition 
between 316L stainless steel and Nitinol.  However, contrary to results observed for 
DNA synthesis, the sham group demonstrated that the decrease in α-actin expression was 
a somewhat lasting response that was not reversible after removal of the strut within the 
24 hr time period tested. 
It is important to note that the higher modulus of elasticity of 316L stainless steel 
employed in this study would result in less wire deformation causing slightly lower 
strains across the culture area as compared to the Nitinol strut as modeled in Aim 1.  
However, results showed that these slightly lower strains did not noticeably affect cell 
proliferation or α-actin expression in the present study.  Additionally, while the 
chromium content of SS was of some concern because of potential to lead to DNA 
damage and apoptosis[98-100], no noticeable effect was observed in DNA synthesis. 
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4.5 Conclusion 
The placement of a model stent strut under dynamic conditions of 5% cyclic 
strain and a 400 ml/min flow rate giving rise to a shear of 0.3 dynes/cm2 were shown to 
lead to increased DNA synthesis and decreased α-actin expression indicating a possible 
shift toward a synthetic phenotype.  These results were somewhat expected and are quite 
representative of what occurs post implantation in an in vivo model.  While the sham 
groups did demonstrate differences in the possible reversibility of these responses within 
24 hrs of the removal of the contact stimulus, there was no observed difference between 
the two materials tested in all assays in response to model strut contact.  This illustrated 
that with respect to its propensity to influence a synthetic phenotypic shift in VSMCs 
cultured under dynamic culture conditions, Nitinol appears to be equally suited for use as 
compared to the traditionally accepted gold standard of 316L stainless steel. 
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-CHAPTER 5- 
Aim 4: Analysis of HA Coated Nitinol Stent Struts and Their Subsequent Effect on the In 
Vitro Phenotypic Behavior of Vascular Smooth Muscle Cells. 
 
5.1 Introduction 
Many studies have been published in the literature attempting to elucidate the role 
of the stent itself, as well as its material and physical properties, on restenosis.  In the 
present study, we used our model to elucidate the response of vascular smooth muscle 
cells due solely to surface coating.  Surface coatings can be beneficial in several ways.  
First, coatings can be loaded with anti-proliferative and/or anti-coagulant drugs to help 
reduce thrombosis and restenosis as is done with drug eluting stents (DESs) currently on 
the market.  Additionally, surface coatings are beneficial to provide a more favorable 
blood-biomaterial interface as well as prevent possible structural weakening of the stent 
itself.[104] 
Polymeric Surface Coatings 
Much of the early work on stent surface coating focused on the use of applied 
polymeric coatings in order to minimize the body’s response to the implanted 
biomaterial.  Researchers sought to develop an optimal surface for tissue contact that 
would elicit a minimal inflammatory and likewise proliferative response.  Porcine models 
have also shown coatings such as PLL-g-PEG to be effective at reducing both thrombosis 
and restenosis.[105]  It is important to note that not all polymer coatings tested have been 
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shown to reduce thrombosis, inflammatory response, and subsequent restenosis compared 
to a bare metal stent.[105, 106]  In fact, many of the early polymers tested caused an 
intense inflammatory response.[107]  Some other polymers that have been the recent 
subject of experimental testing include among others: poly(styrene-b-isobutylene-b-
styrene) trade name Translute [108], ethylene-vinyl acetate (EVA) [109], ethoxyethyl 
methacrylate-based copolymers by Medtronic [110], polyethylene-co-vinyl acetate 
(PEVA), phosphorylcholine [111], and poly n-butyl methacrylate (PBMA) 
copolymer[112].  It has also been shown that similar polymers of slightly different 
formulations can cause very different reactions in vivo.[106, 113]  This was well 
illustrated by the porcine model of Lincoff et al.[113]  This experimental study showed a 
marked difference in the inflammatory response following implantation of stents coated 
with an absorbable coating of poly-L-lactic acid (PLLA).  The low molecular weight 
formulation of the polymer triggered an intense local inflammatory response, whereas the 
high molecular weight formulation was seemingly well tolerated by the animals in the 
experimental group.[113]    
Another issue for concern with the use of polymer coated stents is the long term 
stability of the polymer coating.[107]  The long term exposure of polymers to the harsh 
hemodynamic and chemical environment inside the body may lead to their eventual 
degradation, resulting in the possible release of both toxic byproducts and polymer 
fragments causing cell death as well as late inflammation and thrombosis. 
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Ceramic Surface Coatings 
A number of different ceramic coatings have been investigated for their use with 
intravascular stents.  The use of silicon carbide coatings has been shown to reduce stent 
thrombogenicity at 90 min in the carotid artery of a porcine model compared to an 
uncoated control.[114]  This reduction in thrombus formation could possibly result in a 
reduced inflammatory response and subsequently reduced SMC proliferative response.[4, 
13]  However, the TENISS clinical trial comparing silicon carbide coated stents to 
uncoated stents showed no significant difference between the two in clinical and 
angiographic restenosis rates in humans at approximately 4.7 +/- 1.2 months [115], which 
again held true at approximately 81 +/- 12 weeks follow-up [116].    
Another form of ceramic surface coating currently being studied is hydroxyapatite 
(HA, Ca10(PO4)6(OH)2).[117]  HA coating of stents is a relatively new idea, but may be 
beneficial for several reasons.  First, HA forms a porous coating on the stent surface that 
can be utilized at a drug delivery platform that does not elicit the same degree of 
inflammatory response associated with polymeric delivery systems.[118-121]  
Additionally, HA coated implants including nickel-titanium alloys and stainless steel 
have shown a reduced release of metallic ions including nickel as compared to a non-
coated control in vitro.[122-124]  HA is also a very biocompatible material that promotes 
cell attachment; however, its osteogenic potential may be the cause for some concern. 
Nadra et al. showed that HA crystals were shown to promote TNF-α (a pro-inflammatory 
cytokine and vascular calcifying agent) expression by human macrophages in vitro.[125]  
This study is significant in terms of the potential inflammatory response to an implanted 
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HA coated stent due to the possible generation of HA particles upon stent deployment.  
Additionally, a study by Lin et al. demonstrated the ability of HA to stimulate osteogenic 
activity in mouse mesenchymal stem cells in vitro as compared to cells grown on 
titanium and plastic controls.[126]  This was demonstrated by the increased expression of 
osteo-specific genes including alkaline phosphatase, type I collagen, and osteocalcin.  
Similarly, Sun et al. cultured human mesenchymal stem cells on 
hydroxyapatite/tricalcium phosphate double phase ceramic in vitro.[127]  The cells 
showed increased expression of osteogenic marker genes Runx2, collagen type I, 
osteopontin, and osteocalcin.   
A number of different in vivo studies have also demonstrated the ability of HA to 
stimulate an osteogenic response when implanted both subcutaneously and 
intramuscularly in various animal models.[128-132]  Yuan et al. implanted HA cylinders 
into the dorsal muscle of dogs and observed significant bone formation as early as 30 
days, which increased to time, points up to 6 months.[130, 132]  Le Nihouannan et al. 
injected 1-2 mm biphasic calcium phosphate granules with a 60/40 composition of 
hydroxyapatite and beta-tricalcium phosphate into the dorsal muscles of sheep to evaluate 
their osteogenic potential.[131]  At 6 months, ectopic bone formation was observed with 
trabeculae between the particles similar in size and number to those observed in 
spongious bone indicating the ability of the injected particles to stimulate mature bone 
formation. 
The exact mechanism by which implanted HA stimulates bone formation in vivo 
remains unclear.  De Groot suggested that there is a concentration of endogenous bone 
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morphogenic protein (BMP) accumulated at the ceramic surface that triggers stem cells to 
form bone tissue.[131, 133, 134]  This concentration of BMP at the surface of implanted 
HA was further supported in a study by Yaun et al.[135]  This study investigated the 
ability of calcium phosphate ceramics to absorb BMP both in vitro and in vivo.  The in 
vitro study showed HA to have the strongest absorption ability compared to the other 
calcium phosphate ceramics tested binding all of the BMP in the test solution within 2 
hrs.  This absorbed BMP could not be effectively washed from the surface using distilled 
water or a calcium chloride solution, but was removed by washing with a phosphate 
buffer indicating that BMP may bind to Ca2+ in calcium phosphate ceramics.  In the in 
vivo porcine study, the polymorphic cells and organic matrix on the surface of the HA 
pores stained positive for BMP as did some of the cells within the pores.  Additionally, 
the amount of new bone formed was increased by pre-treating the ceramics with BMP 
prior to implantation.[135]   
Another possible explanation for the observed osteogenic response to implanted 
HA is the dissolution of the ceramic surface and release of calcium phosphate ions.[131, 
136, 137]  A study by Reynolds et al. demonstrated extensive calcification of human 
VSMCs in response to the addition of exogenous calcium phosphate at 24 hours 
compared to a control in standard DMEM.[138]  Similarly, Jono et al. showed in vitro 
calcification of human VSMC in response to the addition of inorganic phosphate to 
standard DMEM at concentrations as low as 2 mmol/L Pi compared to the normal serum 
concentration of 1.4 mmol/L Pi.[139]  Interestingly, this calcification response was not 
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observed in mouse NIH3T3 fibroblasts or bovine aortic endothelial cells with Pi 
concentrations as high as 10 mmol/L. 
Alkaline phosphatase (ALP) has been well linked to bone mineralization for more 
than eighty years.  Recently however, VSMC calcification has been somewhat linked to 
ALP expression.[140, 141]  ALP is a hydrolase enzyme responsible for 
dephosphorylating a number of different molecules and thus liberating more free 
inorganic phosphate previously indicated to lead to increased vascular calcification.  It is 
one of the first genes expressed during the process of calcification.  Additionally, the use 
of ALP inhibitors has been shown to inhibit vascular calcification in vitro [140].  Thus, it 
is often used as a marker for vascular calcification. 
The present study was aimed at evaluating the performance of HA as a possible 
stent coating the three main areas.  First, we wished to evaluate the purity of the HA 
coating as well as it resistance to cracking and flaking upon straining of the stent.  
Secondly, VSMC phenotypic response to the HA coating was evaluated through the 
assessment of DNA synthesis and α-actin expression.  Finally, we investigated the 
osteogenic potential of the HA coating through examination of a number of different 
osteogenic markers such as expression of ALP, osteopontin expression, and cellular 
calcification. 
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5.2a Characterization of HA Coating 
Materials and Methods 
HA Coating of Nitinol Stent Specimens 
As shown in Figure 5-1, Nitinol stents (Cook Biomedical, Bloomington, IN) were 
spray coated with a thin HA film (EnBio, CoCork, Ireland) using a novel proprietary 
CoBlast procedure.  Briefly, the stent surface was simultaneously blasted with two 
powders, an abrasive and a dopant, from two separate Venturi style nozzles.  In our case, 
apatitic MCD (100 µm, Himed Inc., NY), which is a form of sintered calcium 
phosphates, served as the abrasive.  The dopant was hydroxyapatite [Ca10(PO4)6(OH)2] 
powder (25-60µm, S.A.I., Lyon, France).  The process takes advantage of the inherent 
reactivity of titanium rich surfaces in order to firmly bond the doping agent. 
Preparation and HA Coating of 316L Stainless Steel Specimens 
Stainless steel specimens were prepared as described in previous work from our 
lab.[103]  Briefly, annealed 316L stainless steel specimens (Brown metal company, 
Rancho Cucamongo, CA) 1.5 cm in diameter were divided into two groups 
electropolished (EP) and hydroxyapatite coated (HA). Team Metal Finishing of Toccoa 
Georgia performed electropolishing of specimens.  HA coating of specimens was carried 
out as described previously for the Nitinol stent specimens (EnBio, CoCork, Ireland). 
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Figure 5-1: Schematic of CoBlast Coating Procedure Resulting in HA Deposition on 
Outer Surface of Stent Struts 
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EDS Analysis of HA Coating 
Electron dispersive x-rays (EDS, Model S-3400N, Hitachi, Japan) were used to 
gain a quantitative breakdown of elements on the sample stent surface.  This was done in 
order to ensure the purity of the HA surface coating with an appropriate 
calcium/phosphorous ratio. 
Post-Strain Integrity of HA Coating 
The integrity of the HA coating is of particular interest due to the brittle nature of 
HA.  The effect of deployment-induced strains on HA coating integrity was investigated.  
Stent specimens were strained at levels similar to those that would be encountered upon 
placing a stent into its retention sheath on the guide wire.  This was achieved by 
constructing a glass extrusion tip using a 2 ml glass pipette by first heating one end of the 
pipette to its melting point with a propane torch, and then pinching it closed in order to 
seal the end of the pipette.  After the pipette was allowed to cool, the middle portion was 
heated to its melting point while gently blowing air into the open end resulting in an 
expansion of the heated portion.  The pipette was then allowed to cool and the glass was 
trimmed to form a small funnel-shaped extrusion tip.  The HA coated stent was then 
forced through the extrusion tip in order to tentatively simulate strains that would likely 
be encountered during the packaging and implantation processes.  
Following the straining procedure for the HA coated stents, the integrity of the 
coating was then analyzed by scanning electron microscopy (SEM, Model S-3400, 
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Hitachi, Japan).  This was done in order to visually inspect the HA coating for possible 
cracking and flaking.  
 
5.3b Cell Response to HA Coating 
Materials and Methods 
Cell Culture 
In this IACUC approved study, rat vascular smooth muscle cells (VSMC) were 
isolated from the aortas of Sprague-Dawley female rats between 6-10 weeks of age 
(Appendix C) and maintained with Dulbecco’s Modification of Eagle Medium (DMEM) 
(Mediatech, Inc., 10-013-CV, Herndon, VA) supplemented with 10% heat inactivated 
Fetal Bovine Serum (FBS) (Sigma-Aldrich, F-4135, St. Louis, MO) and 1% Antibiotic-
Antimycotic (Sigma-Aldrich, A5955, St. Louis, MO).  Experiments were carried out 
between passages 4-8.  For experimental testing, cells were trypsinized using 0.25% 
Trypsin containing 0.2 mg/mL EDTA (Sigma Chemical Company, E6511, St. Louis, 
MO). 
 Cell Seeding for Dynamic Mechanical Testing 
Silicone membranes were cut into circles 5.25 cm in diameter for each culture 
plate out of biomedical grade silicone sheets (Lot SM04106803, Specialty 
Manufacturing, Inc. Saginaw, MI)  .015" in thickness and 40 durometer Shore A.  The 
cut silicone sheets were then cleaned using sonication in deionized water and press fit 
into the culture plates using a inner Lexan ring.  The culture plates were then autoclaved 
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(Tuttnauer Brinkmann, 3870M, Jerusalem, Israel) at 121 degrees Celsius for 30 minutes 
and put into their appropriate place in the main body of the simulator.  The assembled 
system was then UV sterilized for 3 hours.  The Teflon rings were sonicated in a 1% 
detergent solution (Liquinox Critical Cleaning Detergent, Alconox, Jersey City, NJ) for 
15 minutes followed by three rinses with DI water.  They were then autoclaved and 
centered on the Lexan post on top of the silicone membrane.  The area inside of the 
Teflon rings was then coated with Type I Collagen (Purecol 3mg/ml, Advanced 
Biomatrix, lot# 1356) diluted with sterile DI water.  The coated membranes were rinsed 
with 1.0 ml of Dulbecco’s Phosphate Buffered Saline (DPBS) (Media Tech, Inc., 21-031 
CM, Herndon, VA) before cell seeding.  Cell counting was done using a Millipore 
ScepterTM cell counter, and cells were seeded at a density of 6 x 104 cells suspended in 
1.5 ml culture media per plate, and incubated for 48 hours to allow the cells to attach.   
The vascular simulator described presently was comprised of two simulator 
bodies with each body having three independent channels, which thereby allowed for six 
samples independent from one another.[29]  In order to mimic the in vivo mechanical 
environment, cells were subjected to stimulation from cyclic strain.  Equibiaxial strain 
was applied to cells cultured on the silicone membrane by applying vacuum suction to 
stretch the membrane over the central post.  Silicone lubricant was applied on top of the 
post in order to reduce friction between the membrane and post.  The vacuum pressure 
was controlled using Flexcell 3000 software in order to apply a 5% cyclical strain to the 
membranes at a rate of 1 Hz.  This level of strain is representative of physiological 
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conditions in which the vessel wall experiences strains that are generally lower than 10% 
and may be as low as 0-4%.[102, 142-144]   
The present study consisted of four groups each containing three samples and 
repeated in duplicate.  These groups were comprised of a control group (Ctrl) in which no 
wire was placed, a hydroxyapatite coated Nitinol stent group (HA), a non-coated as-
received Nitinol stent group (NiTi), and a sham wire placement group in which a non-
coated Nitinol stent specimen was placed for a duration of 5-10 seconds and then 
removed in an effort to separate the effect of injury incurred during stent placement from 
that of stent contact on the VSMCs.  Dynamic experiments were carried out at time 
points of 25 hrs and 5 days to judge the changing cellular response over time.  
Cell Seeding for Static Testing 
Contrary to the other experiments carried out in the present study, analysis of 
VSMC calcification was carried out under static conditions using the stainless steel disks.  
For this experiment, the disks were first clean by sonication in 100% isopropyl alcohol 
for a duration of 15 minutes.  Following this, the disks were rinsed in de-ionized water 
and again sonicated for a duration of 20 minutes in a 5% detergent solution (Liquinox, 
Alcon Inc.).  Finally, disks were subjected to three 15-minute ultrasonic rinses in de-
ionized water with complete water changes at each rinsing interval.  The specimens were 
then sterilized using standard 12 hr ethylene oxide sterilization (AN 74i Anproline Gas 
Sterilizer, Andersen Products Inc.). 
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DNA Synthesis 
After mechanical stimulation, DNA synthesis was evaluated via an ELISA based 
bromodeoxyuridine (BrdU) incorporation assay (Roche).  Briefly, cells were BrdU 
labeled for a duration of 2 hours after which they were fixed in the provided 
fixation/DNA denaturation solution for 30 minutes.  Following this, the cells were 
incubated with an enzyme linked anti-BrdU antibody solution for 90 minutes.  After 
several rinses, the cells were then incubated with a substrate solution for 30 minutes, and 
the absorbance was read at 370 nm with a reference wavelength of 492 nm.  The 
remaining cells were then lysed using a 1% Triton X-100 solution and the total protein 
content quantified via BCA assay in order to normalize the absorbance values. 
Expression of α-Actin 
The expression of α-actin was measured using a slight modification of an 
established ELISA assay (Appendix D).[103]  Briefly, the cells were PBS rinsed and 
fixed in a 2% paraformaldehyde solution.  The cells were then covered with 1ml blocking 
solution (47ml PBS, 2g bovine serum albumin, 3ml FBS, and 25µl Triton X-100) for 45 
minutes at room temperature.  They were then treated with the primary mouse anti-α-
actin antibody diluted 1:200 for 2 hrs at RT, followed by a 2hr treatment with a 
biotinylated mouse IgG secondary antibody diluted 1:200.  The cells were then incubated 
for 45 minutes at 37 °C with a streptavidin conjugated alkaline phosphatase diluted 1:500 
in TBST buffer (pH 8).  Finally, the cells were incubated with the subtrate solution (3mM 
pNp, 0.05 M Na2CO3, 0.05 mM MgCl2) for 45 minutes at 37 °C and the absorbance read 
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at 405 nm.  The cells were then lysed using a 1% Triton X-100 solution and total protein 
measured using BCA in order to normalize the absorbance values. 
Expression of Osteopontin 
Following the 24 hr duration of the experiment, the media was removed, and the 
cells were fixed in a 2% paraformaldehyde solution.  The cells were then covered with 
1ml blocking solution (47ml PBS, 2g bovine serum albumin, 3ml goat serum, and 25µl 
Triton X) for 30 minutes at room temperature.  They were then treated with the primary 
rabbit anti-osteopontin antibody (ab46794) for 12 hrs at 4 °C, followed by a 2hr treatment 
with goat anti-rabbit secondary antibody (ab60319).  The cells were then DAPI stained to 
assist in distinguishing individual cells after imaging.  Imaging was done using 
fluorescent microscopy (Nikon Inc., Diaphot 300, Melville, NY).   
Expression of Alkaline Phosphatase (ALP) 
At 24 hrs, the cell culture media was removed and cells were rinsed 2x with PBS 
to remove any residual FBS contained within the media.  Cells were then lysed by adding 
300 ul of a 1% Triton-X 100 solution in PBS per plate for 15 minutes.  The cell lysates 
were then removed and stored at -80 °C.  ALP expression was evaluated using the 
colorimetric QuantioChrom Alkaline Phosphatase Assay Kit (Dalp-250, BioAssay 
Systems). Absorbances were read at 405 nm at times t=0 and 4 min.  This data was then 
used to calculate ALP activity in units of IU/L.  Total protein content of the sample was 
then read using a BCA assay to normalize the data to total protein content.  Additionally, 
88 
	  
7F2 osteoblasts cultured under static conditions on tissue culture treated polystyrene 
served as a positive control to validate the method. 
Smooth Muscle Cell Calcification 
In order to further evaluate the possible osteogenic potential of the VSMCs in 
response to the HA coating, it was desired to evaluate any possible calcification of the 
cells in response to the coating.  In order to do this, it was more desireable to culture the 
VSCMs for a longer time point.  This was achieved by the culture of VSMCs on HA-
coated 316L stainless steel disks. 
This experiment was divided into three groups: hydroxyapatite coated 316L 
stainless steel (HA), electropolished non-coated 316L stainless steel (SS), and a tissue 
culture treated polystyrene control (Ctrl).  Rat VSMCs were seeded at a density of 3x104 
cells per replicate.  7F2 osteoblasts (OB) seeded at a density of 3x104 cells per replicate 
on tissue culture treated polystyrene served as a positive control.  The cells were then 
cultured for a duration of 14 days with media changed every third day.  For the VSMCs, 
DMEM (Cellgro 10-013-CV, 10% FBS, 1% Ab/Am) media was used, whereas α-MEM 
(Cellgro 10-022-CV, 10%FBS, 1% Ab/Am) was used for osteoblast culture. 
Calcium depostion of the cells was done using the QuantiChrom Calcium Assay 
Kit (DICA-500, BioAssay Systems).  Briefly, cells were first lysed using a 500 ul of a 
1% Triton-X 100 solution in PBS, and extracellular matrix deposition was removed 
through scraping using a cell scraper.  Cell lysates were then collected and decalcified by 
adding 30ul of stock 12M HCl solution per sample for 24 hrs at 4 °C. Total protein was 
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quantfied using BCA in order to normalize Ca concentration values.  In order to increase 
Ca concentration values to those within the linear range of the assay method, samples 
were then dried and reconstituted using 25ul deionized water prior to testing. 
Statistical Analysis 
All data was evaluated using an ANOVA statistical analysis paired with Tukey 
analysis.  This was done using SigmaStat statistical analysis software (Systat Software, 
Inc., San Jose, CA) with p<0.05 indicating a significant difference.     
 
5.4 Results 
5.4a Characterization of HA Coating 
EDS Analysis of Surface Coating 
The EDS spectra, shown in Figure 5-2, yielded observable peaks for both calcium 
and phosphorus. Additionally the calcium/phosphorus ratio was calculated to be 
approximately 1.57:1. 
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Element Weight % Weight % σ Atomic % 
Carbon 9.916 0.095 30.666 
Oxygen 5.130 0.074 11.911 
Silicon 0.840 0.046 1.111 
Phosphorus 0.464 0.062 0.556 
Sulfur 0.799 0.075 0.926 
Calcium 0.729 0.366 0.676 
Iron 67.751 0.335 45.063 
Nickel 14.371 0.196 9.092 
 
Figure 5-2: EDS Spectra for HA Coated Stents 
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Post-Strain Integrity of HA Coating 
The post-strain integrity of the HA coating was evaluated through visual 
observation.  The HA coated stent surfaces were SEM imaged at magnifications of up to 
600x post strain.  As can be seen in Figures 5-3 and 5-4, there was very limited cracking 
or chipping of the coating as compared to the pre-strain stents.  
 
 
 
 
 
 
 
 
 
 
92 
	  
 
 
 
	  
Figure 5-3: SEM Images of As-Received (AR) HA Coated Stents Pre-Strain at 30x (a), 
200x (b), and 600x (c) 
 
a	  
	  
b	  
	  
c	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Figure 5-4: SEM Images of HA Coated Stents Post-Strain at 30x (a), 200x (b), and 600x 
(c) 
 
a	  
	  
b	  
	  
c	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5.4b Cell Response 
DNA Synthesis 
DNA synthesis was evaluated using a colorimetric BrdU assay (Roche) at 24 hour 
and 5 day time points.  The experiments consisted of four different groups at each of 
these time points.  These groups were a control group in which no wire was placed (Ctrl), 
a hydroxyapatite coated Nitinol group (HA), a non-coated Nitinol group (NiTi), and a 
sham wire group (Sham).  In the sham group, a non-coated Nitinol wire was placed on 
the cells for approximately 5 seconds prior to mechanical stimulation in an effort to 
separate the cellular response to the presence of the implant from the cellular response to 
injury. 
At the 24 hr time point, a significant increase in DNA synthesis, as evaluated by 
BrdU incorporation, was seen in the HA group (P=<.001), the NiTi group (P=0.005), as 
compared to the control.  However, no significant difference was observed between the 
Ctrl and Sham groups (P=0.097).  Additionally, no significant difference was observed 
between the HA and NiTi groups (P=0.286).   
At 5 days, overall DNA synthesis was greatly reduced compared to the 24 hr time 
point for both the HA and NiTi groups.  DNA synthesis for the Ctrl and Sham groups at 5 
days was not significantly different to that at 24 hrs.  Additionally, a significant increase 
in BrdU incorporation was again observed for the HA (P=0.007) and NiTi (P=0.001) 
experimental groups as compared to the 5 day control.  As before, there was no 
significant difference between the Ctrl and Sham groups at 5 days (P=0.152).   
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Figure 5-5: BrdU Assay of 24 hr (Blue) and 5 day (Red) Studies (*, **, # indicate a 
significant difference with P< 0.05) 
 
Expression of α-Actin 
At 24 hrs, α-actin expression was significantly decreased for both the HA 
(P=0.005) and NiTi (P=< .001) groups as compared to the control. Additionally, no 
significant difference was observed between the Ctrl and Sham groups (P=0.148).  
Furthermore, no significant difference was observed between the HA and NiTi groups 
(P=0.303),  
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At the 5 day time point, both the HA group (P=0.004) as well as the NiTi group 
(P=0.002) exhibited a significant decrease in α-actin expression as compared to the 
control.  Similarly to the 24 hour time point, there was no significant difference between 
the HA group compared to the NiTi group (P=0.812).  Additionally, no significant 
difference was observed between the Ctrl and Sham groups (P=0.609). 
 
 
Figure 5-6: α-Actin ELISA Assay of Cyclically Strained VSMC at 24 hrs (Blue) and 5 
Days (Red) (*, # indicate a significant difference as compared to the control with P< 
0.05) 
Expression of Osteopontin 
There was no observable osteopontin staining in any of the VSMC experimental 
groups employed in the present study.  However, there was detectable concentration of 
*	  
*	  
#
*
*	  
#	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osteopontin present in the 7F2 OB positive control group thereby verifying the method.  
Representative images are shown in Figure 5-7.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-7: Osteopontin Immunostaining of VSMCs Exposed to HA Coated Stent Under 
Dynamic Strain Conditions (a) and 7F2 OB Cells Cultured Under Static Conditions for 
24 hrs (b) 
a	  
b	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Expression of Alkaline Phosphatase 
As illustrated in Figure 5-8 a, following exposure to in vitro strain for 24 hrs, both 
the HA coated stent group as well as the non-coated NiTi group showed a significant 
increase in ALP activity as compared to the Ctrl group (P=0.008 and 0.03 respectively).  
However, no significant difference was observed between the two groups.  Figure 5-8 b 
shows the same data for ALP expression in VSMCs compared to ALP expression 
observed for the 7F2 OB positive control, which demonstrated a significantly higher ALP 
expression compared to any of the other groups (P<0.001). 
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Figure 5-8: ALP Activity of VSMCs Cultured Under Dynamic Strain Conditions In 
Vitro for Stented Groups Compared to a Non-Stented Control (a) and All Experimental 
Groups Compared to a 7F2 OB Positive Control (b) (* indicates a significant difference 
as compared to the control with P< 0.05) 
 
a	  
b	   *	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Smooth Muscle Cell Calcification 
For all of the VSMC groups tested, total calcium content was below the limit of 
detection for the method at 0.08 mg/dL.  However, the method was verified using the 7F2 
OB control.  This indicates that over a time period of 14 days, there was no detectible 
increase in VSMC calcification in response to any of the treatments tested. 
 
5.5 Discussion 
EDS Analysis of Surface Coating 
Results from the EDS analysis showed observable peaks for both calcium and 
phosphorus.  This indicated that there was in fact an intact HA coating on the surface of 
the stent struts. Additionally, the calcium/phosphorus ratio was calculated at 
approximately 1.57:1, which is quite close to values observed for HA coated implants by 
others in the literature. [145, 146]  This demonstrated that the surface was in fact coated 
with the desired dopant during the previously described coating procedure. 
Post-Strain Integrity of HA Coating 
In this experiment, we wished to subject the coated wires to levels of strain 
representative of those encountered during stent implantation.  The purpose of this was to 
evaluate the integrity of the HA coating post implantation.  After the coated stents were 
strained, they were then evaluated visually using SEM.  Results showed very little 
cracking and/or flaking of the HA coating post strain.  This was likely due to several 
features of our HA coating.  First, the coating method used was not a simple adhesive 
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coating process that would allow for possible de-lamination of large portions of the 
coating if the adhesive were to fail.  Rather, the coating was achieved through the 
coblasting procedure described previously.  This procedure results in the HA dopant 
being chemically bonded to the Nitinol surface.  Secondly, the coating method used 
resulted in a very thin layer of HA deposited on the surface allowing it to flex somewhat 
with the stent reducing the likelihood of damage to the coating upon application of strain.  
These results indicated that the HA coating method used resulted in a surface coating that 
is very likely to be able to survive the rigorous strain environment encountered upon stent 
deployment in vivo. 
DNA Synthesis 
At 24 hrs DNA synthesis was significantly increased for both the HA and NiTi 
groups as compared to the control.  Furthermore, no significant difference was observed 
between the Ctrl and Sham groups.  This indicated that at 24 hrs, the proliferative cellular 
response as observed by an increase in DNA synthesis was most likely due primarily to 
model strut contact rather than purely the cellular response to injury.  Additionally, with 
respect to DNA synthesis as an indicator of cellular proliferation, the HA coating 
appeared to have little to no effect on the cells compared to the non-coated Nitinol stent 
as no difference in DNA synthesis was observed between the two groups. 
These results demonstrate that there was an acute response to the implanted stent 
specimens at 24 hours.  While this response was somewhat attenuated at 5 days, the 
effect of continued contact remained apparent.  At both time points, there was no 
observed difference between the non-coated and HA-coated Nitinol specimens indicating 
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that the HA-coated specimen was equally biocompatible to the standard non-coated 
specimen with respect to cellular proliferation as indicated by DNA synthesis. 
Expression of α-Actin 
At 24 hrs results showed a significant decrease in α-actin expression for both the 
HA and NiTi groups compared to the Ctrl.  Similar to the results from DNA synthesis, 
there was no significant difference observed between the HA and NiTi groups indicating 
that the HA coating had little effect on the VSMCs and was no more influential on the 
cells than the bare non-coated Nitinol stent specimen.  These results again held true at the 
5 day time point.  Furthermore, no significant difference was observed between the 24 hr 
and 5 day time points. 
 These results indicated that similar to the DNA synthesis, α-actin expression 
appeared to be unaffected by the applied HA surface coating.  However, in contrast to the 
increase in DNA synthesis observed in the previous experiment, the decrease in α-actin 
expression observed appeared to be less time dependent.  Over the course of the 5-day 
experiment, α-actin expression did not increase significantly compared to the 24 hr 
experiment.   
Expression of Osteopontin 
In addition to being expressed by native osteoblasts, osteoponin is an osteogenic 
marker known to be present in high levels at calcification sites in atherosclerotic lesions 
but not in normal arteries.[147]  Additionally, osteopontin mRNA has been shown to be 
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expressed in smooth muscle-derived foam cells in human atherosclerotic lesions in the 
aorta.[148]   
There was no positive osteopontin staining observed in any of the VSMC 
experimental groups employed in the present study.  However, the 7F2 OB positive 
control group did stain positive for osteopontin.  This indicated that the failure of the 
procedure to immunostain the experimental groups was likely a result of a lack of 
osteopontin protein being expressed rather than a failure of the staining method.  These 
results demonstrate that osteopontin expression, as a positive marker for a cellular 
osteogenic phenotypic shift, is not stimulated as a result of VSMCs cultured in contact 
with HA coated Nitinol in the present dynamic simulator. 
Expression of Alkaline Phosphatase 
Results from the ALP assay showed a significant increase in ALP expression in 
response to placement of both the HA coated and bare NiTi stents as compared to the 
Ctrl; however, no significant difference was observed between the HA and bare NiTi 
groups.  This data suggests that the increased in ALP activity was in response to the 
contact of the stent material as well as any possible injury incurred upon its placement.  
This response appeared to be independent of stent coating.  This increase in ALP 
expression in response to stent contact could shed some light on the patterns of 
calcification that are observed around areas of increased stress in stented arteries in 
vivo.[149]  However, as seen in Figure 5-8 b, levels of ALP activity observed post stent 
implantation were still quite low in comparison to those observed for fully the 
differentiated 7F2 osteoblast positive control indicating that, while ALP expression was 
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increased, it is still much below a level that should be considered indicative of a shift to 
an osteogenic phenotype. 
Smooth Muscle Cell Calcification 
The evaluation of calcium depositions showed total calcium content to be below 
the limit of detection for the method.  However, the method was verified using a 7F2 OB 
control in which calcium level were found to be well within the range of the method at 
the same time point thereby validating the method.  This indicates that over a time period 
of 10 days, there was no detectible increase in VSMC calcification in response to any of 
the treatments tested.  These results indicate that the present HA coating has a negligible, 
if any, effect on VSMC calcification. 
Results from the present study demonstrated good in vitro biocompatibility of 
hydroxyapatite as a possible stent coating.  However, the in vivo use of hydroxyapatite as 
a biomaterial coating for devices exposed to blood flow may be a cause for some concern 
due to HA’s inherent thrombogenicity caused by rapid binding of large amounts of 
protein to the surface and platelet aggregation.[150, 151]  Hydroxyapatite has been 
shown to bind more serum proteins than either titanium or steel.[152]  While the 
exposure of HA to blood flow may the cause for some concern in the construction of a 
vascular stent, this is alleviated in the present case by coating only the outer surface of 
the stent with HA.  Because the HA coating is present only on the outer surface of the 
stent struts, as shown in Figure 5-1, upon implantation in vivo, the struts would imbed 
into the vessel wall thereby preventing continuous contact of the HA coating with 
circulating blood and reducing concern for extensive thrombotic formation. 
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5.6 Conclusion 
Overall, the DNA synthesis results indicate that there was a significant increase in 
DNA synthesis in response to contact of VSMCs with implanted stents in vitro.  This 
increase in DNA synthesis was somewhat attenuated at 5 days, but still remained 
significant.  The lack of difference between the wire groups and the sham groups indicate 
that with respect to DNA synthesis, the HA coated sample wires seemed to be well 
tolerated and did not illicit an enhanced proliferative response beyond that of the non-
coated Nitinol stent specimens. 
In our previous corrosion studies, we demonstrated the ability of Ni ions released 
during Nitinol corrosion to significantly influence α-actin expression in VSMCs.  In a 
long term study, the sealing effect of the HA coating would likely prevent this 
phenomenon; however, in our short term study, there was most likely not enough Ni ions 
released from the bare Nitinol surface to cause a significant effect.  The altered actin 
expression compared to the control group was primarily due to contact from the strut.  
This was demonstrated by the fact that there was no significant difference between the 
HA coated and non-coated groups at either 24 hrs or 5 days.  This indicates that the 
response to the implanted stent was rapid and somewhat stable over the course of 1-5 
days.  Additionally, in the sham group where the stent specimen was removed, actin 
levels returned to levels within one standard deviation of the control group within 24 hrs.  
This indicates that the decreased α-actin expression was an effect of the continued contact 
of the stent with the VSMCs rather than a response to injury from implantation. 
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Results also showed a significant increase in ALP expression in response to 
contact from the model stent specimen.  This response seemed to be as a direct result of 
contact forces and injury incurred upon stent placement.  The increase in ALP expression 
was independent of material coating. 
While no increase of in vitro VSMC calcification was observed in our present 
experiments, it should be noted that calcification is a slow process that may take up to 
several weeks to develop in an in vitro model.  Future experiments should employ longer 
time points out to approximately 30 days to allow a more subtle response to reach 
measurable levels.  However, the use of a positive control in our experiment showed that 
at 10 days, fully differentiated osteoblasts could calcify to detectable levels using our 
present method.  This illustrates there was no acute osteogenic response to the HA 
coating. 
Overall, the results of this study addressed three main concerns involving the use 
of hydroxyapatite as novel stent coating.  First, we demonstrated the purity and post 
strain integrity of the coating using EDS and SEM respectively.  This indicated that we 
did in fact have a pure HA coating capable of withstanding strains representative of those 
encountered upon stent deployment.  Secondly, we evaluated VSMC phenotypic response 
to the coating.  We demonstrated that under dynamic culture conditions, HA-coated 
Nitinol stents appeared to be equally biocompatible compared to non-coated Nitinol 
stents.  Finally, we investigated whether HA would trigger a calcific/osteogenic response 
in VSMCs by evaluating the evaluation of the expression of osteopontin, ALP, and 
calcification.  The results showed no detectible increase in either osteopontin or 
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calcification.  While ALP expression was increased as compared to the control, it was not 
significantly different from the non-coated Nitinol group.  Overall, the results of this 
study demonstrate that hydroxyapatite may serve as a durable and biocompatible stent 
coating capable of possibly serving as a favorable drug delivery platform.  The feasibility 
of using HA as a vehicle for the local delivery of bisphosphonate class drugs such as 
alendronate for the control of VSMC proliferation was evaluated further in Appendix E. 
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-CONCLUSION- 
 
The project hypothesis was that smooth muscle cell hyperplasia, as an important 
causative factor for vascular restenosis following endovascular stent deployment, was 
triggered by the various effects of stent strut contact on the vessel wall including contact 
forces and material biocompatibility.  This project was evaluated in several ways: 
In aim 1, contact forces of the model stent strut wire were simulated using the 
finite element method in order to more fully characterize the mechanical environment 
cells are subjected to inside the vascular simulator.  Additionally a static proof-of-concept 
in vitro study demonstrated a synthetic phenotypic response of VSMCs to the implanted 
Nitinol wire typical of what could be expected in vivo. 
In aim 2, VSMC response to Nitinol corrosion ions was evaluated using clinically 
significant nickel ion concentrations from Nitinol wires corroded in a simulated in vivo 
environment.  Results illustrated that nickel ion concentrations below those capable of 
affecting cellular proliferation have a significant affect on VSMC morphology and α-
actin expression under static in vitro culture conditions.  These results shed some light on 
one possible source of stimulation leading to a synthetic phenotypic VSMC response in 
the stented artery. 
Aim 3 evaluated VSMC response to a model stent strut under dynamic in vitro 
culture conditions of concurrent cyclic strain and flow shear.  This study was aimed to 
elucidate any possible differential response to Nitinol wire samples as compared to 316L 
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stainless steel.  Results from this study showed a synthetic phenotypic response to both 
materials illustrated by an increase in DNA synthesis coupled with a decrease in α-actin 
expression further validating our model of the stented artery.  Importantly, there was no 
observable differential response to the Nitinol specimen compared to 316L stainless steel.  
These results suggest that, in vitro, Nitinol is equally biocompatible with the VSMCs 
with respect to changes in cellular phenotype compared to the traditionally accepted gold 
standard of 316L stainless steel. 
Next, aim 4 evaluated the use of hydroxyapatite as a stent strut coating for use as 
a possible drug delivery platform.  This study had a number of different goals:   
First, we evaluated the HA coating itself.  EDS analysis of the surface 
demonstrated that the surface was in fact coated with a thin layer of hydroxyapatite 
having an calcium/phosphorus ratio on par with other studies available in the literature 
for hydroxyapatite implants.  Additionally, as illustrated through SEM analysis of the 
surface, post strain integrity of the coating was excellent with minimal cracking or 
flaking. 
Next we evaluated any possible osteogenic potential of the coating as well as cell 
phenotypic response.  Results showed the HA coating to have a quite minimal osteogenic 
potential on VSMCs.  This was demonstrated by a lack of osteopontin immunostaining as 
well as cellular calcification.  While ALP expression was slightly elevated, it was still 
vastly lower that ALP expression levels demonstrated by the 7F2 osteoblast positive 
control.  Cellular phenotype studies evaluating DNA synthesis and α-actin expression 
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demonstrated no significant difference in either assay between HA-coated and bare 
Nitinol stent specimens. 
Results from this in vitro study demonstrated that hydroxyapatite is a 
biocompatible stent coating that does not illicit a significant osteogenic response from 
VSMCs.  Additionally, there was no significant difference in phenotypic response 
compared to a non-coated stent.  These results suggest hydroxyapatite is a biocompatible 
coating that could serve as a favorable drug delivery platform for the inhibition of stent 
restenosis. 
Overall, this project was able to demonstrate that an increase in VSMC 
proliferation as well changes in phenotypic indicators such as decreased α-actin 
expression and cell aspect ratio are induced through model stent strut contact in vitro.  
Additionally, it was shown that, with respect to known biocompatible materials such as 
Nitinol and 316L stainless steel, DNA synthesis and α-actin expression are independent 
of stent material composition.  Together, these results indicate that the nickel-titanium 
alloy Nitinol is equally biocompatible under dynamic in vitro culture conditions to the 
traditional gold standard material for vascular stent construction, 316L stainless steel.  
Furthermore, hydroxyapatite was shown to be biocompatible stent surface coating with 
acceptable post-strain integrity.  In a feasibility study given in Appendix E, this coating 
was also shown to be capable of serving as a favorable drug delivery platform capable of 
reliably delivering locally therapeutic doses of bisphosphonates such as alendronate to 
control VSMC proliferation in an in vitro model of a stented blood vessel.  This stent 
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coating/drug combination may be effective for reducing restenosis as a result of VSMC 
hyperplasia in vivo. 
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-PROJECT RECOMMENDATIONS- 
 
1. Evaluating the Response of Various Cells Types. 
The present project evaluated the response of vascular smooth muscle cells from 
Sprague Dawley rats exclusively.  This was done due to the fact that the majority of 
the bulk of neointimal tissue of restenotic stented blood vessels is composed by 
VSMCs of a synthetic phenotype and their extracellular matrix; however, it is 
important to not overlook the importance of the endothelial layer.  While it is known 
that there is a significant denudation of the endothelial layer upon stent deployment, a 
number of these important signaling cells do remain present at the stenting site.  
Endothelial cells are known to significantly influence VSMC response in vivo by 
releasing a number of different signaling molecules.  Therefore, the response of the 
endothelial cells to the same stimuli used in the present study is an important factor 
contributing to the development of in-stent restenosis that should not be overlooked. 
2. Evaluation of Other Stent Coatings. 
For our current project, we evaluated cell response to our HA coating only.  It 
would be beneficial to investigate the in vitro response of other possible drug eluting 
coatings to illustrate any possible benefits of the HA coating.  For example, it would 
be advantageous to evaluate our HA coating as compared to a coating such as (poly-
L-lactic acid) PLLA which releases proinflammatory lactic acid.  While were able to 
demonstrate that HA does not illicit a significant differential in phenotypic response 
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as compared to a non-coated bare metal specimen, it would be prudent to see how HA 
compares to other stent coatings investigated in the literature using our dynamic 
model. 
3. Evaluation of Other Bisphosphonate Drugs 
Our HA coating is capable of binding any one of the numerous 
bisphosphonate drugs currently available on the market.  In the present study, 
alendronate was chosen because it was readily available and relatively 
inexpensive.  However, alendronate is not the most potent member in the family 
of nitrogen containing bisphosphonate drugs.  This study should be repeated 
utilizing the more potent zolendronate.  By utilizing a more potent drug, it may be 
possible to deliver the drug at an effective local concentration over a longer 
period of time in vivo.  Additionally, the drug release profile experiment should 
be repeated using much longer time points in order to evaluate what the long term 
drug delivery profile will be. 
4. In Vivo Modeling 
The present in vitro model has been developed in order to investigate the 
synthetic response of VSMCs in response to the placement of a model stent strut.  
The model was designed to incorporate important mechanical stimuli such as 
cyclical strain and shear in order to mimic to in vivo environment.  The use of in 
vitro modeling is valuable because of the ability to reduce variability of 
experimental data compared to in vivo studies; however, it neglects to account for 
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important responses to implantation in the body such as the inflammatory and 
immunological response.  For this reason, in order to progress in the development 
of bisphosphonate-eluting HA coated stents, it is important to incorporate the use 
of an in vivo animal model. 
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-APPENDIX A- 
Blood Vessel Biology and Atherosclerosis 
 
Blood Vessel Biology 
The blood vessel is divided into three primary layers or tunics: the intima, media, 
and adventitia.[1, 6] These layers are separated by the internal elastic lamina (IEL) and 
external elastic lamina (EEL) respectively.  The primary differences between arteries and 
veins are the valve-like projections of the intima present in the veins of the extremities to 
prevent backflow as well as the more pronounced muscular medial layer in the artery. 
The intima is a simple squamous epithelium known as the endothelium.[153]  It is 
comprised primarily of endothelial cells (ECs).  However, there may also be a few 
scattered vascular smooth muscle cells which will from here on be simply referred to as 
smooth muscle cells (SMCs) as well as a small number of macrophages.[154] The media 
is comprised of primarily SMCs as well as elastic connective tissue whereas the 
adventitia is made up of fibrous connective tissue with a few scattered cells. These layers 
will be discussed in more detail in the paragraphs that follow. 
The endothelium is a very thin monolayer of cells that serves a variety of 
purposes in the vasculature.  Its primary purpose is to serve as a hydrophilic, non-
thrombogenic lining of the blood vessels as well as a selectively permeable diffusive 
barrier.[6]  However, despite its importance, it is so thin that its existence was denied 
until 1865.[155]  In contrast, when considering the endothelium as a whole, it makes up 
the largest endocrine unit in the body weighing in at approximately one kilogram.[155]  It 
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is this endocrine function that is of very high importance in regulation of vascular 
function. 
The most obvious function of the endothelium is the prevention of blood 
coagulation and thrombus formation.  This is accomplished in part by the so-called 
“smoothness” of the endothelial surface thereby preventing activation of the intrinsic 
clotting mechanism.[1]  The cell surface also expresses a layer of the 
mucopolysaccharide glycocalyx which acts to repel platelets and clotting factors.  The 
protein thrombomodulin is also bound to the cell surface and serves to bind with 
thrombin thereby slowing the coagulation cascade. In addition, the thrombomodulin-
thrombin complex activates the plasma protein known as protein C that inactivates 
activated Factors V and VIII in the coagulation cascade.[1]  The endothelium performs a 
rather complex secretory function. Among the molecules it secretes are collagen and 
elastin, clotting or anti-coagulant factors, prostaglandins, cytokines, vasodilators and 
vasoconstrictors including endothelin and nitric oxide (EDRF), free radicals, and 
important cell adhesion molecules such as VCAM-1.[6, 155].  
 The media is comprised of primarily smooth muscle cells and extracellular 
matrix.[6]  It is arranged in such a way that there are layers of similarly oriented SMCs 
interlaced with collagen type III fibers such that the fibers tighten around the cells as the 
vessel wall is put under tension. This thereby holds the group of cells together preventing 
excessive stretching or slippage.  Each subunit of cells, known as a fascicle, is also 
surrounded by similarly oriented elastin fibers forming the effective unit of medial 
structure that is known as a musculoelastic fascicle.[6]  Each of these fascicles is oriented 
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in a direction parallel to the imposed tensile stress in the vessel wall which results in an 
alignment perpendicular to blood flow.  Arteries can be divided into two basic categories, 
either elastic or muscular. The larger elastic arteries include the aorta as well as its larger 
proximal branches.[6]  The arteries of main concern in occlusive vascular disease are the 
smaller muscular arteries.  These arteries have generally less collagen and elastin fibers 
when compared to elastic arteries and are more densely populated by smooth muscle 
cells.  This allows muscular arteries to control blood flow by rapidly constricting or 
dilating.[1, 6, 72] 
The adventitia is what is known as a fibrocellular connective tissue.[6]  It is a 
layered structure composed of both collagen and elastin. It also contains a network of 
vasa vasorum to nourish the medial SMCs as well as nerves that help to mediate SMC 
contraction and tone.[6] The adventitia is distinguished by the presence of fibroblasts and 
less organized collagen/elastin.[156]  It also serves to help provide mechanical support to 
the vessel wall.  
Smooth Muscle Cells 
The most abundant cell type in an artery is the smooth muscle cell.  Interestingly, 
smooth muscle cells exhibit phenotypic plasticity in response to stimuli in a phenomenon 
known as modulation [72, 155, 157]  as first confirmed in vitro by Chamley-Cambell et 
al. in 1979.[158]  They are the only cells of the myogenic lineage with this ability.[157]  
The two ends of the spectrum for SMC phenotype are contractile and synthetic.[154, 157]  
It is important to note that the differentiation state of SMCs is in fact a spectrum where 
cells may exist in any number of differentiation states between the two ends.  It is not a 
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simple black and white issue with cells being easily distinguished into one phenotype or 
the other.  Healthy adult SMCs are primarily of the differentiated contractile 
phenotype.[72, 143]  Their contractile ability is important for the maintenance of blood 
vessel tone as well as regulation of blood pressure and flow.[1, 6, 72]  They exhibit 
properties such as low synthetic activity, low proliferation rate, and expression of unique 
contractile proteins such as smooth muscle α-actin, myosin heavy chain, h-caldesmon, 
and calponin.[72, 143, 159]  The most abundant of these proteins is α-actin, making up 
approximately 40% of the total cell protein.[159] 
Highly synthetic SMCs can be referred to as “immature” and exhibit 
characteristics such as increased proliferation, increased organelles for production of 
lipids and proteins, and increased excretion of extracellular matrix as well as increased 
migration.[72, 157, 159]  They are also characterized by increased expression of the 
proteins vimentin and β-actin.[160-162]  In addition, the cells lose their contractile ability 
which is confirmed by staining for contractile markers such as smooth muscle α-actin, 
myosin heavy chain, h-caldesmon, and calponin.[72, 159, 161]  Synthetic SMCs also 
exhibit altered morphology when examined under a microscope. Contractile SMCs are 
smaller, elongated, and spindle shaped when compared to a synthetic SMC’s 
hypertrophic appearance surrounded by copious extracellular matrix production.  It is 
important to note that SMCs will eventually progress toward a more synthetic phenotype 
when cultured in vitro so it is important to carry out experimentation under low passage 
numbers. 
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As mentioned previously, SMCs of a contractile phenotype are generally referred 
to as a “healthy” phenotype because they are present in healthy adult arteries.  On the 
other hand, SMCs of a highly synthetic phenotype present in vivo are generally indicative 
of diseased conditions.  In addition to excessive extracellular matrix production, synthetic 
SMCs can also release cytokines which are chemotactic for other SMCs, induce cell 
proliferation, and can stimulate phenotypic change from contractile to synthetic.[6] 
Pathology of Atherosclerosis 
The basic pathology of atherosclerosis is characterized by the development of a 
growth of cells and connective tissue with a soft lipid-rich core known as an 
atheromatous plaque.[154]  This lesion can eventually grow to occlude the lumen causing 
complications such as obstruction to blood flow, thrombosis risk, loss of elasticity, and 
impaired contractility.  The development and progression of these lesions will be 
discussed later.  Atherosclerosis is also characterized by a chronic inflammatory 
response. [154, 163] 
The initial cause of atherosclerotic development has been the cause of some 
debate.  The two commonly accepted theories can be referred to as the “fatty streak 
theory” and the “response to injury theory”.  However, these theories are not mutually 
exclusive.  In both cases, high blood triglyceride levels, particularly low density 
lipoproteins (LDLs), are the necessary catalyst for lesion development.[1, 143, 154, 163]  
The primary difference between the two theories is in the modality of monocyte 
recruitment to the lesion site.  
121 
	  
 Following the fatty streak theory, fatty streaks develop early in life as a result of 
lipid accumulation in the vessel wall caused by a high fat diet as well as genetic 
predisposition.[6, 154, 164]  Early childhood lesions commonly regress, but may 
continue to develop rapidly during the 15-34 year age span.[143, 154]  In this process, 
LDLs are transported by transcytosis across the endothelium and deposited in the intima 
where a small amount may be taken up by local SMCs.[143]  However, the LDLs may 
become oxidized during the process of transcytosis thereby forming the toxic oxLDL.  It 
is this injurious oxLDL that is thought to damage neighboring cells thereby triggering the 
inflammatory response.[164]  This results in local macrophage infiltration from nearby 
tissues as well as monocyte recruitment from the blood.  The resulting macrophage 
population then phagocytizes the LDL.  The resulting lipid filled macrophages and SMCs 
form what are known as foam cells that are characteristic of atherosclerotic lesions. 
The response to injury theory varies in that the inflammatory response is thought to be 
initiated by some sort of initial injury to the endothelium.  This can be caused by factors 
such as smoking, high blood pressure, infection, etc.[6]  The damaged endothelium 
promotes platelet adhesion and subsequent release of platelet derived growth factor 
(PDGF) as well as monocyte recruitment.  PDGF has been shown to be both chemotactic 
and mitogenic for SMCs.[14]  The damaged endothelium also exhibits altered 
permeability leading to lipid accumulation in the vessel wall in the presence of high lipid 
content in the blood.  The local macrophages and SMCs will then uptake this lipid 
thereby forming foam cells. 
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Whatever the initial causation, atherosclerosis is a progressive disease marked by 
a chronic inflammatory response.  Lesion progression takes place over the course of years 
through a series of well documented stages.[165]  This is illustrated in Table 3 
reproduced from Stary 1992.[165]  It is important to note that these stages are not 
necessarily linear. 
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Table A.1:  Classification of Atherosclerotic Lesions [165] 
 
Reommended Terms Description Conventional 
terms based on 
appearance 
with the 
unaided eye 
Comments  
Type I (initial lesion) Lipoprotein accumulation in intima; lipid in 
macrophages; these changes discernible 
only microscopically or chemically; no 
tissue damage 
None Types I and II are 
sometimes combined 
as “early lesions” 
Type II 
IIa 
 
 
 
 
IIb 
(fatty streak) 
(progression-
prone:colocalized 
with specific 
adaptive thickening) 
 
(progression 
resistant) 
Lipoprotein accululation in intima; lipid in 
macrophages and smooth muscle cells; 
quantities large enough to be visible to the 
unaided eye but still no tissue damage 
Fatty Streak  
Type III (preatheroma) All type IIa changes plus multiple deposits 
of pooled extracellular lipid; microscopic 
evidence of tissue damage and disorder 
None An “intermediate” or 
“transitional” lesion 
had be suspected 
Type IV (atheroma) All type IIa changes plus confluent mass of 
extracellular lipid (lipid core) with massive 
structural damage to intima 
Fibrous plaque; 
fibrolipid 
plaque; plaque 
Types IV to VIII are 
sometimes combined 
as “advanced lesions” 
Type V (fibroatheroma) All type IV changes plus development of 
marked collagen and smooth muscle cell 
increase (cap) above lipid core 
  
Type VI 
 
VIa 
VIb 
VIc 
(complicated 
fibroatheroma)  
(thrombo-
hemmorrhagic) 
(thrombotic) 
(hemmorrhagic) 
All type V changes plus a thrombotic 
deposit, and /or erosion or fissure 
Complicated 
plaque 
 
Type VII (calcific lesion) Any advanced lesion type composed 
predominantly of calcium; substantial 
structural deformity 
Calcified plaque  
Type VIII (fibrotic lesion) Any advanced lesion type composed 
predominantly of collagen; lipid may be 
absent 
Fibrous plaque  
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In addition to simply growing in size to physically occlude the lumen, the ongoing 
progression of a plaque often leads to fissuring and rupture which in turn causes 
thrombosis.[166] These thrombi give rise to the serious risk of emboli formation and 
subsequent heart attack or stroke.  It is important to note that the progression of 
atherosclerosis can be clinically silent until the very late stages of plaque formation.  This 
is the reason for the somewhat common incidences of sudden death from sudden 
coronary blockage or stroke caused by emboli arising from atherosclerotic lesions.  
Diagnosis of Atherosclerosis 
Atherosclerosis is known as the silent killer because it often presents no easily 
distinguished symptoms to the patient until it is too late to prevent a major myocardial 
infarction or stroke.  The physician must consider a number of factors in the initial patient 
consultation.  As given in Rutherford’s Vascular surgery, the list of steps in this 
procedure are as follows:  (1) reaching a presumptive diagnosis by the physician based 
upon clinical grounds, (2) using noninvasive methods of diagnosis to either confirm the 
diagnosis or discern the severity of the condition, (3) weigh the patient’s degree of 
disability with the known natural progression of the disease in conjunction with the best 
possible treatment against the risk and potential benefit of the various interventional 
options, and (4) when it is deemed necessary to intervene, confirming the initial diagnosis 
and extent of progression using angiography.[6]  It is also important to note that when 
percutaneous intervention is the likely modality of treatment following angiographic 
confirmation, arrangements should be made in advance such that the surgeon can proceed 
with the appropriate treatment procedure at the time of angiography to avoid unnecessary 
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additional risk to the patient from a follow up procedure.  In order to reach the 
presumptive diagnosis of various forms of vascular disease, physicians must evaluate 
each patient individually considering all of the possible risk factors as well as detecting 
and evaluating any possible symptoms. 
In the evaluation of peripheral vascular disease (PVD), diagnosis may be slightly 
easier than of obstructions in the coronary arteries.  Blockages in the coronary arteries 
can be somewhat more difficult to diagnose non-invasively because of anatomical 
location.  However, the diagnosis of PVD is a marker for coronary artery disease (CAD) 
thus it is relevant to discuss the use of the following methods for the eventual diagnosis 
of both conditions.[6, 167]  PVD in the lower extremities is most commonly marked by 
leg pain with exercise known as claudication.[6]  This is often described by the patient as 
simply a cramp that goes away after a short rest.  Not surprisingly, the degree of leg pain 
experienced by the patient with the least amount of exercise indicates the severity of the 
blockage with severe cases having pain at rest or even ulceration and tissue loss. It is 
important to note that claudication can also be caused by a number of conditions other 
than restriction of blood flow due to vascular disease. A careful evaluation of various 
variables concerning the claudication experienced is valuable in discerning various 
conditions responsible for the pain.  Pain is the most important tool in a list of symptoms 
evaluated upon observation by the physician known as the “five P’s” which are: Pain, 
Pallor, Pulselessness, Paresthesias, and Paralysis.  However, a grey-blue or purplish tint 
known as cyanosis often replaces pallor.[6, 168]  
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Following the initial office consultation to gather information about patient 
history, risk factors, and obvious symptoms, the physician will then follow up using any 
of a number of non invasive diagnostic techniques to further confirm a diagnosis.  In the 
treatment of PVD, perhaps the easiest of these is the measurement of the patient’s ABI or 
Ankle Brachial Index.  This is simply a ratio of the blood pressure taken at the patient’s 
ankle and the blood pressure taken in the patient’s arm at the brachialis taken bilaterally. 
The lower of these two numbers is taken to be the patient’s overall ABI.  Generally, 
evaluation of an ABI is as follows: between 0.9 and 1.2 is considered normal, between 
0.5 and 0.8 for patients with claudication, and between 0 and 0.4 for patients with rest 
pain or tissue loss.[169]  However, ABI may be limited for evaluating patients with less 
severe degrees of stenosis or those with calcified arteries.[170] 
Following the simple methods stated previously, the next most commonly 
employed non invasive techniques are duplex scanning followed by computed 
tomography (CT) and magnetic resonance imaging (MRI).[6]  The most commonly 
employed of these methods is duplex scanning. 
A duplex scan is the combination of a B-mode scan with the use of pulsed 
Doppler.[171, 172]  It can provide very important information about the degree and exact 
location of an occlusion. The B-mode gives a black and white image of the walls of the 
blood vessel and the Doppler measures blood velocity.  In areas where the vessel is 
narrowed by an occlusion, the cross sectional area is decreased such that there is a local 
increase in flow velocity in order to maintain flow.  The Doppler portion of the duplex 
scan utilizes color to give the operator easily decipherable information about direction of 
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flow.  This is useful in detecting things such as areas of turbulent flow or veins with 
incompetent valves allowing excessive backflow.   
Angiography is the final tool employed prior to surgical intervention, and it is the 
principal tool for the evaluation of coronary stenoses.[4, 173]  It is the gold standard to 
which other diagnostic techniques are compared for the diagnosis of nearly all forms of 
occlusive vascular disease.[172]  This procedure is done via the intravascular injection of 
a radio opaque contrast dye upstream of the location of the suspected stenosis with the 
aid of a catheter.  It is then immediately imaged using x-ray.  This procedure is performed 
immediately prior to percutaneous intervention to confirm the location of the occlusion 
and then immediately following the procedure to insure restoration of flow was achieved.  
It is important to note that the x-ray scan used for the angiogram is also used to visualize 
the stent as it is advanced to the location of the lesion.  However, many stents are 
somewhat difficult to pick up on the x-ray.  For that reason, many stent manufacturers 
incorporate radiopaque gold markers on the ends of the stent as a solution to visualization 
problems. 
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-APPENDIX B-  
Effect of Various Mechanical Stimuli Applied to Cells In Vitro Effect of Strain on 
Smooth Muscle Cells 
 
Although a number of approaches for the exposure of cells to strains exist, the 
most popular experimental setups use vacuum suction to the bottom of a flexible 
membrane on which cells are cultured. [73, 76, 77, 174]  Some of these systems are able 
to produce approximately equibiaxial strain to which cells are subjected during 
experiments while other systems generate non-uniform distributions of applied strain. 
[73, 102, 175]   
The exposure of SMCs to cyclic strain has been shown to increase cell 
proliferation and induce a shift toward a synthetic phenotype in some experiments [73-
77] while preventing cell proliferation and promoting a contractile phenotype expression 
in others.[142, 176-178]  However, efforts to explain the phenomenon governing these 
observations regarding SMC response have been the cause of some debate.  On initial 
observation, the underlying reasons for these discrepancies in results may be unclear.  
However, upon closer evaluation these results can be roughly separated into two groups: 
those stretched at high and low strain rates with the separation point being approximately 
10%.  For example, Hipper et al. cyclically stretched SMCs of the A10 cell line derived 
from the aortas of embryonic rats grown on type I collagen coated membranes at 0.5 Hz 
using 5% elongation.[142]  This resulted in decreased DNA synthesis of 30% at 24 hrs 
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and 50% at 48 hrs compared to a static control.[142]  This observation remained 
unaffected when the experiment was repeated on laminin and pronectin coated 
membranes.  Chapman et al. used flow cytometry to show that cyclic stretch of type I 
collage coated membranes prevented rat aortic VSMC proliferation via a G1/S phase 
transition inhibition using strain levels of 10% at 1 Hz compared to a static control.[176]  
In contrast, Mills et al. found that cyclic stretching of the type I collagen coated culture 
substrate ( 24% at the edges and 7% in the center) caused increased bovine aortic VSMC 
proliferation and cyclic adenosine monophosphate (cAMP) accumulation compared to 
static controls.[77]  Hasaneen et al. subjected human airway SMCs grown on type I 
collagen coated membranes to cyclic strain between 17-18.5% and observed increased 
SMC proliferation at 3 and 5 days compared to a static control.[73]  Additionally, the 
conditioned media from the strain group contained elevated levels of matrix 
metalloproteinase-1 (MMP-1), MMP-3, and both pro and activated MMP-2 likely 
indicating an increase in SMC migration.  This increase in cyclically strained SMC 
migration compared to statically cultured SMCs was then confirmed using a modified 
Boyden chamber assay that operates based on counting the number of cells able to 
migrate through a gelatin coated membrane.  Addition of the broad spectrum MMP 
inhibitor Prinomastat prevented this increase in proliferation and migration while also 
inhibiting MMP-2 activation in a dose dependent manner.    
Physiological levels of strain in vivo are generally less than 10% and may be as 
low as 0-4% depending on the location in the vasculature.[102, 142-144]  The previously 
mentioned studies by Mills, Hu, and Sotoudeh show that SMC proliferation and de-
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differentiation into a synthetic phenotype is enhanced by high strain.  This may explain 
the fact that high blood pressure, and thus increased force on the vessel wall and 
increased strain by as much as 15%,  causes thickening of the blood vessel wall due in 
part to SMC proliferation in vivo.[76, 78, 179, 180]  In addition, it has been observed that 
high levels of strain experienced during balloon angioplasty also leads to varying degrees 
of restenosis caused by SMC proliferation.  Together, it can be concluded that the 
maintenance of healthy contractile SMCs with low proliferation rates is achieved by 
closely mimicking the physiological strain level experienced in vivo while deviations 
from this normal mechanical environment lead to a shift towards a synthetic phenotype. 
Effects of Fluid Shear Stress on Endothelial Cells and Smooth Muscle Cells 
A number of different custom-designed systems have been devised in order to 
stimulate cells with the use of fluid shear.  These systems generally break down into two 
basic design configurations:  the cone and plate system and the parallel plate flow 
chamber.[175]  In the cone model, variations in angular velocity of the cone provide 
kinematic control of fluid shear stress on the cells under investigation.  The parallel plate 
setup uses a simple pressure differential between the inlet and outlet to drive cell culture 
media across the culture area.  This can be achieved via either gravity heads or active 
pumps.  The parallel plate setup is advantageous in that the entrance length can be 
designed to allow the development of a laminar flow proximal to the culture area thereby 
providing a highly homogeneous stress stimulus.   
In vivo, the artery is lined by a monolayer of highly hemophilic endothelial cells 
in direct contact with blood.  Subsequently, SMCs are not directly exposed to fluid shear 
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from blood flow.  However, following the deployment of a vascular sent, it is common to 
experience a near complete denudation of the endothelial layer thereby exposing the 
underlying SMCs and thrombogenic collagen and sub-endothelial matrix.[4, 12]  The 
restoration of this endothelial layer is important for the recovery of the artery to its native 
state preventing late thrombosis and reducing restenosis.[4]  For this reason, much of the 
work available in the literature focuses on the exposure of endothelial cells (ECs) to fluid 
shear in vitro.  In the stented artery model by Punchard et al., a vascular stent was 
deployed inside a fibronectin coated silicone tube seeded with human umbilical cord 
ECs.[181]  It was hypothesized that the turbulent areas of flow caused by the stent struts, 
along with cell injury from the stent strut, was a major contributing factor to the observed 
increased expression of genes by ECs for E-Selectin, inter-cellular adhesion molecule-1 
(ICAM-1), and VCAM-1. [181]  Lin et al. utilized bovine ECs exposed to laminar shear 
stress for 24 hrs using a parallel plate flow chamber, and observed an increase in the 
expression of the tumor suppressor gene p53.[182]  The transcription factor p53 can be 
activated in a number of different cell types in response to various stresses such as UV 
and ionizing radiation, DNA-damaging agents, and hypoxia.[182, 183]  It is known to 
lead to the induction of various growth arrest genes such as p21cip1 as well as the DNA 
damage inducible gene 45 (GADD45) thereby leading to growth inhibition.    This 
increase in p53 expression was observed at shear stress levels of 3 dynes/cm2 and higher, 
but not at 1.5 dynes/cm2.[182]  These results indicate that the threshold of growth 
inhibition for ECs caused by shear stress may lie between 1.5 and 3 dynes/cm2.  This is 
further supported by the work of Akimoto et al. that found an inhibition of DNA 
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synthesis in bovine aortic ECs subjected to shear stress levels of 30 and 5 dynes/cm2 
compared to a static control, but no significant inhibition was observed at 1 
dyne/cm2.[184] 
Following an angioplasty procedure, it is common to observe a denudation of the 
endothelial layer thereby directly exposing the underlying SMCs to shear stress from 
blood flow.  The direct stimulation of SMCs with shear stress in vitro is done in order to 
model this situation.  Asada et al. stimulated bovine SMCs using orbital shear stress 
levels of 11.5 dynes/cm2 and observed increased proliferation as well as decreased α-
actin and calponin expression along with increased expression of vimentin and β-actin 
compared to a static control.[185]  In another study, bovine SMCs were stimulated with 
oscillatory shear stress of 14 dynes/cm2 using an orbital shaker by Haga et al. which 
resulted in a significant increase in cell number and 3[H]thymidine incorporation 
compared to a static control at 5 days.[186]  Moreover, Qi et al. demonstrated a decreased 
expression of protein Rho-GDP dissociation inhibitor alpha (Rho-GDIα) in rat aortic 
SMCs exposed to low levels of shear stress (5 dynes/cm2) as compared to those exposed 
to higher levels of shear stress (15 dynes/cm2).[187]  Since decreased Rho-GDIα 
expression has been associated with enhanced vascular SMC migration and apoptosis in 
SMCs, this molecule may become a drug target in the development of future 
pharmaceutical treatments to reduce SMC migration and vascular remodeling following 
angioplasty in vivo.   
It can be seen from evaluating these and a number of other studies that, shear 
stress plays an important role in the activity of both ECs and SMCs.  In both cases, there 
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is threshold level at which shear stress acts to inhibit cell proliferation.  At higher levels 
of shear stress of approximately 15-28 dynes/cm2, which is within the normal range of 
physiologic shear stress of 5-25 dynes/cm2, SMC proliferation is reduced.[188, 189]  The 
shear level at which EC proliferation is inhibited in vitro is much lower at approximately 
1.5-3 dynes/cm2.[149, 182, 184] 
Effect of Combined Strain and Fluid Shear on Endothelial and Smooth Muscle Cells 
Exposure of SMCs to concurrent fluid shear and cyclic strain stimuli adds another 
level of complexity to modeling of the in vivo environment experienced by SMCs in an 
artery following the denudation of the endothelial layer.  The development of 
experimental setups to apply controlled shear stress and equibiaxial strain could lead to 
cost effective and time efficient test systems with a much higher degree of reproducibility 
than that observed using in vivo experimentation.  To date, however, few experimental 
models are available to evaluate the combined effect of these two stimuli applied 
simultaneously.   
To the best of our knowledge, the earliest example of such an in vitro study was 
reported by Moore et al.[144]  This device made use of compliant silicone tubes coated 
with fibronectin and seeded with bovine pulmonary endothelial cells and allowed to reach 
confluence.  After which, they were subjected to pulsatile pressurized flow in order to 
apply both cyclic stretch and fluid shear.  Although it was not reported, based on the 
design it can be speculated that cell seeding inside the tube as well as visualization of 
adherent cells would be problematic.  This general test setup, however has been used by 
several groups to test the response of ECs to cyclic stretch and fluid shear.[190-192]  For 
134 
	  
example, Zhao et al. observed a significantly elongated morphology as well as an 
orientation in the direction of flow and perpendicular to stretch in bovine aortic 
endothelial cells seeded in fibronectin coated Sylgard tubes subjected to shear stress 
greater than 2 dynes/cm2 or hoop stress greater than 2% at 24 hrs compared to a static 
control.[192]  The formation of stress fibers aligned with the long axis of the cell was 
induced by both shear stress as well as hoop stress.  Stress fiber size and alignment were 
significantly enhanced by the concurrent application of shear and hoop stress as 
compared to application of either stimuli singularly indicating a possible synergistic 
effect between the two stimuli on the cell morphology of ECs.   
Another 3D vascular simulator that utilized a silicone compliant tube was 
developed by Punchard et al.[181, 193]  This study differed from the previously 
mentioned compliant tube studies in that a Libertè bare metal stent (Boston Scientific 
Corporation, USA) was deployed inside the silicone tube using a balloon catheter in order 
to evaluate the effects of the deployed stent on human umbilical cord vein endothelial 
cells (HUVECs) in vitro.[181]  The group observed local endothelial denudation 
immediately after stent deployment at 15 atm for 30 seconds as a result of physical 
damage to the cell layer.[181]  Additionally, the HUVECs subjected to flow without a 
deployed stent oriented themselves in the direction of flow.  Patterns of cell orientation 
were less apparent in the stented model subjected to flow and completely randomized in 
the stented model not subjected to flow indicating a possible response of ECs to regions 
of turbulent flow caused by stent struts.[181]  Furthermore, the deployed stent increased 
the expression of E-Selectin, ICAM-1, and VCAM-1 by the ECs 24 hrs following stent 
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deployment.[181]  While these studies highlight the effects of fluid shear and cyclic 
strain on ECs, little is known about the effects of combined cyclic strain and fluid shear 
on SMCs.   
The work of Acampora et al. conducted in our laboratory utilized a parallel plate 
flow chamber combined with computer controlled vacuum pressure to strain a silicone 
membrane across a stationary post in order to provide independently controlled fluid 
shear and cyclic strain stimuli.[102]  Using this setup, Acampora et al. for the first time 
exposed rat aortic SMC to a stain stimulus (two cycles of 12% strain) to mimic 
angioplasty injury followed by combined strain and fluid shear (4% and 0.5 dynes/ cm2 
respectively) to mimic physiological hemodynamic conditions.  This study demonstrated 
a 75% increase in SMC proliferation compared to the dynamic control not subjected to 
the 12% strain injury at a time point of 8 hrs.[102]  Additionally, the authors reported a 
19% decrease in the expression of the contractile marker smooth muscle α-actin in the 
angioplasty injury model compared to a static control.[102]  In a follow up study when 
cells were subjected to similar concurrent strain and shear conditions for 24 hrs, rat aortic 
SMC proliferation, expression of the synthetic marker vimentin, cellular apoptosis, and 
hypertrophy were all observed higher compared to the group stimulated with cyclic strain 
alone.[194]  Interestingly, the cells exposed to concurrent cyclic strain and fluid shear 
exhibited similar SMC proliferation compared to the cells stimulated with cyclic tension 
only.  This lack of effect on SMC proliferation and apoptosis is likely due to the low level 
of fluid shear (0.5 dynes/cm2) employed in the experiment as it was shown in previous 
shear only studies that shear stress levels below approximately 15 dynes/cm2 do not act to 
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inhibit SMC proliferation.[185-189]  However, the increased expression of the synthetic 
marker vimentin in the Acampora angioplasty injury model subjected to concurrent shear 
and strain demonstrates that there may be a synergistic effect on synthetic marker 
expression from concurrent force application.[195]  Previous studies in the literature have 
shown decreased contractile marker expression and increased vimentin expression 
independently in response to oscillations shear stress and strain compared to static 
controls, the Acampora study was the first to illustrate the important additive effects of 
shear and tensile forces.  
The experimental setup developed by Acampora et al. also allowed investigation 
of cell response to various pharmacologic treatments encountered during vascular 
intervention.  For example, the authors investigated the effect of combined shear and 
strain in the presence of heparin, an anticoagulant commonly administered during 
angioplasty procedures.[29]  In addition to its properties as an anticoagulant, heparin has 
also been shown to decrease SMC migration and proliferation.[29, 196, 197]  A common 
clinical protocol is to administer a three to five minute 10,000 unit bolus IV injection of 
heparin immediately prior to balloon angioplasty.[198]  When simulated in vitro, this 
10,000 unit bolus injection of heparin was held in contact with the cells for 5 min 
followed by a 100 µg/ml heparin dosage for 24 hrs and resulted in decreased rat aortic 
SMC proliferation.[29]  Thus, the aim of the study by Acampora et al. was to test the 
efficacy of the drug treatment in minimizing intimal hyperplasia following balloon injury.  
Furthermore, Fasciano et al. demonstrated a decrease in rat SMC proliferation using 100 
µg/ml heparin under static conditions  as compared to a negative control.[199]  This was 
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thought to be due to a block in the G1 to S phase caused by an inhibition of cyclin-
dependent kinase 2 activity.  This is in agreement with other studies reported in the 
literature in which SMC proliferation decreased following heparin administration.[29, 
196, 199-202]  A unique finding in the Acampora study was the differential expression of 
calponin, a calcium binding protein that inhibits the ATPase activity of myosin, in 
response to changes in mechanical environment.[29]  It was shown that the cells 
subjected to concurrent strain and fluid shear in the presence of heparin exhibited 
decreased calponin expression compared to a static control.  However, heparin 
administration to static SMCs increased calponin expression compared to a static 
control.[29]  The results of this study highlight the differences in calponin expression by 
SMCs in response to certain stimuli under varying culture conditions.  This differential 
cell response clearly illustrates the need for such a dynamic simulator in order to 
investigate the possibility of other varying SMC responses to pharmaceutical treatments 
as a result of mechanical environment.  This is necessary in order to gather experimental 
data more likely to mirror the in vivo response and thus be of significant value in the 
clinical realm. 
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-APPENDIX C- 
Rat Aortic Smooth Muscle Cell Isolation Protocol 
 
Modified Rat Vascular SMC Primary Isolation protocol based on a pooling of advice 
from Dr. Aggie Simionescu, Dr. Jiro Nagatomi, and Dr. Anand Ramamurthi as well as 
several additions based on first-hand experience 
1. Euthanize adult Sprague-Dawley rats by CO2 asphyxiation as per established 
animal protocol guidelines. 
2. Split the abdomen longitudinally from the pelvis all the way through the rib cage. 
3. Carefully dissect away the internal organs to expose the aorta along the posterior 
abdominal wall. 
4. Clip aorta at the pelvic bifurcation and dissect it away from the dorsal abdominal 
wall to the aortic arch. 
5. Flush aorta with approximately 3ml of cold transport medium using via 
hypodermic injection through the wall of the left ventricle. 
Note: it is important that the aorta be dissected away from the dorsal abdominal 
cavity prior to flushing as blood present in the aorta is beneficial for visualization of 
the artery. 
6. Clip the aorta at the aortic arch and place into ice cold transport medium 
(DMEM+100ug/ml pen/strep+2ug/ml fungizone) for transport back to lab. 
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7. Peel away excess fat and adventitial layer using two pair of sterile tweezers using 
a dissection microscope under a laminar flow hood on a sterile petri dish with a 
small amount of PBS added to prevent drying and maintain cell viability. 
Note: Adipose tissue is easily distinguished by the glistening appearance of the 
contained fat globules.  Adventitial tissue will appear as a somewhat ragged 
yellowish-white tough material covering the outside of the artery.  The exposed 
medial layer will appear as a clean pink tube. 
8. After removing all excess fat and adventitial tissue, carefully trim away any larger 
arterioles from the aorta to prevent later endothelial contamination in the culture. 
9. Split aortic segments lengthwise and lay them open with the intima facing 
upward. 
10. Use a sterile scalpel to scrape away the endothelial layer. 
Note: The very thin endothelial layer is not distinguishable under such low 
magnification.  However it is important to thoroughly but gently scrape the entire 
intimal surface to remove this cell layer. Very little pressure is required. 
11. Rinse aortic segments in PBS to remove any loose cells on the surface. 
12. Finely mince aortic segments into approximately 0.5mm pieces under 
magnification using sterile scissors. 
13. Place minced artery segments in 15ml tube containing 10ml DMEM/protease 
solution comprised of 10ml DMEM +10mg collagenase type II (Worthington 
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Biomedical) +2.5mg Elastase (Worthington Biomedical)+ 1.5mg soybean trypsin 
inhibitor (Worthington Biomedical). 
14.  Incubate for 20-25 min at 37C gently inverting tube 2-3 times about every 5 
minutes to mix. 
15. Allow aortal segments to settle to bottom of tube and carefully aspirate the 
digestion solution. 
16. Resuspend in 10ml DMEM+10% FBS+100ug/ml Pen/Strep to dilute and 
deactivate the digestion solution. 
17. Use a sterile scalpel blade or fine tipped tweezers to lightly scratch a small 
asterisk shaped pattern on bottom of each well in a six well plate to aid in 
adhesion of tissue segments. 
18. Remove arterial segments using sterile tweezers and plate approximately 4 pieces 
into each well directly atop the approximate center of the scratched pattern. (Two 
pairs of tweezers may be required as the segments tend to clump together and may 
need to be gently pulled apart.) 
19. Supplement segments with a single drop of DMEM+FBS+pen/strep to keep them 
moist and viable without allowing them to float away from the surface. 
20. Incubated plates for 24 hrs to allow adhesion and then supplement with 1.5ml 
additional media being careful not to dislodge the attached tissue. 
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21. Incubate for approximately 7-10 days or until cells can be seen growing away 
from the tissue segments in several “patches”.  
Note: It is important to change the media every approximately 2-3 days for the initial 
growth period regardless of the small number of viable cells present to remove any 
toxins from the breakdown of the non viable portions of the tissue.  Special care must 
be taken not to dislodge or remove the tissue segments. 
22. When the “patches” of adherent cells (not the entire well surface) reach 
confluence, the tissue segments are then carefully removed and the cells passaged 
and sub-cultured normally. 
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-APPENDIX D-  
Cell-Based ELISA Assay Protocol for the Evaluation of Cellular α-Actin Content 
 
1. Fix VSMCs on plates with 1 ml 2% paraformaldehyde for 20 minutes at RT. 
2. Rinse wells with PBS 2x to remove paraformaldehyde. 
3. Block with 1 ml blocking agent (2gm BSA, 3ml FBS, 25µ TritonX-100, and 47ml 
PBS) for 45 minutes at RT. 
4. Add primary antibody to smooth muscle α-actin (diluted 1:200 in blocking agent) 
for 2 hours at RT. 
Note: Negative control group received blocking agent without any primary antibody 
for the same time. 
5. Rinse with PBS 3x for 5 minutes each to remove any unbound antibody. 
6. Add biotinylated mouse IgG (diluted 1:200 in blocking agent) for 2 hours at RT. 
7. Rinse with PBS three times waiting 5 minutes in each washing step to remove any 
unbound antibody. 
8. Incubate with streptavidin conjugated alkaline phosphatases (diluted 1:500 in 
TBST at pH8) for 45 minutes at 37oC. 
9. Rinse with PBS 3x for 5 minutes to remove any unbound enzyme. 
10. Incubate with 500 µl chromogenic substrate (3 mM p-nitrophenyl phosphate, 0.05 
M Na2CO3, and 0.05 mM MgCI2) for 45 minutes at 37oC. 
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11. Transfer 125µl of colored product from each well to a 96 well plate in triplicate 
and measure absorbance at 405 nm. 
12.  Rinse cells with PBS 2x to remove pnpp and add 350 µl 1% Triton-X 100 
solution diluted in PBS for 20 minutes 
13. Remove cell lysates and store at -80C for BCA assay to normalize absorbance 
values to total protein content 
14. Subtract absorbance of respective negative controls from their experimental 
counterparts and normalize against protein content. 
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-APPENDIX E-   
Analysis of Hydroxyapatite as a Novel Drug Eluting Stent Coating to Control VSMC 
Proliferation Under Dynamic Culture Conditions In Vitro 
 
E.1 Introduction 
Drug eluting stents have been shown to significantly decrease the incidence of in 
stent restenosis.  Delivery of the drug directly to the site where is needed allows for a 
therapeutic dose at the stenting site while maintaining very low systemic concentrations.  
These combine in order to illicit a more favorable response following implantation into 
the body with the ultimate goal of preventing restenosis caused by intimal hyperplasia. 
Drug eluting stents have been shown to greatly reduce the incidence of in-stent 
restenosis.[107, 203, 204]  The only two drugs currently on the market with FDA 
approval for widespread use with drug eluting stents are Sirolimus (Cypher stent) [112] 
and Paclitaxel (Taxus stent) [108].  However, Medtronic is currently developing a 
Zotarolimus drug eluting version of their Driver stent under the name Endeavor.[111]  
Other research groups are looking at a number of other immunosuppressant and anti-
inflammatory drugs for use with DESs such as rapamycin [205, 206], biolimus A9 [207, 
208], cyclosporine A [209], everolimus [210-212], methylprednisolone [213, 214], and 
dexamethasone [113, 215] just to name a few.  However, while some experimental drugs 
have proven more effective than others in certain applications, the main problem 
associated with DESs that are currently on the market lies not in the efficacy of the drug 
in preventing VSMC hyperplasia.  Rather, while somewhat rare, a few patients receiving 
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DESs suffer from issues such as incidences of late thrombosis, and incomplete stent 
apposition.[107]  This is thought to be primarily due to the fact that the locally high drug 
administration causes an inhibition of the body’s natural healing response following stent 
implantation.[107]  The lack of tissue in-growth causes incomplete apposition of the stent 
and delayed re-endothelialization.  This results in an increased risk for late thrombosis 
and myocardial infarction following the discontinuation of anti-thrombotic medications. 
[107, 204, 216]  
Recently, some researchers have investigated the off label use of drugs such as 
bisphosphonates (BPs) to manage SMC proliferation and migration. [217-220]  
Traditionally, bisphosphonates are used for the treatment of osteoporosis.  They serve to 
increase bone mineral density by inhibiting osteoclast activity as well as limiting 
apoptosis of both osteoblasts and osteocytes.[221]  The inhibitory effect of nitrogen-
containing BPs such as alendronate on osteoclasts is thought to be due to preventing 
protein prenylation.[222]  In vivo, BPs bind to hydroxyapatite in the bone thereby 
preventing them from being rapidly cleared from the blood as well as inhibiting HA 
resorption thereby inhibiting bone turnover.[223]  In addition to osteoclast deactivation, 
this effect is thought to be due in part to the inactivation of monocytes and macrophages. 
[219] 
Addtionally, BPs have been shown to inhibit the development of atherosclerotic 
lesions in vivo.  Bisphosphonates have also been shown to inhibit LDL accumulation and 
degradation in macrophage cultures thereby inhibiting foam cell formation.[220]  
Furthermore, BPs are known to inhibit in vivo atherogenesis and calcification without 
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affecting serum cholesterol or calcium.[224, 225]  Injection of liposomal alendronate has 
been shown to reduce neointimal hyperplasia in a rabbit model after intravascular stent 
deployment.[226]  Table D.1 reproduced from a review by Ylitalo et al shows results 
from a number in animal studies demonstrating the ability of various bisphosphonate 
drugs to inhibit atherosclerotic development and progression.  Additionally, 
bisphosphonates form a very rapid and stable bond with hydroxyapatite present in bone.  
In fact, the terminal skeletal half-life of alendronate in man is estimated at approximately 
10 years. [220, 227, 228]  This stable binding ability makes hydroxyapatite an excellent 
drug delivery platform for bisphosphonates.   
This study was aimed at the evaluation of the previously described HA coating as 
a drug delivery platform for bisphosphonate-class drugs such alendronate sodium.  
Additionally, we wished to evaluate the efficacy of locally delivered alendronate at 
attenuating the proliferative response of VSMCs following implantation of a model stent 
strut under dynamic culture conditions in vitro. 
 
 
 
 
 
 
147 
	  
Table E.1: Effect of Bisphosphonates on Experimental Atherosclerosis [220] 
 
Drug	   Animal	  Model	   Results	  
Mechanism	  Postulated	  
by	  Authors	  
Etidronate	  (5	  
mg/kg/day	  sc)	  for	  8	  
weeks[229,	  230]	  
Rabbit	  fed	  peanut	  oil	  and	  
cholesterol	  for	  8	  weeks	  before	  
drug	  treatment,	  
preestablished	  atherosclerosis	  
Reduced	  the	  amount	  of	  lesions	  and	  
accumulation	  of	  lipids,	  calcium,	  
collagen,	  and	  elastin	  in	  aorta	  during	  
regression	  period	  
Formation	  of	  
lipoprotein-­‐
mucopolysaccharide-­‐
calcium	  complexes	  as	  
well	  as	  their	  binding	  to	  
connective	  tissue	  
proteins	  may	  be	  
reduced	  due	  to	  altered	  
calcium	  metabolism.	  	  
Etindronate	  (2.5	  
mg/kg/day	  sc)[225]	  
Rabbits	  fed	  cholesterol,	  
nicotine,	  and	  vitamin	  D	  for	  12	  
weeks	  
Reduced	  the	  calcification	  of	  aorta	  and	  
the	  amount	  of	  lipid	  lesions	  in	  arteries;	  
inhibited	  thromboarteritis	  and	  death	  
rate.	  
Effects	  on	  calcium	  
metabolism	  in	  arterial	  
wall	  
Etidronate	  (20-­‐40	  
mg/kg/day	  po)[231]	  
Rabbits	  fed	  peanut	  oil	  and	  
cholesterol	  and	  8	  weeks	  
Reduced	  the	  amount	  of	  lesions	  and	  
accumulation	  of	  lipids,	  calcium,	  
collagen,	  elastin,	  and	  
glycoaminoglycans	  in	  aorta	  
Cell	  proliferation	  and	  
mobility,	  secretion	  of	  
connective	  tissue	  
proteins,	  deposition	  of	  
calcium	  in	  elastica	  and	  
cholesterol	  binding	  to	  
elastin	  protein	  were	  
decreased.	  
Cloronate	  (5	  mg/kg/day	  
sc)[232]	  
Cynomolgus	  monkeys	  fed	  fat	  
and	  cholesterol	  for	  6	  months	  
Reduced	  aortic	  calcification	  but	  
increased	  sudanophilic	  lesions	  in	  
peripheral	  lesions	  in	  peripheral	  
arteries.	  
Bisphosphonate	  inhibits	  
only	  the	  advanced	  form	  
of	  atherosclerosis	  but	  
not	  the	  less	  severe	  
disease.	  
Pamidronate	  (40	  
mg/kg)	  or	  etidronate	  
(40-­‐120	  mg/kg)	  po	  
daily[233]	  
Cynomolgus	  monkeys	  fed	  fat	  
and	  cholesterol	  for	  24	  months	  
Inhibited	  gross	  and	  microscopic	  
atherosclerosis	  and	  decreased	  aortic	  
calcium,	  cholesterol,	  collagen,	  and	  
elastin	  
Cell	  proliferation	  and	  
mobility,	  secretion	  of	  
connective	  tissue	  
proteins,	  deposition	  of	  
calcium	  in	  elastica	  and	  
cholesterol	  binding	  to	  
elastin	  protein	  were	  
decreased,	  which	  may	  
be	  due	  to	  effects	  on	  
calcium-­‐dependent	  cell	  
responses.	  
Etidronate	  (20	  
mg/kg/day	  po)	  for	  5	  
months[234]	  
Swine	  fed	  cholesterol	  for	  4	  
months	  and	  aorta	  injured	  
before	  drug	  treatment,	  
preestablished	  atherosclerosis.	  
Reduced	  aortic	  calcification	  but	  not	  
sudanophilic	  lesion	  areas	  and	  
inhibited	  lipid-­‐rich	  necrosis	  of	  lesions.	  
Inhibition	  of	  necrosis	  
may	  be	  due	  to	  
prevention	  of	  
intracellular	  calcium	  
overload	  and	  
subsequent	  cell	  death.	  
Clodronate	  (25	  mg/kg	  
iv)	  twice	  a	  week	  for	  12	  
weeks[235]	  
Rabbits	  fed	  high-­‐cholesterol	  
diet	  for	  12	  weeks	  and	  
simultaneously	  treated	  with	  
clodronate.	  
Reduced	  the	  area	  of	  visible	  and	  lipid-­‐
stained	  atheromatous	  lesions	  and	  
accumulation	  of	  lipids	  and	  calcium	  in	  
aorta.	  
Inhibition	  of	  
accumulation	  of	  
atherogenic	  lipoproteins	  
in	  arterial	  macrophages	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E.2 Materials and Methods 
Drug loading of HA coated stents 
HA coated Nitinol stent specimens were first cleaned by sonication in 100% 
isopropyl alcohol for 15 minutes. Following which, they were then sonicated in a 5% 
Liquinox solution in milli-Q water for 15 minutes followed by 3 rinses in milli-Q water 
with the water being completely changed for each rinse step. 
HA stents were then loaded with alendronate by soaking them in a saturated 
solution (10 mg/ml) of alendronate sodium dissolved in HPLC grade water for a duration 
of 48 hours.  Specimens were removed from the soaking solution and allowed to air dry. 
Drug Elution	  
Stent specimens previously loaded with alendronate were placed in 2ml fresh 
HPLC-grade water at RT to allow the drug to release from the surface.  One ml samples 
were then taken between 12 hrs and 5 days. Samples were repeated in triplicate. 
There have been a number of different methods for measuring alendronate sodium 
using HPLC reported in the literature.  However, many of these methods either require 
time-intensive ion complexing, or perchloric acid, which is undesirable because of its 
flammable, corrosive, and explosive properties.  For our pilot experiments, an ion 
chromatography method with refractive index detection previously published in the 
literature was used [236].  However, because the needed sensitivity could not be achieved 
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using this method, another method employing in-line copper II nitrate complexation was 
used. [237]  A Waters HPLC column with anion-exchange (Milford, MA) was used in the 
present method.  This column was packed with polymethacrylate resin having a 
quaternary ammonium functional group (6µm particles size, 4.6x75mm ID).   Additional 
parameters were replicated following those previously published [237]:  a column 
temperature of 25°C, 0.85 mL/minute flow rate, and injection volume of 50µL. It is 
important to note that a flow rate of 0.85ml/min was used instead of the 1.0mL/min rate 
used in the literature because the manufacturer’s maximum recommended flow rate for 
our column was 1.0mL/min.  Thus, we selected a slightly lower value in order to insure 
we did not exceed the maximum.  Dilute nitric acid (Fluka) of 6mM with copper II nitrate 
(0.5mM, Alfa Aesar) was used for the mobile phase because it yielded the shortest 
alendronate retention time and sharpest peak [237].  Additionally, immediately prior to 
the elution experiments, a calibration curve was generated.  Over the course of the elution 
testing, the same HPLC column was used.  Additionally, equilibration of the column was 
accomplished through injection of the alendronate standard solution until reproducible 
retention times and peaks could be generated.  The standard 0.4mg/mL alendronate 
solution was formulated by dissolving 40mg of alendronate sodium into 100mL DI 
water.  The resulting solution was then filtered using a 0.2µm filter (Nalgene) for HPLC 
use.  Furthermore, individual samples were also filtered using 0.45 µm polypropylene 
syringe filters (National Scientific).  Experimental analysis showed the alendronate peak 
had an approximate retention time of 4 min and a detection level of 0.4µg/mL, which is 
similar to detection limit values reported in the literature of approximately 0.3µg/mL 
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[237]. 
	  
Samples (n=4; triplicate) were analyzed using high pressure liquid 
chromatography (HPLC, Waters, Milford, MA) anion exchange using in-line 
complexation. A 6mM nitric acid (Fluka) + 1.5mM copper II nitrate (Alfa Aesar) mobile 
phase were used which employed a flow rate of 0.85mL/min using a Waters IC-Pak 
Anion HR column. 
Cell Seeding for Mechanical Testing 
Silicone membranes were cut into circles 5.25 cm in diameter for each culture 
plate out of biomedical grade silicone sheets (Lot SM04106803, Specialty 
Manufacturing, Inc. Saginaw, MI)  .015" in thickness and 40 durometer Shore A.  The 
cut silicone sheets were then cleaned using sonication in deionized water and press fit 
into the culture plates using an inner Lexan ring.  The culture plates were then autoclaved 
(Tuttnauer Brinkmann, 3870M, Jerusalem, Israel) at 121 °C for 30 minutes and put into 
their appropriate place in the main body of the simulator.  The assembled system was 
then UV sterilized for 3 hours.  The Teflon rings were sonicated in a 1% detergent 
solution (Liquinox Critical Cleaning Detergent, Alconox, Jersey City, NJ) for 15 minutes 
followed by three rinses DI water.  The rings were then autoclaved and centered on the 
Lexan post on top of the silicone membrane.  The area inside of the Teflon rings was 
coated with Type I Collagen (Purecol 3mg/ml, Advanced Biomatrix, lot# 1356) diluted 
with sterile DI water.  The coated membranes were rinsed with 1.0 ml of Dulbecco’s 
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Phosphate Buffered Saline (DPBS) (Media Tech, Inc., 21-031 CM, Herndon, VA) before 
cell seeding.  Cell counting was done using a Millipore ScepterTM cell counter, and cells 
were seeded at a density of 6 x 104 cells suspended in 1.5 ml culture media per plate, and 
incubated for 48 hours to allow the cells to attach.   
The vascular simulator employed in the present study was made up of two 
independent simulator bodies.[29]  Each body has three independent channels, which 
thereby allows for six different samples, which are independent from one another.  In 
order to mimic the mechanical environment experienced in vivo, cells were subjected to a 
cyclical strain stimulus.  Equibiaxial strain was applied to the silicone membrane via 
vacuum suction in order to stretch the membrane over the central Lexan post.  Silicone 
lubricant was applied on top of the post in order to reduce friction.  The vacuum pressure 
used to stretch the membrane was controlled using Flexcell 3000 software in order to 
apply 5% cyclical strain to the membranes at a rate of 1 Hz.  This level of strain is 
representative of physiological conditions in which the vessel wall experiences strains 
that are generally lower than 10% and may be as low as 0-4%.[102, 142-144]   
The study consisted of three groups: an alendronate loaded HA coated stent 
(Alendronate), a bare Nitinol stent (NiTi), and a stent free control group (Ctrl).  One 
group was subjected to stimulation from the HA wire and compared to a control group 
without a wire.  Each group contained three samples and was repeated in duplicate.  
DNA Synthesis 
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After mechanical stimulation, DNA synthesis was evaluated via an ELISA based 
bromodeoxyuridine (BrdU) incorporation assay (Roche).  Briefly, cells were BrdU 
labeled for a duration of 2 hours after which they were fixed in the provided 
fixation/DNA denaturation solution for 30 minutes.  Following this, the cells were 
incubated with an enzyme linked anti-BrdU antibody solution for 90 minutes.  After 
several PBS rinses, the cells were then incubated with a substrate solution for 30 minutes 
and absorbance was read at 370 nm with a reference wavelength of 492 nm.  The 
remaining cells were then lysed using a 1% Triton X-100 solution and the total protein 
content quantified via BCA assay in order to normalize the absorbance values. 
Expression of α-Actin 
The expression of α-actin was measured using a slight modification of an 
established ELISA assay (Appendix C).[103]  Briefly, the cells were PBS rinsed and 
fixed in a 2% paraformaldehyde solution.  The cells were then covered with 1ml blocking 
solution (47ml PBS, 2g bovine serum albumin, 3ml FBS, and 25µl Triton X-100) for 45 
minutes at room temperature.  They were then treated with the primary mouse anti-α-
actin antibody diluted 1:200 for 2 hrs at RT, followed by a 2hr treatment with a 
biotinylated mouse IgG secondary antibody diluted 1:200.  The cells were then incubated 
for 45 minutes at 37 °C with a streptavidin conjugated alkaline phosphatase diluted 1:500 
in TBST buffer (pH 8).  Finally, the cells were incubated with the subtrate solution (3mM 
pNp, 0.05 M Na2CO3, 0.05 mM MgCl2) for 45 minutes at 37 °C and the absorbance read 
at 405 nm.  The cells were then lysed using a 1% Triton X-100 solution and total protein 
measured using BCA in order to normalize the absorbance values. 
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Statistical Analysis 
All data was evaluated using an ANOVA statistical analysis paired with Tukey 
analysis.  This was done using SigmaStat statistical analysis software (Systat Software, 
Inc., San Jose, CA) with p<0.05 indicating a significant difference.     
 
E.3 Results 
Drug Elution 
 Results from the drug elution study showed an initial burst release from the stent 
surface within the first 12 hrs of soaking in HPLC grade water.  This amounted to 
approximately 13 µg of alendronate released per stent segment.  After the 12 hr burst 
release, the alendronate concentration in the soaking solution stayed relatively constant 
over the course of 5 days.  In this study, each time point was repeated in triplicate under 
the same preparation; however, the results showed a rather large standard deviation 
between the different replicates.   
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Figure E-1: HPLC Quantification of Alendronate Released from 0.5-5 Days 
 
DNA Synthesis 
As illustrated in Figure 6-2, results from the BrdU assay showed a significant 
increase in DNA synthesis as a result of the bare Nitinol stent placement as compared to 
the control (P=0.025).  However, the alendronate-loaded hydroxyapatite-coated Nitinol 
stent group showed a significant decrease in DNA synthesis as compared to the bare 
Nitinol stent (P=0.039).  In fact, there was almost no observable increase in absorbance 
for the alendronate group as compared to the Ctrl group with values remaining within 
approximately 5%.  
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Figure E-2 : BrdU Assay of Cyclically Strained VSMCs in Response to an Alendronate-
Loaded, Hydroxyapatite-Coated Nitinol Stent In Vitro (* indicates a significant 
difference as compared to the control with P< 0.05) 
 
Expression of α-Actin 
As expected based on results from previous studies, there was a significant 
decrease in α-actin expression in response to placement of the model stent specimen for 
both the alendronate-loaded HA group as well as the HA coating that was not loaded with 
alendronate as compared to the control (P=0.026 and 0.02 respectively).  However, there 
was no significant difference in α-actin expression between the two HA-coated 
experimental groups (P=0.65).  
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Figure E-3: α-Actin ELISA Assay of Cyclically Strained VSMCs in Response to an 
Alendronate-Loaded, Hydroxyapatite-Coated Nitinol Stent In Vitro (* indicates a 
significant difference as compared to the control with P< 0.05) 
 
E.4 Discussion 
Drug Elution 
Results from the elution study showed an initial burst release of alendronate 
within the first 12 hrs with a rather large standard deviation between samples.  In future 
studies, this could be improved by using a larger number of replicates at each time point.  
Additionally, using our current method it was not possible to determine the total amount 
of alendronate deposited on the stent surface during the 48 hr loading period.  This was 
due to the fact that the extremely high concentration of alendronate present in our 
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aqueous solution used to drug-load our stent segments was above the concentration range 
of our study.  In future studies, it would be beneficial to measure the alendronate 
concentration both before and after drug loading of the stent segment.  This would allow 
us to determine the total amount of drug present on the hydroxyapatite-coated surface.  It 
is important to obtain a profile of percent of total drug released over time in order to 
determine the length of time our present drug eluting stent would be effective if 
implanted in vivo. 
DNA Synthesis 
As expected based on experience from previous studies, results showed a 
significant increase in DNA synthesis as a result of the bare Nitinol stent placement as 
compared to the control.  More importantly; however, results showed locally delivered 
alendronate from the HA coating capable of nearly eliminating this increase in DNA 
synthesis resulting in BrdU incorporation levels within 5% of the control group.  Overall, 
these results indicated that alendronate was capable of significantly attenuating cell 
proliferation marked by an increase in DNA synthesis in the present dynamic in vitro 
model. 
This response may be explained by similar studies present in the literature which 
have shown BPs such as risedronate and zolendronate to have antiproliferative effects on 
mouse mesothelioma cell lines in vitro marked by a decrease in DNA synthesis.[238] 
This was thought to be a result of inducing phosphorylation of the p38 mitogen-activated 
protein kinase.[238, 239]  Similar to their action on osteoclasts, nitrogen containing BPs 
have also been shown to inhibit VSMC proliferation in vitro by preventing G-protein 
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prenylation through inhibition of farnesyl pyrophosphate synthase.[240]  While their 
exact role in triggering VSMC pathogenesis is not exactly known, recent studies have 
shown a number of G-protein coupled receptors to be important regulators of SMC 
functions such as migration and proliferation.[241-243]  Furthermore, in vivo, chronic 
inhibition of farnesyl pyrophosphate synthase using alendronate has been shown to 
improve endothelial function in spontaneously hypertensive rats marked up an up 
regulation of nitric oxide synthase coupled with an inhibition of  the G-protein RhoA 
activation.[244] 
Expression of α-Actin 
As expected based on results from previous studies, there was a significant 
decrease in α-actin expression in response to placement of the model stent specimen for 
both the alendronate-loaded HA group as well as the HA coating that was not loaded with 
alendronate as compared to the control; however, no significant difference was observed 
between the two groups.  These results show that, with regard to the expression of α-
actin, alendronate has little to no effect on the VSMCs while still maintaining the ability 
to significantly reduce DNA synthesis.  This is contrary to results observed following 
sirolimus and paclitaxel treatment of VSMCs, which showed, in addition to inhibition of 
proliferation, a differential expression of important structural proteins such as α-
actin.[245, 246]  
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E.5 Conclusion 
Results of the present study showed that alendronate is in fact able to be loaded 
on a hydroxyapatite-coated Nitinol stent specimen.  HPLC analysis demonstrated an 
initial burst release of alendronate within the first 12 hrs.  Further investigation is needed 
to calculate the total amount of drug loaded on the stent surface in order to determine the 
percent released from the stent surface.  This is important to evaluate the potential 
performance of the drug eluting stent over a longer period of time. 
 In vitro studies employed in the present work demonstrated that, under dynamic 
culture conditions of cyclic strain, alendronate-loaded HA coated stents were effective at 
reducing VSMC proliferation.  This was marked by a significant decrease in DNA 
synthesis as compared to HA coated stents that were not loaded with alendronate.  
Additionally, results showed that alendronate did not significantly affect α-actin 
expression. 
While some further investigation is needed in several areas, results from this 
preliminary proof-of-concept study are quite positive.  The present study demonstrated 
that a Nitinol stent with a hydroxyapatite coating can serve as a drug delivery platform 
for the delivery of bisphosphonate drugs such as alendronate.  Additionally, it was shown 
that alendronate eluded from the surface of the HA-coated stent can be delivered at 
concentrations, immediately local to the stent, high enough to inhibit VSMC proliferation 
with not significantly affecting α-actin expression.  Overall, these results indicate that, 
while further investigation is still needed, hydroxyapatite as a favorable drug delivery 
platform for the administration of bisphosphonate class drugs such as alendronate may be 
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effective as a new class of drug eluting stents for the prevention of in-stent restenosis due 
to VSMC hyperplasia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
161 
	  
-REFERENCES- 
 
1. Guyton, A., Hall, J., Textbook of Medical Physiology. 11 ed2006: Elsevier 
Saunders. 
2. Copstead, L. and J. Banasik, Pathophysiology. 3 ed2005: Elsevier Saunders. 
3. Douglas, J., Pharmacologic Approaches to Restenosis Prevention. The Americal 
Journal of Cardiology, 2007. 100(5, Supplement 1): p. S10-S16. 
4. Restenosis: A Guide to Therapy, ed. D. Faxon2001: Martin Dunitz Ltd. 
5. Terzo, G., Taking the Pulse of the Stent Market: A new type of stent could juice 
the cardiac device market, in Investment Dealers Digest2006. 
6. Vascular Surgery. 5 ed, ed. R. Rutherford. Vol. 1. 2000: W.B. Saunders. 
7. Mueller, R. and T. Sanborn, The History of Interventional Cardiology: Cardiac 
Catherterization, Angioplasty, and Related Interventions. American Heart 
Journal, 1994. 129(1). 
8. Payne, M., Charles Theodore Dotter: The Father of Intervention. Texas Heart 
Institute Journal, 2001. 28(1): p. 28-38. 
9. Dotter, C., Transluminally-Placed Coilspring Endarterial Tube Grafts: Long-
Term Patency in Canine Popliteal Artery. Invest Radiol, 1969. 4: p. 329-332. 
10. Zollikofer, C., et al., Historical Overview on the Development and Characteristics 
of Stents and Future Outlooks. Cardiovascular and Interventional Radiology, 
1992. 15(5). 
162 
	  
11. Ryan, T., The Coronary Angiogram and its Seminal Contributions to 
Cardiovascular Medicine Over Five Decades. Transactions of the American 
Clinical and Climatological Association, 2002. 113: p. 261-71. 
12. Welt, F. and C. Rogers, Inflammation and Restenosis in the Stent Era. 
Arteriosclerosis, Thrombosis, and Vascular Biology, 2002. 22(11): p. 1769. 
13. Dee, K., Puleo, D., Bizios, R., An Introduction to Tissue-Biomaterial 
Interactions2002: Wiley-Liss. 
14. Martin, A., et al., Dual Regulation of Cofilin Activity by LIM Kinase and 
Slingshot-1L Phosphatase Controls Platelet-Derived Growth Factor-Induced 
Migration of Human Aortic Smooth Muscle Cells. Circulation Research, 2008. 
102(4): p. 432-438. 
15. Edelman, E. and C. Rogers, Hoop Dreams: Stents Without Restenosis. 
Circulation, 1996. 94: p. 1199-1202. 
16. Casscells, W., Migration of Smooth Muscle and Endothelial Cells: Critical Events 
in Restenosis. Circulation, 1992. 86(3): p. 723-29. 
17. Morton, A., R. Walker, and J. Gunn, Current Challenges in Coronary Stenting: 
From Bench to Bedside. Biochemical Society Transactions, 2007. 35(Part 5). 
18. Kornowski, R., et al., In-Stent Restenosis: Contributions of Inflammatory 
Responses and Arterial Injury to Neointimal Hyperplasia. JACC, 1998. 31(1): p. 
224-30. 
19. Bertrand, O., et al., Biocompatibility Aspects of New Stent Technology. JACC, 
1998. 32(3): p. 562-71. 
163 
	  
20. Palmaz, J., Intravascular Stents: Tissue-Stent Interactions and Design 
Considerations. AJR, 1993. 160: p. 613-618. 
21. Rajagopal, V. and S. Rockson, Coronary Restenosis: A Review of Mechanisms 
and Management. Am. J. Med., 2003. 115: p. 547-553. 
22. Serruys, P., et al., Incidence of Restenosis After Successful Coronary Angioplasty: 
A Time-Related Phenomenon. Circulation, 1988. 77(2): p. 361-371. 
23. Singh, M., et al., Clinical and angiographic predictors of restenosis after 
percutaneous coronary intervention: insights from the Prevention of Restenosis 
With Tranilast and Its Outcomes (PRESTO) trial. Circulation, 2004. 109(22): p. 
2727-31. 
24. Watasha, J., et al., Relating Nickel-Induced Tissue Inflammation to Nickel Release 
in vivo. Journal of Applied Biomedical Materials Research, 2001. 58: p. 537-544. 
25. Okazaki, Y. and E. Gotoh, Metal Release from Stainless Steel, Co-Cr-Mo-Ni-Fe 
and Ni-Ti Alloys in Vascular Implants. Corrosion Science, 2008. 50: p. 3429-
3438. 
26. Hanawa, T., Metal Ion Release from Metal Implants. Materials Science and 
Engineering C, 2004. 24: p. 745-752. 
27. Koster, R., et al., Nickel and Molybdenum Contact Allergies in Patients with 
Coronary in-stent Restenosis. The Lancet, 2000. 356: p. 1895-1897. 
28. Hillen, U., et al., Evaluation of Metal Allergies in Patients with Coronary Stents. 
Contact Dermatitis, 2002. 47: p. 353-356. 
164 
	  
29. Acampora, B., Effect of Clinically Relevant Mechanical Forces on Smooth 
Muscle Cell Response in Model of Balloon Angioplasty, in Department of 
Bioengineering2008, Clemson University: Clemson. 
30. Hara, H., et al., Role of Stent Design and Coatings on Restenosis and Thrombosis. 
Advanced Drug Delivery Reviews, 2006. 58: p. 377-386. 
31. Lau, K.-W., et al., Clinical Impact of Stent Construction and Design in 
Percutaneous Coronary Intervention. American Heart Journal, 2004. 147: p. 764-
73. 
32. Rittersma, S., et al., Impact of Strut Thickness on Late Luminal Loss After 
Coronary Artery Stent Placement. The Americal Journal of Cardiology, 2004. 
93(4): p. 477-80. 
33. Bae, W., B. Schumacher, and R. Sah, Indentation Probing of Human Articular 
Cartilage: Effect on Chondrocyte Viability. OsteoArthritis and Cartilage, 2006. 
15: p. 9-18. 
34. Bae, W., et al., Indentation Testing of Human Articular Cartilage: Effects of 
Probe Tip Geometry and Indentation Depth on Intra-tissue Strain. Journal of 
Biomechanics, 2006. 39: p. 1039-1047. 
35. De Croos, J., et al., Cyclic Compressive Mechanical Stimulation Induces 
Sequential Catabolic and Anabolic Gene Changes in Chondrocytes Resulting in 
Increased Extracellular Matrix Accululation. Matrix Biology, 2006. 25: p. 323-
331. 
165 
	  
36. Loening, A., et al., Injurious Mechanical Compression of Bovine Articular 
Cartilage Induces Chondrocyte Apoptosis. Archives of Biochemistry and 
Biophysics, 2000. 381(2): p. 205-212. 
37. Guilak, F., Compression-Induced Changes in the Shape and Volume of the 
Chondrocyte Nucleus. Journal of Biomechanics, 1995. 28(12): p. 1529-1541. 
38. Ragan, P., et al., Chondrocyte Extracellular Matrix Synthesis and Turnover Are 
Influenced by Static Compression in a New Alginate Disk Culture System. 
Archives of Biochemistry and Biophysics, 2000. 383(2): p. 256-264. 
39. Davisson, T., et al., Static and Dynamic Compression Modulate Matrix 
Metabolism in Tissue Engineered Cartilage. Journal of Orthopaedic Research, 
2002. 20: p. 842-848. 
40. EFI, A.V., User Documentation, 2010, Dassault Systems: Providence, RI. 
41. Grujicic, M., et al., Fluid/Structure Interaction Computational Investigation of the 
Blast-Wave Mitigation Efficacy of the Advanced Combat Helmet. J. Materials 
Engineering and Performance, 2010. 20(6): p. 877-893. 
42. Peeters, E., et al., Viscoelastic Properties of Single Attached Cells Under 
Compression. Journal of Biomechanical Engineering, 2005. 127(2): p. 237-243. 
43. Hemmer, J., Characterization of Vascular Smooth Muscle Cell Mechanical and 
Frictional Properties Using Atomic Force Microscopy, in Department of 
Bioengineering 2008, Clemson University: Clemson, SC. 
166 
	  
44. Schwartz, R., et al., Differential Neointimal Response to Coronary Artery Injury 
in Pigs and Dogs. Implications for Resteonosis Models. Arterioscler Thromb Vasc 
Biol, 1994. 14: p. 395-400. 
45. White, C.J., et al., A New Balloon-Expandable Tantalum Coil Stent: Angiographic 
Patency and Histologic Findings in an Atherogenic Swine Model. Journal of the 
American College of Cardiology, 1992. 19(4): p. 870-876. 
46. Grinstead, C.W., et al., Comparison of Three Porcine Restenosis Models: The 
Relative Importance of Hypercholesterolemia, Endothelial Abrasion, and 
Stenting. Coronary Artery Disease, 1994. 5(5). 
47. Rogers, C. and E.R. Edelman, Endovascular Stent Design Dictates Experimental 
Restenosis and Thrombosis. Circulation, 1995. 91: p. 2995-3001. 
48. Brown, G., P. Hughes, and R. Michell, Cell differentiation and proliferation- 
simultaneous but independent? Experimental Cell Research, 2003. 291(2): p. 282-
288. 
49. Sachs, L., Constitutive uncoupling of pathways of gene expression that control 
growth and differentiation in myeloid leukemia: a model for the origin and 
progression of malignancy. Proc. Natl. Acad. Sci., 1980. 77: p. 6152-6156. 
50. Maione, R. and P. Amati, Interdependence between muscle differentiation and 
cell-cycle control. Biochimica et Biophysica Acta, 1997. 1332: p. M19-M30. 
51. Walsh, K. and H. Perlman, Cell cycle exit upon myogenic differentiation. Curr. 
Opin. Genet. Dev., 1997. 7: p. 597-602. 
167 
	  
52. Tamayo, P., D. Slonim, and J. Mesirov, Interpreting patterns of gene expression 
with self-organizing maps: methods and application to hematopoietic 
differentiation. Proc. Natl. Acad. Sci., 1999. 96: p. 2907-2912. 
53. Liu, T.X., J.W. Zhang, and J. Tao, Gene expression networks underlying retinoic 
acid-induced differentiation of acute promyelocytic leukemia cells. Blood, 2000. 
96(1496-1504). 
54. Wever, D.J., et al., Cytotoxic, Allergic and Genotoxic Activity of a Nickel-
Titanium Alloy. Biomaterials, 1997. 18: p. 1115-1120. 
55. Weaver, D.J., et al., Cytotoxic, Allergic and Genotoxic Activity of a Nickel-
Titanium Alloy. Biomaterials, 1997. 18: p. 1115-1120. 
56. Bogdanski, D., et al., Easy Assessment of the Biocompatibility of Ni-Ti alloys by 
in vitro Cell Culture Experiments on a Functionally Graded Ni-NiTi-Ti Material. 
Biomaterials, 2002. 23: p. 4549-4555. 
57. Putters, J., et al., Comparative Cell-Culture Effects of Shape Memory Metal 
(Nitinol(R)), Nickel and Titanium- A Biocompatibility Estimation. European 
Surgical Research, 1992. 24(6): p. 378-382. 
58. Shih, C., et al., The Cytotoxicity of Corrosion Products of Nitinol Stent Wire on 
Cultured Smooth Muscle Cells. Journal of Biomedical Materials Research, 2000. 
52(2): p. 395-403. 
59. Rose, E., I. Jonas, and H. Kappert, In Vitro Investigatin into the Biological 
Assessment of Orthodontic Wires. Journal of Orofacial Orthopedics, 1998. 59: p. 
253-264. 
168 
	  
60. Ryhanen, J., et al., Biocompatability of Nickel-Titanium Shape Memory Metal and 
its Corrosion Behavior in Human Cell Cultures. Journal of Biomedical Materials 
Research, 1996. 35(4): p. 451-457. 
61. Li, Q., et al., Nickel compounds Induce Apoptosis in Human Bronchial Epithelial 
Beas-2B Cells by Activation of c_Myc Through ERK Pathway. Toxicology and 
Applied Pharmacology, 2009. 235: p. 191-198. 
62. Ke, Q., et al., Fluorescent Tracking of Nickel Ions in Human Cultured Cells. 
Toxicology and Applied Pharmacology, 2007. 219: p. 18-23. 
63. Okazaki, Y., et al., Comparison of Metal Concentrations in Rat Tibia Tissues with 
Various Metallic Implants. Biomaterials, 2004. 25: p. 5913-5920. 
64. Liu, D.L., et al., Effects of Molybdenum, Silicon and Nickel on α1-Adrenoceptor-
Induced Contriction of Rat Isolated Aorta. Clinical and Experimental 
Pharmacology and Physiology, 2002. 29: p. 395-398. 
65. Pazzaglia, U., et al., Metal Determination in Organic Fluids of Patients with 
Stainless Steel Hip Arthroplasty. Acta Orthopaedica Scandinavica, 1983. 54: p. 
574-579. 
66. Rahil-Khazen, R., et al., Multi-element analysis of trace element levels in human 
autopsy tissues by using inductively coupled atomic emission spectrometry 
technique (ICP-AES). J Trace Elem Med Biol, 2002. 16(1): p. 15-25. 
67. Rahil-Khazen, R., et al., Validation of inductively coupled plasma atomic 
emission spectrometry technique (ICP-AES) for multi-element analysis of trace 
elements in human serum. Scand J Clin Lab Invest, 2000. 60(8): p. 677-86. 
169 
	  
68. Hennig, F., et al., Nickel-Concentrations, Chrom-Concentrations and Cobalt-
Concentrations in Human Tissue and Body-Fluids of Hip-Prosthesis Patients. 
Journal of Trace Elements and Electrolytes in Health and Disease, 1992. 6: p. 
239-243. 
69. Sunderman, F., et al., Cobalt, Chromium, and Nickel Concentrations in Body 
Fluids of Patients with Porous-Coated Knee or Hip Prosthesis. Journal of 
Orthopedic Research, 1989. 7: p. 307-315. 
70. Wataha, J., et al., Relating Nickel-Induced Tissue Inflammation to Nickel Release 
in vivo. Journal of Biomedical Materials Research, 2001. 58: p. 537-544. 
71. Castro, J., J.C. Spraul, and R.K. Marcus, Metals analysis of botanical products in 
various matrices using a single microwave digestion and inductively coupled 
plasma optical emission spectrometry (ICP-OES) method. Analytical Methods, 
2009. 1: p. 188-194. 
72. Rzucidlo, E., Martin, K., Powell, R., Regulation of Vascular Smooth Muscle Cell 
Differentiation. Journal of Vascular Surgery, 2007. 45(A). 
73. Hasaneen, N., et al., Cyclic Mechanical Strain-Induced Proliferation and 
Migration of Human Airway Smooth Muscle Cells: Role of EMMPRIN and 
MMPs. FASEB J., 2005. 19: p. 1507-1509. 
74. Wilson, E., et al., Mechanical Strain Induces Growth of Vascular Smooth Muscle 
Cells via Autocrine Action of PDGF. The Journal of Cell Biology, 1993. 123(3): 
p. 741-747. 
170 
	  
75. Butcher, J., B. Barrett, and R. Nerem, Equibiaxial Strain Stimulates Fibroblastic 
Phenotype Shift in Smooth Muscle Cells in an Engineered Tissue Model of the 
Aortic Wall. Biomaterials, 2006. 27: p. 5252-5258. 
76. Hu, Y., et al., Activation of PDGF Receptor α in Vascular Smooth Muscle Cells 
by Mechanical Stress. FASEB J., 1998. 12(12): p. 1135-1142. 
77. Mills, I., et al., Strain Activation of Bovine Aortic Smooth Muscle Cell 
Proliferation and Alignment: Study of Strain Dependency and the Role of Protein 
Kinase A and C Signaling Pathways. Journal of Cellular Physiology, 1997. 170: 
p. 228-234. 
78. Haga, J., Y. Li, and S. Chien, Molecular Basis of the Effects of Mechanical 
Stretch on Vascular Smooth Muscle Cells. Cardiovascular and Interventional 
Radiology, 2007. 40: p. 947-960. 
79. Sudhir, K., et al., Mechanical strain and collagen potentiate mitogenic activity of 
angiotensin II in rat vascular smooth muscle cells. J Clin Invest, 1993. 92(6): p. 
3003-7. 
80. Safar, M., et al., Pulsed Doppler: Diameter, Blood Flow Velocity, and Volumic 
Flow of the Brachial Artery in Sustained Essential Hypertension. Circulation, 
1981. 63: p. 393-400. 
81. Webb, M. and S.M. Weinzierl, Uptake of 63 Ni 2+ from its complexes with 
proteins and other ligands by mouse dermal fibroblasts in vitro. Br J Cancer, 
1972. 26(4): p. 292-8. 
171 
	  
82. Heath, J.C. and M. Webb, Content and intracellular distribution of the inducing 
metal in the primary rhabdomyosarcomata induced in the rat by cobalt, nickel 
and cadmium. Br J Cancer, 1967. 21(4): p. 768-79. 
83. DalleDonne, I., et al., The assembly of Ni2+-actin: some peculiarities. Biochim 
Biophys Acta, 1999. 1426(1): p. 32-42. 
84. Li, W., Y. Zhao, and I.N. Chou, Mg2+ antagonism on Ni(2+)-induced changes in 
microtubule assembly and cellular thiol homeostasis. Toxicol Appl Pharmacol, 
1996. 136(1): p. 101-11. 
85. Gunaratnam, M. and M.H. Grant, Damage to F-actin and cell death induced by 
chromium VI and nickel in primary monolayer cultures of rat hepatocytes. 
Toxicol In Vitro, 2004. 18(3): p. 245-53. 
86. Costa, M., et al., Molecular biology of nickel carcinogenesis. Mol Cell Biochem, 
2001. 222(1-2): p. 205-11. 
87. Lee, J.H., et al., Nickel block of three cloned T-type calcium channels: low 
concentrations selectively block alpha1H. Biophys J, 1999. 77(6): p. 3034-42. 
88. Conway, K., et al., Effect of magnesium on nickel-induced genotoxicity and cell 
transformation. Carcinogenesis, 1987. 8(8): p. 1115-21. 
89. Hong, Y.C., et al., Magnesium inhibits nickel-induced genotoxicity and formation 
of reactive oxygen. Environ Health Perspect, 1997. 105(7): p. 744-8. 
90. Lynn, S., F.H. Yew, and K.Y. Jan, Magnesium reduces nickel inhibition of DNA 
polymerization. Biol Trace Elem Res, 1997. 59(1-3): p. 1-11. 
172 
	  
91. Mlinar, B. and J.J. Enyeart, Block of current through T-type calcium channels by 
trivalent metal cations and nickel in neural rat and human cells. The Journal of 
Physiology, 1993. 469: p. 639-652. 
92. Black, J., Biological Performance of Materials: Fundamentals of 
Biocompatability. 4 ed2006: CRC Press. 
93. Shih, C., et al., Increased Corrosion Resistance of Stent Materials by Converting 
Current Surface Film of Polycrystalline Oxide into Amorphous Oxide. Journal of 
Biomedical Materials Research, 2000. 52: p. 323-332. 
94. Fitz, M., C. Tarapata, and J. Wang, Electro-polishing Fixture and Electrolyte 
Solution for Polishing Stents and Method, 2000, Advanced Cardiovascular 
Systems, Inc.: USA. 
95. Browne, M. and P. Gregson, Surface Modification of Titanium Alloy Implants. 
Biomaterials, 1994. 15(11): p. 894-898. 
96. O'Brien, B., W. Carroll, and M. Kelly, Passivation of Nitinol Wire for Vascular 
Implants- a Demonstration of the Benefits. Biomaterials, 2002. 23: p. 1739-1748. 
97. Shih, C., et al., Growth Inhibition of Cultured Smooth Muscle Cells by Corrosion 
Products of 316L Stainless Steel Wire. Journal of Biomedical Materials Research, 
2001. 57(2): p. 200-207. 
98. Shi, H., L.G. Hudson, and K.J. Liu, Oxidative stress and apoptosis in metal ion-
induced carcinogenesis. Free Radic Biol Med, 2004. 37(5): p. 582-93. 
99. Carlisle, D.L., et al., Chromium(VI) induces p53-dependent apoptosis in diploid 
human lung and mouse dermal fibroblasts. Mol Carcinog, 2000. 28(2): p. 111-8. 
173 
	  
100. Blankenship, L.J., et al., Apoptosis is the mode of cell death caused by 
carcinogenic chromium. Toxicol Appl Pharmacol, 1994. 126: p. 75-83. 
101. Acampora, K.B., et al., Increased synthetic phenotype behavior of smooth muscle 
cells in response to in vitro balloon angioplasty injury model. Ann Vasc Surg, 
2010. 24(1): p. 116-26. 
102. Acampora, K., et al., Development of a Novel Vascular Simulator and Injury 
Model to Evaluate Smooth Muscle Cell Response Following Balloon Angioplasty. 
Annals of Vascular Surgery, 2007. 21(6): p. 734-41. 
103. Teneja, V., Influence of Topography of Endovascular Stent Material on Smooth 
Muscle Cell Response, in Department of Bioengineering2010, Clemson 
University: Clemson. 
104. Mazumder, M.M., et al., Corrosion Resistance of Polyurethane-Coated Nitinol 
Cardiovascular Stents. J. Biomater. Sci. Polymer Edn, 2003. 14(12): p. 1351-
1362. 
105. Billinger, M., et al., Polymer Stent Coating for Prevention of Neointimal 
Hyperplasia. Journal of Invasive Cardiology, 2006. 18(9): p. 423-6. 
106. Van Der Giessen, W., et al., Marked Inflammatory Sequelae to Implantation of 
Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries. 
Circulation, 1996. 94: p. 1690-1697. 
107. van der Hoeven, B., et al., Drug-Eluting Stents: Results, Promises, and Problems. 
International Journal of Cardiology, 2005. 99: p. 9-17. 
108. Summary of Safety and Effectiveness: Taxus Express Stent, FDA, Editor 2004. 
174 
	  
109. Guo, Q., S. Guo, and Z. Wang, Estimation of 5-Fluorouracil-Loaded Ethylene-
Vinyl Acetate Stent Coating Based on Percolation Thresholds. International 
Journal of Pharmaceutics, 2007. 333(1-2): p. 95-102. 
110. Cheng, P., et al., Ethoxyethyl Methacrylate-Based Copolymers- A novel Platform 
for Drug-Eluting Stent Coatings. Journal of Controlled Release, 2006. 116(2): p. 
e92-e94. 
111. Summary of Safety and Effectiveness Data Sheet: Endeavor Stent, FDA, Editor 
2008. 
112. Summary of Safety and Effectiveness Data: Cypher Stent, FDA, Editor 2003. 
113. Lincoff, A., et al., Sustained Local Delivery of Dexamethasone by a Novel 
Intravascular Eluting Stent to Prevent Restenosis in the Porcine Coronary Injury 
Model. Journal of the American College of Cardiology, 1997. 29(4): p. 808-816. 
114. Amon, M., et al. Coating of Cardiovascular Stents with Amorphous Silicon 
Carbide to Reduce Thrombogenicity. in Proceedings of the 16th Annual 
International Conference of the IEEE. 1994. Baltimore, MD, USA: Institute of 
Electrical and Electronics Engineers. 
115. Unverdorben, M., et al., Comparison of a Silicon Carbide Coated Stent Versus a 
Noncoated Stent in Humans: The Tenax- Versus Nir- Stent Study (TENISS). 
Journal of Interventional Cardiology, 2003. 16: p. 325-333. 
116. Unverdorben, M., et al., Comparison of a Silicon Carbide-Coated Stent Versus a 
Noncoated Stent in Human Beings: The Tenax Versus Nir Stent Study's Long-
Term Outcome. American Heart Journal, 2003. 145(4). 
175 
	  
117. Auclair-Daigle, C., et al., Bioactive hydroxyapatite coatings on polymer 
composites for orthopedic implants. J Biomed Mater Res A, 2005. 73(4): p. 398-
408. 
118. Rajtar, A., et al., Hydroxyapatite-coated cardiovascular stents. EuroIntervention, 
2006. 2(1): p. 113-5. 
119. van der Giessen, W.J., et al., Lowering the dose of sirolimus, released from a 
nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed 
healing. JACC Cardiovasc Interv, 2009. 2(4): p. 284-90. 
120. Costa, J.R., Jr., et al., Preliminary results of the hydroxyapatite nonpolymer-based 
sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-
in-human analysis of a third-generation drug-eluting stent system. JACC 
Cardiovasc Interv, 2008. 1(5): p. 545-51. 
121. Luscher, T.F., et al., Drug-eluting stent and coronary thrombosis: biological 
mechanisms and clinical implications. Circulation, 2007. 115(8): p. 1051-8. 
122. Jiang, H.C. and L.J. Rong, Effect of hydroxyapatite coating on nickel release of 
the porous NiTi shape memory alloy fabricated by SHS method. Surface & 
Coatings Technology, 2006. 201: p. 1017-1021. 
123. Sousa, S.R. and M.A. Barbosa, Effect of hydroxyapatite thickness on metal ion 
release from Ti6Al4V substrates. Biomaterials, 1996. 17(4): p. 397-404. 
124. Ozeki, K., et al., Inhibition of Ni release from NiTi alloy by hydroxyapatite, 
alumina, and titanium sputtered coatings. Biomed Mater Eng, 2003. 13(3): p. 
271-9. 
176 
	  
125. Nadra, I., et al., Effect of particle size on hydroxyapatite crystal-induced tumor 
necrosis factor alpha secretion by macrophages. Atherosclerosis, 2008. 196(1): p. 
98-105. 
126. Lin, L., K.L. Chow, and Y. Leng, Study of hydroxyapatite osteoinductivity with an 
osteogenic differentiation of mesenchymal stem cells. J Biomed Mater Res A, 
2009. 89(2): p. 326-35. 
127. Sun, H., et al., The upregulation of osteoblast marker genes in mesenchymal stem 
cells prove the osteoinductivity of hydroxyapatite/tricalcium phosphate 
biomaterial. Transplant Proc, 2008. 40(8): p. 2645-8. 
128. Ripamonti, U., Osteoinduction in porous hydroxyapatite implanted in heterotopic 
sites of different animal models. Biomaterials, 1996. 17(1): p. 31-5. 
129. Yamasaki, H. and H. Sakai, Osteogenic response to porous hydroxyapatite 
ceramics under the skin of dogs. Biomaterials, 1992. 13(5): p. 308-12. 
130. Yuan, H., et al., Osteoinduction by calcium phosphate biomaterials. J Mater Sci 
Mater Med, 1998. 9(12): p. 723-6. 
131. Le Nihouannen, D., et al., Ectopic bone formation by microporous calcium 
phosphate ceramic particles in sheep muscles. Bone, 2005. 36(6): p. 1086-93. 
132. Yuan, H., et al., A preliminary study on osteoinduction of two kinds of calcium 
phosphate ceramics. Biomaterials, 1999. 20(19): p. 1799-806. 
133. Groot, K.D., Carriers That Concentrate Native Bone Morphogenetic Protein In 
Vivo. Tissue Engineering, 1998. 4(4): p. 337-341. 
177 
	  
134. Kuznetsov, S.A., et al., Circulating skeletal stem cells. J Cell Biol, 2001. 153(5): 
p. 1133-40. 
135. Yuan, H., et al., Bone morphogenetic protein and ceramic-induced osteogenesis. J 
Mater Sci Mater Med, 1998. 9(12): p. 717-21. 
136. Daculsi, G., et al., Formation of carbonate-apatite crystals after implantation of 
calcium phosphate ceramics. Calcif Tissue Int, 1990. 46(1): p. 20-7. 
137. Barrere, F., et al., Osteogenecity of octacalcium phosphate coatings applied on 
porous metal implants. J Biomed Mater Res A, 2003. 66(4): p. 779-88. 
138. Reynolds, J.L., et al., Human vascular smooth muscle cells undergo vesicle-
mediated calcification in response to changes in extracellular calcium and 
phosphate concentrations: a potential mechanism for accelerated vascular 
calcification in ESRD. J Am Soc Nephrol, 2004. 15(11): p. 2857-67. 
139. Jono, S., et al., Phosphate regulation of vascular smooth muscle cell calcification. 
Circ Res, 2000. 87(7): p. E10-7. 
140. Narisawa, S., et al., Novel inhibitors of alkaline phosphatase suppress vascular 
smooth muscle cell calcification. Journal of Bone and Mineral Research, 2007. 
22(11): p. 1700-1710. 
141. Golub, E.E. and K. Boesze-Battaglia, The role of alkaline phosphatase in 
mineralization. Current Opinions in Orthopaedics, 2007. 18: p. 444-448. 
142. Hipper, A. and G. Isenberg, Cyclic Mechanical Strain Decreases the DNA 
Synthesis of Vascular Smooth Muscle Cells. Pflugers Archiv European Journal of 
Physiology, 2000. 440(1): p. 19-27. 
178 
	  
143. Atherosclerosis and Coronary Artery Disease, ed. V. Fuster, R. Ross, and E. 
Topol. Vol. 1. 1996: Lippincott-Raven. 
144. Moore, J., et al., A Device for Subjecting Vascular Endothelial Cells to Both Fluid 
Shear Stress and Circumferential Cyclic Stretch. Annals of Biomedical 
Engineering, 1994. 22: p. 416-422. 
145. Brendel, T., A. Engel, and C. Russel, Hydroxyapatite coatings by a polymeric 
route. Journal of Materials Science-Materials in Medicine, 1992. 3(3): p. 175-179. 
146. Moroni, A., et al., Improvement of the Bone-Pin Interface with Hydroxyapatite 
Coating: An In Vivo Long-Term Experimental Study. Journal of Othopaedic 
Trauma, 1996. 10(4): p. 236-242. 
147. Wada, T., et al., Calcification of Vascular Smooth Muscle Cell Cultures: 
Inhibition by Osteopontin. Circulation Research, 1999. 84: p. 166-178. 
148. Ikeda, T., et al., Osteopontin mRNA is expressed by smooth muscle-derived foam 
cells in human atherosclerotic lesions of the aorta. J Clin Invest, 1993. 92(6): p. 
2814-2820. 
149. Ainsworth, S., Modeling of Artery Restenosis Influenced by Endovascular Stent 
Geometry, in Department of Bioengineering1999, Clemson University: Clemson. 
150. Gorbunoff, M.J. and S.N. Timasheff, The interaction of proteins with 
hydroxyapatite: III. Mechanism. Analytical Biochemistry, 1984. 136(2): p. 440-
445. 
179 
	  
151. Arimura, S.-I., et al., Hydroxyapatite formed on/in agarose gel induces activation 
of blood coagulation and platelets aggregation. Journal of Biomedical Materials 
Research, 2007. 81B(2): p. 456-461. 
152. Kilpadi, K.L., P.-L. Chang, and S.L. Bellis, Hydroxyapatite binds more serum 
proteins, purified integrins, and osteoblast precursor cells than titanium or steel. 
Journal of Biomedical Materials Research Part A, 2001. 57(2): p. 258-267. 
153. Scanlon, V., Essentials of Anatomy and Physiology. 5 ed2007: F.A. Davis Co. 
154. Atherosclerosis: Gene expression , cell interactions, and oxidation, ed. R. Dean 
and D. Kelly2000: Oxford University Press. 
155. Majno, G., Joris, I., Cells, Tissues, and Disease. 2 ed2004: Oxford University 
Press. 
156. Sartore, S., et al., Contribution of Adventitial Fibroblasts to Neointima Formation 
and Vascular Remodeling: From Innocent Bystander to Active Participant. 
Circulation Research, 2001. 89(12): p. 1111-1121. 
157. Halayko, A., Solway, J., Molecular Mechanisms of Phenotypic Plasticity in 
Smooth Muscle Cells. Journal of Applied Physiology, 2001. 90(1): p. 358-368. 
158. Chamley-Campbell, J., Campbell, G., Ross, R., The Smooth Muscle Cell in 
Culture. Physiological Reviews, 1979. 59(1). 
159. Owens, G., Regulation of Differentiation of Vascular Smooth Muscle Cells. 
Physiological Reviews, 1995. 75(3): p. 487-517. 
180 
	  
160. Jones, B., et al., Phenotypic Characterization of Human Smooth Muscle Cells 
Derived From Atherosclerotic Tibial and Peroneal Arteries. Journal of Vascular 
Surgery, 1996. 24: p. 883-91. 
161. Glukhova, M., et al., Modulation of Human Aorta Smooth Muscle Cell 
Phenotype: A Study of Muscle-Specific Variants of Vinculin, Caldesmon, and 
Actin Expression. Proc. Natl. Acad. Sci. USA, 1988. 85: p. 9542-9546. 
162. Thyberg, J., et al., Regulation of Differentiated Properties and Proliferation of 
Arterial Smooth Muscle Cells. Arteriosclerosis, Thrombosis, and Vascular 
Biology, 1990. 10(6): p. 966-989. 
163. Lipids and Atherosclerosis. Advances in Translational Medical Science, ed. C. 
Packard and D. Rader2006: Taylor & Francis. 
164. Napoli, C., et al., Fatty Streak Formation Occurs in Human Fetal Aortas and is 
Greatly Enhanced by Maternal Hypercholesterolemia- Intimal Accumulation of 
Low Density Lipoprotein and its Oxidation Precede Monocyte Recruitment into 
Early Atherosclerotic Lesions. Journal of Clinical Investigation, 1997. 100(11): p. 
2680. 
165. Stary, H., Composition and Classification of Human Atherosclerotic Lesions. 
Virchows Archiv A Pathological Anatomy and Histopathology, 1992. 421: p. 
277-290. 
166. Waddington, E., et al., Fatty Acid Oxidation Products in Human Atherosclerotic 
Plaque: an Analysis of Clinical and Histopathological Correlates. 
Atherosclerosis, 2003. 167: p. 111-120. 
181 
	  
167. Hirsch, A., et al., Peripheral Arterial Disease Detection, Awareness, and 
Treatment in Primary Care. Journal of the American Medical Association, 2001. 
286(11): p. 1317-1324. 
168. Taber's Cyclopedic Medical Dictionary. 20 ed., ed. D. Venes2001, F. A. Davis 
Company: Philadelphia. 
169. Tafreshi, M., Medical Management of Peripheral Arterial Disease, in Pharmacy 
Times, Bristol-Myers Squibb. 
170. Stein, R., et al., Limitations of the Resting Ankle-Brachial Index in Symptomatic 
Patients with Peripheral Arterial Disease. Vascular Medicine, 2006. 11: p. 29-33. 
171. Kohler, T., et al., Duplex Scanning for Diagnosis of Aortoiliac and 
Femoropopliteal Disease: A Prospective Study. Circulation, 1987. 76(5): p. 1074. 
172. Killewich, L., et al., Diagnosis of Deep Venous Thrombosis: A Prospective Study 
Comparing Duplex Scanning to Contrast Venography. Circulation, 1989. 79(4): 
p. 810. 
173. Kim , Y., et al., Coronary Magnetic Resonance Angiography for the Detection of 
Coronary Stenosis. The New England Journal of Medicine, 2001. 345(26). 
174. Grote, K., et al., Stretch-inducible Expression of the Angiogenic Factor CCN1 in 
Vascular Smooth Muscle Cells in Mediated by Egr-1. The Journal of Biological 
Chemistry, 2004. 279(53): p. 55675-55681. 
175. Brown, T., Techniques for Mechanical Stimulation of Cells in vitro: a Review 
Journal of Biomechanics, 2000. 33: p. 3-14. 
182 
	  
176. Chapman, G., et al., Physiological Cyclic Stretch Causes Cell Cycle Arrest in 
Cultured Vascular Smooth Muscle Cells. Am. J. Physiol. Heart Circ. Physiol., 
2000. 278: p. H748-H754. 
177. Grenier, G., et al., Mechanical Loading Modulates the Differentiation State of 
Vascular Smooth Muscle Cells. Tissue Engineering, 2006. 12(11). 
178. Schulze, P., et al., Biomechanically Induced Gene iex-1 Inhibitis Vascular Smooth 
Muscle Cell Proliferation and Neointima Formation. Circulation Research, 2003. 
93: p. 1210-1217. 
179. Sudir, K., et al., Mechanical Strain and Collagen Potentiate Mitogenic Activity of 
Angiotensin II in Rat Vascular Smooth Muscle Cells. Journal of Clinical 
Investigation, 1993. 92: p. 3003-3007. 
180. Safar, M.E., et al., Pulsed doppler: diameter, blood flow velocity, and volumic 
flow of the brachial artery in sustained essential hypertension. Circulation, 1981. 
63: p. 393-400. 
181. Punchard, M.A., et al., Evaluation of Human Endothelial Cells Post Stent 
Deployment in a Cardiovascular Simulator In Vitro. Annals of Biomedical 
Engineering, 2009. 37(7): p. 1322-1330. 
182. Lin, K., et al., Molecular Mechanism of Endothelial Growth Arrest by Laminar 
Shear Stress. Proc. Natl. Acad. Sci. USA, 2000. 97: p. 9385-9389. 
183. Levine, A.J., p53, the Cellular Gatekeeper for Growth and Division. Cell, 1997. 
88(3): p. 323-331. 
183 
	  
184. Akimoto, S., et al., Laminar Shear Stress Inhibits Vascular Endothelial Cell 
Proliferation by Inducing Cyclin-Dependent Kinase Inhibitor p21 
Sdi1/Cip1/Waf1. Circulation Research, 2000. 86: p. 185-190. 
185. Asada, H., et al., Sustained Orbital Shear Stress Stimulates Smooth Muscle Cell 
Proliferation via the Extracellular Signal-Regulated Protein Kinase 1/2 Pathway. 
Journal of Vascular Surgery, 2005. 42: p. 772-80. 
186. Haga, M., et al., Oscillatory Shear Stress Increases Smooth Muscle Cell 
Proliferation and Akt Phosphorylation. J Vasc Surg, 2003. 37: p. 1277-84. 
187. Qi, Y.-X., et al., Rho-GDP dissociation inhibitor alpha downregulated by low 
shear stress promotes vascular smooth muscle cell migration and apoptosis: a 
proteomic analysis. Cardiovascular Research, 2008. 80: p. 114-122. 
188. Ueba, H., M. Kawakami, and T. Yaginuma, Shear Stress as an Inhibitor of 
Vascular Smooth Muscle Cell Proliferation. Arteriosclerosis, Thrombosis, and 
Vascular Biology, 1997. 17: p. 1512-1516. 
189. Papadaki, M., S. Eskin, and L. McIntire, Flow Modulation of Smooth Muscle 
Cells (SMC) Proliferation and Metabolism. Cardiovascular Pathology, 1996. 5(5). 
190. Walsh, P., et al. Morphological Response of Endothelial Cells to Combined 
Pulsatile Shear Stress Plus Cyclic Stretch. in BMES/EMBS Joint Conference: 
Serving Humanity, Advancing Technology. 1999. Atlanta, GA, USA. 
191. Moreno, M., et al. Combined Effects of Pulsatile Shear Stress and Pressure 
Driven Cyclic Strain on Protein Expression by the Isolated Endothelium. in 
184 
	  
Summer Bioengineering Conference. 2003. Sonesta Beach Resort, Key Biscayne, 
Florida. 
192. Zhao, S., et al., Synergistic Effects of Fluid Shear Stress and Cyclic 
Circumferential Stretch on Vascular Endothelial Cell Morphology and 
Cytoskeleton. Arteriosclerosis, Thrombosis, and Vascular Biology, 1995. 15: p. 
1781-1786. 
193. Punchard, M.A., et al., Endothelial cell response to biomechanical forces under 
simulated vascular loading conditions. Journal of Biomechanics, 2007. 40: p. 
3146-3154. 
194. Acampora, K.B., et al., Increased Synthetic Phenotype Behavior of Smooth 
Muscle Cells in Response to In Vitro Balloon Angioplasty Injury Model. Annals 
of Vascular Surgery, 2010. 24(1): p. 116-126. 
195. Acampora, K., et al., Increased synthetic phenotype behavior of smooth muscle 
cells in response to in vitro balloon angioplasty injury model. Annals of Vascular 
Surgery, 2009. 24(1): p. 116-126. 
196. Marcum, J., C. Reilly, and R. Rosenberg, The role of specific forms of heparin 
sulfate in regulating blood vessel wall function. Prog Hemost Thromb, 1986. 8: p. 
185-215. 
197. Clowes, A.W. and M.J. Karnowsky, Suppression by heparin of smooth muscle 
cell proliferation in injured arteries. Nature, 1977. 265: p. 625-626. 
185 
	  
198. Hirsh, J., et al., Heparin and low-molecular-weight heparin: mechanisms of 
action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest, 2001. 
119: p. 64S-94-S. 
199. Fasciano, S., et al., Regulation of Vascular Smooth Muscle Proliferation by 
Heparin. The Journal of Biological Chemistry, 2005. 280(16): p. 15682-15689. 
200. Reilly, C., et al., Heparin prevents vascular smooth muscle cell progression 
through the G1 phase of the cell cycle. J Biol Chem, 1989. 264: p. 6990-6995. 
201. Castellot, J., D. Cochran, and M. Karnovsky, Effect of heparin on vascular 
smooth muscle cells. I. Cell metabolism. Journal of Cellular Physiology, 1985. 
124: p. 21-28. 
202. Clowes, A. and M. Karnowsky, Suppression by heparin of smooth muscle cell 
proliferation in injured artieries. Nature, 1977. 265: p. 625-626. 
203. Siqueira, D., et al., Late Incomplete Apposition After Drug-Eluting Stent 
Implantation: Incidence and Potential for Adverse Clinical Outcomes. European 
Heart Journal, 2007. 28(11): p. 1304-9. 
204. Ong, A., et al., Late Angiographic Stent Thrombosis (LAST) Events With Drug-
Eluting Stents. Journal of the American College of Cardiology, 2005. 45(12): p. 
2088-2092. 
205. Marx, S. and A. Marks, Bench to Bedside: The Development of Rapamycin and 
Its Application to Stent Restenosis. Circulation, 2001. 104: p. 852-855. 
186 
	  
206. Colombo, A., et al., Preliminary Observations Regarding Angiographic Pattern 
of Restonsis After Rapamycin-Eluting Stent Implantation. Circulation, 2003. 107: 
p. 2178-2180. 
207. Miyazawa, A., et al., Analysis of Bifurcation Lesions Treated with Novel Drug-
Eluting Dedicated Bifurcation Stent System: Intravascular Ultrasound Results of 
the AXXESS PLUS Trial. Catheter Cardiovasc Interv, 2007. 70(7): p. 952-57. 
208. Costa, R., et al., Angiographic Results of the First Human Experience with the 
Biolimus A9 Drug-Eluting Stent for De Novo Coronary Lesions. The Americal 
Journal of Cardiology, 2006. 98(4): p. 443-446. 
209. Sternberg, K., et al., In Vitro Study of Drug-Eluting Stent Coatings Based on 
Poly(L-lactide) Incorporating Cyclosporine A Drug Release, Polymer 
Degradation and Mechanical Integrity. Journal of Materials Science. Materials in 
Medicine, 2007. 18(7): p. 1423-32. 
210. Honda, H., et al., Use of Everolimus-Eluting Stent with a Bioresorbable Polymer 
Coating for Treatment of Recurrent In-Stent Restenosis. Journal of Invasive 
Cardiology, 2005. 17(2): p. 112-5. 
211. Serruys, P., et al., A Randomized Comparison of a Durable Polymer Everolimus-
Eluting Stent with a Bare Metal Coronary Stent: The SPIRIT First Trial. 
EuroIntervention, 2005. 1(1): p. 58-65. 
212. Ormiston, J., et al., A Bioabsorbable Everolimus-Eluting Coronary Stent System 
for Patients with Single De-Novo Coronary Artery Lesions (ABSORB): A 
Prospective Open-Lable Trial. The Lancet, 2008. 371(9616): p. 899-907. 
187 
	  
213. Huang, Y., et al., Optimization of Local Methylprednisolone Delivery to Inhibit 
Inflammatory Reaction and Neointimal Hyperplasia of Coated Coronary Stents. 
Journal of Invasive Cardiology, 2002. 14(9): p. 505-13. 
214. Wang, L., et al., Stent-Mediated Methylprednisolone Delivery Reduces 
Macrophage Contents and In-Stent Neointimal Formation. Coronary Artery 
Disease, 2005. 16(4): p. 237-243. 
215. Park, S. and A. Lincoff, Anti-Inflammatory Stent Coatings: Dexamethasone and 
Related Compounds. Seminars in Interventional Cardiology, 1998. 3(3-4): p. 191-
195. 
216. Bavry, A. and D. Bhatt, Appropriate use of Drug-Eluting Stents: Balancing the 
Reduction in Restenosis with the Concern of Late Thrombosis. The Lancet, 2008. 
371(9630): p. 2134-2143. 
217. Wu, L., et al., Zolendronate inhibits the proliferation, adhesion, and migration of 
vascular smooth muscle cells. European Journal of Pharmacology, 2009. 602(1): 
p. 124-131. 
218. Guzeloglu, M., et al., The effects of zoledronic acid on neointimal hyperplasia: a 
rabbit carotid anastomosis model. The Anatolian Journal of Cardiology, 2011. 
11(2): p. 93-100. 
219. Wu, L., et al., Zoledronate Inhibits Intimal Hyperplasia in Balloon-injured Rat 
Carotid Artery. European Journal of Vascular and Endovascular Surgery, 2011. 
41(2): p. 288-293. 
188 
	  
220. Ylitalo, R., Bisphosphonates and Atherosclerosis. General Phamacology, 2002. 
35(6): p. 287-296. 
221. Rodan, G. and A. Reszka, Bisphosphonate Mechanism of Action. Current 
Molecular Medicine, 2002. 2(6): p. 571-577. 
222. Frith, J. and M. Rogers, Antagonistic effects of different classes of 
bisphosphonates in osteoclasts and macrophages in vitro. Journal of Bone and 
Mineral Research, 2003. 18(2): p. 204-212. 
223. Drake, M., B. Clarke, and S. Khosla, Bisphosphonates: Mechanism of Action and 
Role in Clinical Practice. Mayo Clinic Proceedings, 2008. 83(9): p. 1032-1045. 
224. Ylitalo, R., Bisphosphonates and atherosclerosis. General Phamacology: The 
Vascular System, 2000. 35(6): p. 287-296. 
225. Rosenblum, I., L. Flora, and R. Eisenstein, The effect of disodium ethane-1-
hydroxy-1, 1-diphosphonate (EDHP) on a rabbit model of athero-arteriosclerosis. 
Atherosclerosis, 1975. 22: p. 411-424. 
226. Danenberg, H.D., et al., Liposomal Alendronate Inhibits Systemic Innate 
Immunity and Reduces In-Stent Neointimal Hyperplasia in Rabbits. Circulation, 
2003. 108: p. 2798-2804. 
227. Fleisch, H., Bisphosphonates. Pharmacology and use in the treatment of tumor-
induced hypercalcaemic and metastatic bone diseases. Drugs, 1991. 42: p. 919-
944. 
189 
	  
228. Khan, S., et al., Elimination and biochemical responses to intravenous 
alendronate in postmenopausal osteoporosis. Journal of Bone Mineralization 
Research, 1997. 12: p. 1700-1707. 
229. Hollander, W., et al., Influence of the articalcifying agen, ethane-1-hydroxy-1, 1-
diphosphate (EHDP) on pre-established atheroma in rabbits. Circulation, 1974. 
50. 
230. Hollander, W., et al., Effects of anticalcifying and antifibrotic drugs on pre-
established atherosclerosis in the rabbit. Atherosclerosis, 1979. 33: p. 111-123. 
231. Kramsch, D. and C. Chan, The effect of agent interfering with soft tissue 
calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits. 
Circulation Research, 1978. 42: p. 562-571. 
232. Hollander, W., et al., Comparative effects of cetaben (PHB) and 
dichloromethylene diphosphonate (Cl2MDP) on the development of 
atherosclerosis in the cynomolgus monkey. Atherosclerosis, 1978. 31: p. 307-325. 
233. Kramsch, D., A. Aspen, and L. Rozler, Atherosclerosis: prevention by agents not 
affecting abnormal levels of blood lipids. Science, 1981. 213: p. 1511-1512. 
234. Daoud, A., et al., The effect of ethane-1-hydroxy-1, 1-diphosphonate (EHDP) on 
necrosis of atherosclerotic lesions. Atherosclerosis, 1987. 67: p. 41-48. 
235. Ylitalo, R., et al., Effects of clodronate (dichloro-methylene diphosphate) on the 
development of experimental atherosclerosis in rabbits. J. Lab. Clin. Med., 1994. 
123: p. 769-776. 
190 
	  
236. Han, Y. and X. Qin, Determination of alendronate sodium by ion 
chromatography with refractive index detection. Journal of Chromatography A, 
1996. 719(2): p. 345-352. 
237. Cornelio, R., et al., Quantification of Sodium Alendronate by LC Anion Exchange 
Using In Line Complexion. Journal of Liquid Chromatography & Related 
Technologies, 2009. 32(19): p. 2857-2865. 
238. Wakchoure, S., et al., Bisphosphonates Inhibit the Growth of Mesothelioma Cells 
In vitro and In vivo. Clinical Cancer Research, 2006. 12: p. 2862. 
239. Merrell, M., et al., Bisphosphonate induced growth inhibition of breast cancer 
cells is augmented by p38 inhibition. Breast Concer Res Treat, 2003. 81: p. 231-
241. 
240. Cohen, L.H., et al., Inhibitors of Prenylation of Ras and Other G-proteins and 
Their Application as Therapeutics. Biochemical Pharmacology, 2000. 60: p. 
1061-1068. 
241. Schieffer, B., et al., G protein-coupled receptors control vascular smooth muscle 
cell proliferation via pp60c-src and p21 ras. American Journal of Physiology Cell 
Physiology, 1997. 272(6): p. C2019-C2030. 
242. Krymshaya, V., et al., Mechanisms of proliferation synergy by receptor tyrosine 
kinase and G protein-coupled receptor activation in human airway smooth 
muscle. Am J Respir Cell Mol Biol, 2000. 23(4): p. 546-554. 
243. Laccarino, G., et al., Targeting Gβγ signaling in arterial vascular smooth muscle 
proliferation: A novel strategy to limit restenosis. Proceedings of the National 
191 
	  
Acadamy of Sciences of the United States of America (PNAS), 1999. 96(7): p. 
3945-3950. 
244. Chen, G.-P., et al., Chronic inhibition of farnesyl pyrophosphate synthase 
improves endothelial function in spontaneously hypertensive rats. Biochemical 
Pharmacology, 2010. 80(11): p. 1684-1689. 
245. Buerke, M., et al., Intramural delivery of Sirolimus prevents vascular remodeling 
following balloon injury. Biochimica et Biophysica Acta (BBA)- Proteins & 
Proteomics, 2007. 1774(1): p. 5-15. 
246. Axel, D.I., et al., Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation 
and Migration In Vitro and In Vivo Using Local Drug Delivery. Circulation, 
1997. 96: p. 636-645. 
 
 
